#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Transdiagnostic multimodal neuroimaging in psychosis: structural, resting-state, and task MRI correlates of cognitive control
#Text=Background:
#Text=Disorders with psychotic features, including schizophrenia and some bipolar disorder, are associated with impairments in regulation of goal-directed behavior, termed cognitive control.
1-1	0-15	Transdiagnostic	_	
1-2	16-26	multimodal	_	
1-3	27-39	neuroimaging	_	
1-4	40-42	in	_	
1-5	43-52	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
1-6	52-53	:	_	
1-7	54-64	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging	
1-8	64-65	,	_	
1-9	66-79	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
1-10	79-80	,	_	
1-11	81-84	and	_	
1-12	85-89	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[1]	
1-13	90-93	MRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[1]	
1-14	94-104	correlates	_	
1-15	105-107	of	_	
1-16	108-117	cognitive	_	
1-17	118-125	control	_	
1-18	126-136	Background	_	
1-19	136-137	:	_	
1-20	138-147	Disorders	_	
1-21	148-152	with	_	
1-22	153-162	psychotic	_	
1-23	163-171	features	_	
1-24	171-172	,	_	
1-25	173-182	including	_	
1-26	183-196	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-27	197-200	and	_	
1-28	201-205	some	_	
1-29	206-213	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-30	214-222	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-31	222-223	,	_	
1-32	224-227	are	_	
1-33	228-238	associated	_	
1-34	239-243	with	_	
1-35	244-255	impairments	_	
1-36	256-258	in	_	
1-37	259-269	regulation	_	
1-38	270-272	of	_	
1-39	273-286	goal-directed	_	
1-40	287-295	behavior	_	
1-41	295-296	,	_	
1-42	297-303	termed	_	
1-43	304-313	cognitive	_	
1-44	314-321	control	_	
1-45	321-322	.	_	

#Text=Cognitive control related neural alterations have been studied in psychosis.
2-1	323-332	Cognitive	_	
2-2	333-340	control	_	
2-3	341-348	related	_	
2-4	349-355	neural	_	
2-5	356-367	alterations	_	
2-6	368-372	have	_	
2-7	373-377	been	_	
2-8	378-385	studied	_	
2-9	386-388	in	_	
2-10	389-398	psychosis	_	
2-11	398-399	.	_	

#Text=However, studies are typically unimodal and relationships across modalities of brain function and structure remain unclear.
3-1	400-407	However	_	
3-2	407-408	,	_	
3-3	409-416	studies	_	
3-4	417-420	are	_	
3-5	421-430	typically	_	
3-6	431-439	unimodal	_	
3-7	440-443	and	_	
3-8	444-457	relationships	_	
3-9	458-464	across	_	
3-10	465-475	modalities	_	
3-11	476-478	of	_	
3-12	479-484	brain	_	
3-13	485-493	function	_	
3-14	494-497	and	_	
3-15	498-507	structure	_	
3-16	508-514	remain	_	
3-17	515-522	unclear	_	
3-18	522-523	.	_	

#Text=Thus, we performed transdiagnostic multimodal analyses to examine cognitive control related neural variation in psychosis.
4-1	524-528	Thus	_	
4-2	528-529	,	_	
4-3	530-532	we	_	
4-4	533-542	performed	_	
4-5	543-558	transdiagnostic	_	
4-6	559-569	multimodal	_	
4-7	570-578	analyses	_	
4-8	579-581	to	_	
4-9	582-589	examine	_	
4-10	590-599	cognitive	_	
4-11	600-607	control	_	
4-12	608-615	related	_	
4-13	616-622	neural	_	
4-14	623-632	variation	_	
4-15	633-635	in	_	
4-16	636-645	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
4-17	645-646	.	_	

#Text=Methods:
#Text=Structural, resting, and working memory task imaging for 31 controls, 27 bipolar, and 23 schizophrenia patients were collected and processed identically to the Human Connectome Project (HCP), enabling identification of relationships with prior multimodal work.
5-1	647-654	Methods	_	
5-2	654-655	:	_	
5-3	656-666	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging	
5-4	666-667	,	_	
5-5	668-675	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
5-6	675-676	,	_	
5-7	677-680	and	_	
5-8	681-688	working	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[3]	
5-9	689-695	memory	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[3]	
5-10	696-700	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[3]	
5-11	701-708	imaging	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[3]	
5-12	709-712	for	_	
5-13	713-715	31	_	
5-14	716-724	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
5-15	724-725	,	_	
5-16	726-728	27	_	
5-17	729-736	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder	
5-18	736-737	,	_	
5-19	738-741	and	_	
5-20	742-744	23	_	
5-21	745-758	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
5-22	759-767	patients	_	
5-23	768-772	were	_	
5-24	773-782	collected	_	
5-25	783-786	and	_	
5-26	787-796	processed	_	
5-27	797-808	identically	_	
5-28	809-811	to	_	
5-29	812-815	the	_	
5-30	816-821	Human	_	
5-31	822-832	Connectome	_	
5-32	833-840	Project	_	
5-33	841-842	(	_	
5-34	842-845	HCP	_	
5-35	845-846	)	_	
5-36	846-847	,	_	
5-37	848-856	enabling	_	
5-38	857-871	identification	_	
5-39	872-874	of	_	
5-40	875-888	relationships	_	
5-41	889-893	with	_	
5-42	894-899	prior	_	
5-43	900-910	multimodal	_	
5-44	911-915	work	_	
5-45	915-916	.	_	

#Text=Two cognitive control related independent components (ICs) derived from the HCP using multiset canonical correlation analysis + joint independent component analysis (mCCA+jICA) were used to predict performance in psychosis.
6-1	917-920	Two	_	
6-2	921-930	cognitive	_	
6-3	931-938	control	_	
6-4	939-946	related	_	
6-5	947-958	independent	_	
6-6	959-969	components	_	
6-7	970-971	(	_	
6-8	971-974	ICs	_	
6-9	974-975	)	_	
6-10	976-983	derived	_	
6-11	984-988	from	_	
6-12	989-992	the	_	
6-13	993-996	HCP	_	
6-14	997-1002	using	_	
6-15	1003-1011	multiset	_	
6-16	1012-1021	canonical	_	
6-17	1022-1033	correlation	_	
6-18	1034-1042	analysis	_	
6-19	1043-1044	+	_	
6-20	1045-1050	joint	_	
6-21	1051-1062	independent	_	
6-22	1063-1072	component	_	
6-23	1073-1081	analysis	_	
6-24	1082-1083	(	_	
6-25	1083-1087	mCCA	_	
6-26	1087-1088	+	_	
6-27	1088-1092	jICA	_	
6-28	1092-1093	)	_	
6-29	1094-1098	were	_	
6-30	1099-1103	used	_	
6-31	1104-1106	to	_	
6-32	1107-1114	predict	_	
6-33	1115-1126	performance	_	
6-34	1127-1129	in	_	
6-35	1130-1139	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
6-36	1139-1140	.	_	

#Text=De novo mCCA+jICA was performed and results correlated with cognitive control.
7-1	1141-1143	De	_	
7-2	1144-1148	novo	_	
7-3	1149-1153	mCCA	_	
7-4	1153-1154	+	_	
7-5	1154-1158	jICA	_	
7-6	1159-1162	was	_	
7-7	1163-1172	performed	_	
7-8	1173-1176	and	_	
7-9	1177-1184	results	_	
7-10	1185-1195	correlated	_	
7-11	1196-1200	with	_	
7-12	1201-1210	cognitive	_	
7-13	1211-1218	control	_	
7-14	1218-1219	.	_	

#Text=Results:
#Text=A priori working memory and cortical thickness maps significantly predicted cognitive control in psychosis.
8-1	1220-1227	Results	_	
8-2	1227-1228	:	_	
8-3	1229-1230	A	_	
8-4	1231-1237	priori	_	
8-5	1238-1245	working	_	
8-6	1246-1252	memory	_	
8-7	1253-1256	and	_	
8-8	1257-1265	cortical	_	
8-9	1266-1275	thickness	_	
8-10	1276-1280	maps	_	
8-11	1281-1294	significantly	_	
8-12	1295-1304	predicted	_	
8-13	1305-1314	cognitive	_	
8-14	1315-1322	control	_	
8-15	1323-1325	in	_	
8-16	1326-1335	psychosis	_	
8-17	1335-1336	.	_	

#Text=De novo mCCA+jICA identified an IC correlated with cognitive control that also discriminated groups.
9-1	1337-1339	De	_	
9-2	1340-1344	novo	_	
9-3	1345-1349	mCCA	_	
9-4	1349-1350	+	_	
9-5	1350-1354	jICA	_	
9-6	1355-1365	identified	_	
9-7	1366-1368	an	_	
9-8	1369-1371	IC	_	
9-9	1372-1382	correlated	_	
9-10	1383-1387	with	_	
9-11	1388-1397	cognitive	_	
9-12	1398-1405	control	_	
9-13	1406-1410	that	_	
9-14	1411-1415	also	_	
9-15	1416-1429	discriminated	_	
9-16	1430-1436	groups	_	
9-17	1436-1437	.	_	

#Text=Structural contributions included insular and cingulate regions; task contributions included precentral, posterior parietal, cingulate, and visual regions; and resting-state contributions highlighted canonical network organization.
10-1	1438-1448	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging	
10-2	1449-1462	contributions	_	
10-3	1463-1471	included	_	
10-4	1472-1479	insular	_	
10-5	1480-1483	and	_	
10-6	1484-1493	cingulate	_	
10-7	1494-1501	regions	_	
10-8	1501-1502	;	_	
10-9	1503-1507	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging	
10-10	1508-1521	contributions	_	
10-11	1522-1530	included	_	
10-12	1531-1541	precentral	_	
10-13	1541-1542	,	_	
10-14	1543-1552	posterior	_	
10-15	1553-1561	parietal	_	
10-16	1561-1562	,	_	
10-17	1563-1572	cingulate	_	
10-18	1572-1573	,	_	
10-19	1574-1577	and	_	
10-20	1578-1584	visual	_	
10-21	1585-1592	regions	_	
10-22	1592-1593	;	_	
10-23	1594-1597	and	_	
10-24	1598-1611	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
10-25	1612-1625	contributions	_	
10-26	1626-1637	highlighted	_	
10-27	1638-1647	canonical	_	
10-28	1648-1655	network	_	
10-29	1656-1668	organization	_	
10-30	1668-1669	.	_	

#Text=Follow-up analyses suggested correlations with cognitive control were primarily influenced by schizophrenia patients.
11-1	1670-1679	Follow-up	_	
11-2	1680-1688	analyses	_	
11-3	1689-1698	suggested	_	
11-4	1699-1711	correlations	_	
11-5	1712-1716	with	_	
11-6	1717-1726	cognitive	_	
11-7	1727-1734	control	_	
11-8	1735-1739	were	_	
11-9	1740-1749	primarily	_	
11-10	1750-1760	influenced	_	
11-11	1761-1763	by	_	
11-12	1764-1777	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
11-13	1778-1786	patients	_	
11-14	1786-1787	.	_	

#Text=Conclusions:
#Text=A priori and de novo imaging replicably identified a set of interrelated patterns across modalities and the healthy-to-psychosis spectrum suggesting robustness of these features.
12-1	1788-1799	Conclusions	_	
12-2	1799-1800	:	_	
12-3	1801-1802	A	_	
12-4	1803-1809	priori	_	
12-5	1810-1813	and	_	
12-6	1814-1816	de	_	
12-7	1817-1821	novo	_	
12-8	1822-1829	imaging	_	
12-9	1830-1840	replicably	_	
12-10	1841-1851	identified	_	
12-11	1852-1853	a	_	
12-12	1854-1857	set	_	
12-13	1858-1860	of	_	
12-14	1861-1873	interrelated	_	
12-15	1874-1882	patterns	_	
12-16	1883-1889	across	_	
12-17	1890-1900	modalities	_	
12-18	1901-1904	and	_	
12-19	1905-1908	the	_	
12-20	1909-1929	healthy-to-psychosis	_	
12-21	1930-1938	spectrum	_	
12-22	1939-1949	suggesting	_	
12-23	1950-1960	robustness	_	
12-24	1961-1963	of	_	
12-25	1964-1969	these	_	
12-26	1970-1978	features	_	
12-27	1978-1979	.	_	

#Text=Relationships between imaging and cognitive control performance suggest shared symptomatology may be key to identifying transdiagnostic relationships in psychosis.
13-1	1980-1993	Relationships	_	
13-2	1994-2001	between	_	
13-3	2002-2009	imaging	_	
13-4	2010-2013	and	_	
13-5	2014-2023	cognitive	_	
13-6	2024-2031	control	_	
13-7	2032-2043	performance	_	
13-8	2044-2051	suggest	_	
13-9	2052-2058	shared	_	
13-10	2059-2073	symptomatology	_	
13-11	2074-2077	may	_	
13-12	2078-2080	be	_	
13-13	2081-2084	key	_	
13-14	2085-2087	to	_	
13-15	2088-2099	identifying	_	
13-16	2100-2115	transdiagnostic	_	
13-17	2116-2129	relationships	_	
13-18	2130-2132	in	_	
13-19	2133-2142	psychosis	_	
13-20	2142-2143	.	_	

#Text=Introduction
#Text=Psychosis, classically a hallmark of schizophrenia (SZ), is present in several other disorders including schizoaffective and bipolar (BP) disorders.
14-1	2144-2156	Introduction	_	
14-2	2157-2166	Psychosis	_	
14-3	2166-2167	,	_	
14-4	2168-2179	classically	_	
14-5	2180-2181	a	_	
14-6	2182-2190	hallmark	_	
14-7	2191-2193	of	_	
14-8	2194-2207	schizophrenia	_	
14-9	2208-2209	(	_	
14-10	2209-2211	SZ	_	
14-11	2211-2212	)	_	
14-12	2212-2213	,	_	
14-13	2214-2216	is	_	
14-14	2217-2224	present	_	
14-15	2225-2227	in	_	
14-16	2228-2235	several	_	
14-17	2236-2241	other	_	
14-18	2242-2251	disorders	_	
14-19	2252-2261	including	_	
14-20	2262-2277	schizoaffective	_	
14-21	2278-2281	and	_	
14-22	2282-2289	bipolar	_	
14-23	2290-2291	(	_	
14-24	2291-2293	BP	_	
14-25	2293-2294	)	_	
14-26	2295-2304	disorders	_	
14-27	2304-2305	.	_	

#Text=Importantly, alterations in cognition, including cognitive control, are a key feature of psychosis.
15-1	2306-2317	Importantly	_	
15-2	2317-2318	,	_	
15-3	2319-2330	alterations	_	
15-4	2331-2333	in	_	
15-5	2334-2343	cognition	_	
15-6	2343-2344	,	_	
15-7	2345-2354	including	_	
15-8	2355-2364	cognitive	_	
15-9	2365-2372	control	_	
15-10	2372-2373	,	_	
15-11	2374-2377	are	_	
15-12	2378-2379	a	_	
15-13	2380-2383	key	_	
15-14	2384-2391	feature	_	
15-15	2392-2394	of	_	
15-16	2395-2404	psychosis	_	
15-17	2404-2405	.	_	

#Text=Furthermore, cognitive control alterations are observed transdiagnostically, including in individuals with SZ, BP, and other disorders.
16-1	2406-2417	Furthermore	_	
16-2	2417-2418	,	_	
16-3	2419-2428	cognitive	_	
16-4	2429-2436	control	_	
16-5	2437-2448	alterations	_	
16-6	2449-2452	are	_	
16-7	2453-2461	observed	_	
16-8	2462-2481	transdiagnostically	_	
16-9	2481-2482	,	_	
16-10	2483-2492	including	_	
16-11	2493-2495	in	_	
16-12	2496-2507	individuals	_	
16-13	2508-2512	with	_	
16-14	2513-2515	SZ	_	
16-15	2515-2516	,	_	
16-16	2517-2519	BP	_	
16-17	2519-2520	,	_	
16-18	2521-2524	and	_	
16-19	2525-2530	other	_	
16-20	2531-2540	disorders	_	
16-21	2540-2541	.	_	

#Text=Here, we expand beyond prior work by using multimodal image analysis to examine transdiagnostic patterns of neural variation in structural, resting-state, and task imaging related to cognitive control.
17-1	2542-2546	Here	_	
17-2	2546-2547	,	_	
17-3	2548-2550	we	_	
17-4	2551-2557	expand	_	
17-5	2558-2564	beyond	_	
17-6	2565-2570	prior	_	
17-7	2571-2575	work	_	
17-8	2576-2578	by	_	
17-9	2579-2584	using	_	
17-10	2585-2595	multimodal	_	
17-11	2596-2601	image	_	
17-12	2602-2610	analysis	_	
17-13	2611-2613	to	_	
17-14	2614-2621	examine	_	
17-15	2622-2637	transdiagnostic	_	
17-16	2638-2646	patterns	_	
17-17	2647-2649	of	_	
17-18	2650-2656	neural	_	
17-19	2657-2666	variation	_	
17-20	2667-2669	in	_	
17-21	2670-2680	structural	_	
17-22	2680-2681	,	_	
17-23	2682-2695	resting-state	_	
17-24	2695-2696	,	_	
17-25	2697-2700	and	_	
17-26	2701-2705	task	_	
17-27	2706-2713	imaging	_	
17-28	2714-2721	related	_	
17-29	2722-2724	to	_	
17-30	2725-2734	cognitive	_	
17-31	2735-2742	control	_	
17-32	2742-2743	.	_	

#Text=Within the broad construct of cognition, cognitive control refers to the set of cognitive functions that enable and support goal-directed behavior and regulation of one’s thoughts and actions, including the ability to maintain information over time (e.g., working memory), protect against distraction, and combine novel inputs to provide flexibility in task execution.
18-1	2744-2750	Within	_	
18-2	2751-2754	the	_	
18-3	2755-2760	broad	_	
18-4	2761-2770	construct	_	
18-5	2771-2773	of	_	
18-6	2774-2783	cognition	_	
18-7	2783-2784	,	_	
18-8	2785-2794	cognitive	_	
18-9	2795-2802	control	_	
18-10	2803-2809	refers	_	
18-11	2810-2812	to	_	
18-12	2813-2816	the	_	
18-13	2817-2820	set	_	
18-14	2821-2823	of	_	
18-15	2824-2833	cognitive	_	
18-16	2834-2843	functions	_	
18-17	2844-2848	that	_	
18-18	2849-2855	enable	_	
18-19	2856-2859	and	_	
18-20	2860-2867	support	_	
18-21	2868-2881	goal-directed	_	
18-22	2882-2890	behavior	_	
18-23	2891-2894	and	_	
18-24	2895-2905	regulation	_	
18-25	2906-2908	of	_	
18-26	2909-2912	one	_	
18-27	2912-2913	’	_	
18-28	2913-2914	s	_	
18-29	2915-2923	thoughts	_	
18-30	2924-2927	and	_	
18-31	2928-2935	actions	_	
18-32	2935-2936	,	_	
18-33	2937-2946	including	_	
18-34	2947-2950	the	_	
18-35	2951-2958	ability	_	
18-36	2959-2961	to	_	
18-37	2962-2970	maintain	_	
18-38	2971-2982	information	_	
18-39	2983-2987	over	_	
18-40	2988-2992	time	_	
18-41	2993-2994	(	_	
18-42	2994-2997	e.g	_	
18-43	2997-2998	.	_	
18-44	2998-2999	,	_	
18-45	3000-3007	working	_	
18-46	3008-3014	memory	_	
18-47	3014-3015	)	_	
18-48	3015-3016	,	_	
18-49	3017-3024	protect	_	
18-50	3025-3032	against	_	
18-51	3033-3044	distraction	_	
18-52	3044-3045	,	_	
18-53	3046-3049	and	_	
18-54	3050-3057	combine	_	
18-55	3058-3063	novel	_	
18-56	3064-3070	inputs	_	
18-57	3071-3073	to	_	
18-58	3074-3081	provide	_	
18-59	3082-3093	flexibility	_	
18-60	3094-3096	in	_	
18-61	3097-3101	task	_	
18-62	3102-3111	execution	_	
18-63	3111-3112	.	_	

#Text=Evidence in psychosis suggests that task flexibility may be the source of generalized neurocognitive deficit in schizophrenia and possibly bipolar disorder.
19-1	3113-3121	Evidence	_	
19-2	3122-3124	in	_	
19-3	3125-3134	psychosis	_	
19-4	3135-3143	suggests	_	
19-5	3144-3148	that	_	
19-6	3149-3153	task	_	
19-7	3154-3165	flexibility	_	
19-8	3166-3169	may	_	
19-9	3170-3172	be	_	
19-10	3173-3176	the	_	
19-11	3177-3183	source	_	
19-12	3184-3186	of	_	
19-13	3187-3198	generalized	_	
19-14	3199-3213	neurocognitive	_	
19-15	3214-3221	deficit	_	
19-16	3222-3224	in	_	
19-17	3225-3238	schizophrenia	_	
19-18	3239-3242	and	_	
19-19	3243-3251	possibly	_	
19-20	3252-3259	bipolar	_	
19-21	3260-3268	disorder	_	
19-22	3268-3269	.	_	

#Text=Within the psychosis spectrum, SZ have poorer cognitive control performance than healthy controls (HC), and BP often have intermediary performance between SZ and HC.
20-1	3270-3276	Within	_	
20-2	3277-3280	the	_	
20-3	3281-3290	psychosis	_	
20-4	3291-3299	spectrum	_	
20-5	3299-3300	,	_	
20-6	3301-3303	SZ	_	
20-7	3304-3308	have	_	
20-8	3309-3315	poorer	_	
20-9	3316-3325	cognitive	_	
20-10	3326-3333	control	_	
20-11	3334-3345	performance	_	
20-12	3346-3350	than	_	
20-13	3351-3358	healthy	_	
20-14	3359-3367	controls	_	
20-15	3368-3369	(	_	
20-16	3369-3371	HC	_	
20-17	3371-3372	)	_	
20-18	3372-3373	,	_	
20-19	3374-3377	and	_	
20-20	3378-3380	BP	_	
20-21	3381-3386	often	_	
20-22	3387-3391	have	_	
20-23	3392-3404	intermediary	_	
20-24	3405-3416	performance	_	
20-25	3417-3424	between	_	
20-26	3425-3427	SZ	_	
20-27	3428-3431	and	_	
20-28	3432-3434	HC	_	
20-29	3434-3435	.	_	

#Text=This graded performance further supports conceptualizations of psychosis as a dimensional transdiagnostic construct.
21-1	3436-3440	This	_	
21-2	3441-3447	graded	_	
21-3	3448-3459	performance	_	
21-4	3460-3467	further	_	
21-5	3468-3476	supports	_	
21-6	3477-3495	conceptualizations	_	
21-7	3496-3498	of	_	
21-8	3499-3508	psychosis	_	
21-9	3509-3511	as	_	
21-10	3512-3513	a	_	
21-11	3514-3525	dimensional	_	
21-12	3526-3541	transdiagnostic	_	
21-13	3542-3551	construct	_	
21-14	3551-3552	.	_	

#Text=The imaging literature has identified transdiagnostic neural alterations in psychosis related to cognitive control.
22-1	3553-3556	The	_	
22-2	3557-3564	imaging	_	
22-3	3565-3575	literature	_	
22-4	3576-3579	has	_	
22-5	3580-3590	identified	_	
22-6	3591-3606	transdiagnostic	_	
22-7	3607-3613	neural	_	
22-8	3614-3625	alterations	_	
22-9	3626-3628	in	_	
22-10	3629-3638	psychosis	_	
22-11	3639-3646	related	_	
22-12	3647-3649	to	_	
22-13	3650-3659	cognitive	_	
22-14	3660-3667	control	_	
22-15	3667-3668	.	_	

#Text=For example, with structural imaging, working memory performance was inversely correlated with cortical thickness in the right rostral anterior cingulate and positively correlated with surface area in the left rostral anterior cingulate and right rostral middle frontal region in a cohort of individuals with SZ and BP.
23-1	3669-3672	For	_	
23-2	3673-3680	example	_	
23-3	3680-3681	,	_	
23-4	3682-3686	with	_	
23-5	3687-3697	structural	_	
23-6	3698-3705	imaging	_	
23-7	3705-3706	,	_	
23-8	3707-3714	working	_	
23-9	3715-3721	memory	_	
23-10	3722-3733	performance	_	
23-11	3734-3737	was	_	
23-12	3738-3747	inversely	_	
23-13	3748-3758	correlated	_	
23-14	3759-3763	with	_	
23-15	3764-3772	cortical	_	
23-16	3773-3782	thickness	_	
23-17	3783-3785	in	_	
23-18	3786-3789	the	_	
23-19	3790-3795	right	_	
23-20	3796-3803	rostral	_	
23-21	3804-3812	anterior	_	
23-22	3813-3822	cingulate	_	
23-23	3823-3826	and	_	
23-24	3827-3837	positively	_	
23-25	3838-3848	correlated	_	
23-26	3849-3853	with	_	
23-27	3854-3861	surface	_	
23-28	3862-3866	area	_	
23-29	3867-3869	in	_	
23-30	3870-3873	the	_	
23-31	3874-3878	left	_	
23-32	3879-3886	rostral	_	
23-33	3887-3895	anterior	_	
23-34	3896-3905	cingulate	_	
23-35	3906-3909	and	_	
23-36	3910-3915	right	_	
23-37	3916-3923	rostral	_	
23-38	3924-3930	middle	_	
23-39	3931-3938	frontal	_	
23-40	3939-3945	region	_	
23-41	3946-3948	in	_	
23-42	3949-3950	a	_	
23-43	3951-3957	cohort	_	
23-44	3958-3960	of	_	
23-45	3961-3972	individuals	_	
23-46	3973-3977	with	_	
23-47	3978-3980	SZ	_	
23-48	3981-3984	and	_	
23-49	3985-3987	BP	_	
23-50	3987-3988	.	_	

#Text=Recent meta-analysis of structural alterations in a broad mental illness sample identified significant psychosis-related gray-matter losses in medial prefrontal cortex (PFC), insula, thalamus, and amygdala and significant gray-matter increases in the striatum as compared to HC and non-psychotic mental illnesses.
24-1	3989-3995	Recent	_	
24-2	3996-4009	meta-analysis	_	
24-3	4010-4012	of	_	
24-4	4013-4023	structural	_	
24-5	4024-4035	alterations	_	
24-6	4036-4038	in	_	
24-7	4039-4040	a	_	
24-8	4041-4046	broad	_	
24-9	4047-4053	mental	_	
24-10	4054-4061	illness	_	
24-11	4062-4068	sample	_	
24-12	4069-4079	identified	_	
24-13	4080-4091	significant	_	
24-14	4092-4109	psychosis-related	_	
24-15	4110-4121	gray-matter	_	
24-16	4122-4128	losses	_	
24-17	4129-4131	in	_	
24-18	4132-4138	medial	_	
24-19	4139-4149	prefrontal	_	
24-20	4150-4156	cortex	_	
24-21	4157-4158	(	_	
24-22	4158-4161	PFC	_	
24-23	4161-4162	)	_	
24-24	4162-4163	,	_	
24-25	4164-4170	insula	_	
24-26	4170-4171	,	_	
24-27	4172-4180	thalamus	_	
24-28	4180-4181	,	_	
24-29	4182-4185	and	_	
24-30	4186-4194	amygdala	_	
24-31	4195-4198	and	_	
24-32	4199-4210	significant	_	
24-33	4211-4222	gray-matter	_	
24-34	4223-4232	increases	_	
24-35	4233-4235	in	_	
24-36	4236-4239	the	_	
24-37	4240-4248	striatum	_	
24-38	4249-4251	as	_	
24-39	4252-4260	compared	_	
24-40	4261-4263	to	_	
24-41	4264-4266	HC	_	
24-42	4267-4270	and	_	
24-43	4271-4284	non-psychotic	_	
24-44	4285-4291	mental	_	
24-45	4292-4301	illnesses	_	
24-46	4301-4302	.	_	

#Text=Finally, Shepherd et al. examined a transdiagnostic psychosis cohort and dichotomized patients into high and low executive function groups based on two-back working memory performance.
25-1	4303-4310	Finally	_	
25-2	4310-4311	,	_	
25-3	4312-4320	Shepherd	_	
25-4	4321-4323	et	_	
25-5	4324-4326	al	_	
25-6	4326-4327	.	_	
25-7	4328-4336	examined	_	
25-8	4337-4338	a	_	
25-9	4339-4354	transdiagnostic	_	
25-10	4355-4364	psychosis	_	
25-11	4365-4371	cohort	_	
25-12	4372-4375	and	_	
25-13	4376-4388	dichotomized	_	
25-14	4389-4397	patients	_	
25-15	4398-4402	into	_	
25-16	4403-4407	high	_	
25-17	4408-4411	and	_	
25-18	4412-4415	low	_	
25-19	4416-4425	executive	_	
25-20	4426-4434	function	_	
25-21	4435-4441	groups	_	
25-22	4442-4447	based	_	
25-23	4448-4450	on	_	
25-24	4451-4459	two-back	_	
25-25	4460-4467	working	_	
25-26	4468-4474	memory	_	
25-27	4475-4486	performance	_	
25-28	4486-4487	.	_	

#Text=Compared to HC, the low executive function group exhibited decreased gray matter volume in bilateral superior and medial frontal gyri, and right inferior operculum and hippocampus.
26-1	4488-4496	Compared	_	
26-2	4497-4499	to	_	
26-3	4500-4502	HC	_	
26-4	4502-4503	,	_	
26-5	4504-4507	the	_	
26-6	4508-4511	low	_	
26-7	4512-4521	executive	_	
26-8	4522-4530	function	_	
26-9	4531-4536	group	_	
26-10	4537-4546	exhibited	_	
26-11	4547-4556	decreased	_	
26-12	4557-4561	gray	_	
26-13	4562-4568	matter	_	
26-14	4569-4575	volume	_	
26-15	4576-4578	in	_	
26-16	4579-4588	bilateral	_	
26-17	4589-4597	superior	_	
26-18	4598-4601	and	_	
26-19	4602-4608	medial	_	
26-20	4609-4616	frontal	_	
26-21	4617-4621	gyri	_	
26-22	4621-4622	,	_	
26-23	4623-4626	and	_	
26-24	4627-4632	right	_	
26-25	4633-4641	inferior	_	
26-26	4642-4651	operculum	_	
26-27	4652-4655	and	_	
26-28	4656-4667	hippocampus	_	
26-29	4667-4668	.	_	

#Text=Resting-state imaging has also identified transdiagnostic neural alterations related to general cognition, with fewer studies examining cognitive control.
27-1	4669-4682	Resting-state	_	
27-2	4683-4690	imaging	_	
27-3	4691-4694	has	_	
27-4	4695-4699	also	_	
27-5	4700-4710	identified	_	
27-6	4711-4726	transdiagnostic	_	
27-7	4727-4733	neural	_	
27-8	4734-4745	alterations	_	
27-9	4746-4753	related	_	
27-10	4754-4756	to	_	
27-11	4757-4764	general	_	
27-12	4765-4774	cognition	_	
27-13	4774-4775	,	_	
27-14	4776-4780	with	_	
27-15	4781-4786	fewer	_	
27-16	4787-4794	studies	_	
27-17	4795-4804	examining	_	
27-18	4805-4814	cognitive	_	
27-19	4815-4822	control	_	
27-20	4822-4823	.	_	

#Text=For example, trail making task performance in persons with SZ and BP positively correlated with average connectivity strength between the whole brain and left caudate, thalamus, and temporal occipital fusiform cortex/lingual gyrus.
28-1	4824-4827	For	_	
28-2	4828-4835	example	_	
28-3	4835-4836	,	_	
28-4	4837-4842	trail	_	
28-5	4843-4849	making	_	
28-6	4850-4854	task	_	
28-7	4855-4866	performance	_	
28-8	4867-4869	in	_	
28-9	4870-4877	persons	_	
28-10	4878-4882	with	_	
28-11	4883-4885	SZ	_	
28-12	4886-4889	and	_	
28-13	4890-4892	BP	_	
28-14	4893-4903	positively	_	
28-15	4904-4914	correlated	_	
28-16	4915-4919	with	_	
28-17	4920-4927	average	_	
28-18	4928-4940	connectivity	_	
28-19	4941-4949	strength	_	
28-20	4950-4957	between	_	
28-21	4958-4961	the	_	
28-22	4962-4967	whole	_	
28-23	4968-4973	brain	_	
28-24	4974-4977	and	_	
28-25	4978-4982	left	_	
28-26	4983-4990	caudate	_	
28-27	4990-4991	,	_	
28-28	4992-5000	thalamus	_	
28-29	5000-5001	,	_	
28-30	5002-5005	and	_	
28-31	5006-5014	temporal	_	
28-32	5015-5024	occipital	_	
28-33	5025-5033	fusiform	_	
28-34	5034-5040	cortex	_	
28-35	5040-5041	/	_	
28-36	5041-5048	lingual	_	
28-37	5049-5054	gyrus	_	
28-38	5054-5055	.	_	

#Text=Further, a network connectivity approach in another transdiagnostic cohort identified a significant relationship between global efficiency of the cingulo-opercular network and cognitive and executive function, along with significant decreases in cingulo-opercular network efficiency in psychosis.
29-1	5056-5063	Further	_	
29-2	5063-5064	,	_	
29-3	5065-5066	a	_	
29-4	5067-5074	network	_	
29-5	5075-5087	connectivity	_	
29-6	5088-5096	approach	_	
29-7	5097-5099	in	_	
29-8	5100-5107	another	_	
29-9	5108-5123	transdiagnostic	_	
29-10	5124-5130	cohort	_	
29-11	5131-5141	identified	_	
29-12	5142-5143	a	_	
29-13	5144-5155	significant	_	
29-14	5156-5168	relationship	_	
29-15	5169-5176	between	_	
29-16	5177-5183	global	_	
29-17	5184-5194	efficiency	_	
29-18	5195-5197	of	_	
29-19	5198-5201	the	_	
29-20	5202-5219	cingulo-opercular	_	
29-21	5220-5227	network	_	
29-22	5228-5231	and	_	
29-23	5232-5241	cognitive	_	
29-24	5242-5245	and	_	
29-25	5246-5255	executive	_	
29-26	5256-5264	function	_	
29-27	5264-5265	,	_	
29-28	5266-5271	along	_	
29-29	5272-5276	with	_	
29-30	5277-5288	significant	_	
29-31	5289-5298	decreases	_	
29-32	5299-5301	in	_	
29-33	5302-5319	cingulo-opercular	_	
29-34	5320-5327	network	_	
29-35	5328-5338	efficiency	_	
29-36	5339-5341	in	_	
29-37	5342-5351	psychosis	_	
29-38	5351-5352	.	_	

#Text=Additionally, an independent component analysis (ICA) approach to resting-state data identified significant decreases in connectivity between a fronto-occipital component and a combined anterior default mode and prefrontal component in individuals with SZ, psychotic BP, and unaffected siblings.
30-1	5353-5365	Additionally	_	
30-2	5365-5366	,	_	
30-3	5367-5369	an	_	
30-4	5370-5381	independent	_	
30-5	5382-5391	component	_	
30-6	5392-5400	analysis	_	
30-7	5401-5402	(	_	
30-8	5402-5405	ICA	_	
30-9	5405-5406	)	_	
30-10	5407-5415	approach	_	
30-11	5416-5418	to	_	
30-12	5419-5432	resting-state	_	
30-13	5433-5437	data	_	
30-14	5438-5448	identified	_	
30-15	5449-5460	significant	_	
30-16	5461-5470	decreases	_	
30-17	5471-5473	in	_	
30-18	5474-5486	connectivity	_	
30-19	5487-5494	between	_	
30-20	5495-5496	a	_	
30-21	5497-5513	fronto-occipital	_	
30-22	5514-5523	component	_	
30-23	5524-5527	and	_	
30-24	5528-5529	a	_	
30-25	5530-5538	combined	_	
30-26	5539-5547	anterior	_	
30-27	5548-5555	default	_	
30-28	5556-5560	mode	_	
30-29	5561-5564	and	_	
30-30	5565-5575	prefrontal	_	
30-31	5576-5585	component	_	
30-32	5586-5588	in	_	
30-33	5589-5600	individuals	_	
30-34	5601-5605	with	_	
30-35	5606-5608	SZ	_	
30-36	5608-5609	,	_	
30-37	5610-5619	psychotic	_	
30-38	5620-5622	BP	_	
30-39	5622-5623	,	_	
30-40	5624-5627	and	_	
30-41	5628-5638	unaffected	_	
30-42	5639-5647	siblings	_	
30-43	5647-5648	.	_	

#Text=In the same study, decreased connectivity was also identified between meso/paralimbic and sensory/motor components, but this was only observed in individuals with SZ and not psychotic BP.
31-1	5649-5651	In	_	
31-2	5652-5655	the	_	
31-3	5656-5660	same	_	
31-4	5661-5666	study	_	
31-5	5666-5667	,	_	
31-6	5668-5677	decreased	_	
31-7	5678-5690	connectivity	_	
31-8	5691-5694	was	_	
31-9	5695-5699	also	_	
31-10	5700-5710	identified	_	
31-11	5711-5718	between	_	
31-12	5719-5723	meso	_	
31-13	5723-5724	/	_	
31-14	5724-5734	paralimbic	_	
31-15	5735-5738	and	_	
31-16	5739-5746	sensory	_	
31-17	5746-5747	/	_	
31-18	5747-5752	motor	_	
31-19	5753-5763	components	_	
31-20	5763-5764	,	_	
31-21	5765-5768	but	_	
31-22	5769-5773	this	_	
31-23	5774-5777	was	_	
31-24	5778-5782	only	_	
31-25	5783-5791	observed	_	
31-26	5792-5794	in	_	
31-27	5795-5806	individuals	_	
31-28	5807-5811	with	_	
31-29	5812-5814	SZ	_	
31-30	5815-5818	and	_	
31-31	5819-5822	not	_	
31-32	5823-5832	psychotic	_	
31-33	5833-5835	BP	_	
31-34	5835-5836	.	_	

#Text=Furthermore, recent analyses from the same dataset identified seven abnormal networks exhibiting significant correlations with cognitive control including visual, working-memory, visuomotor integration, default mode, and frontoparietal control networks.
32-1	5837-5848	Furthermore	_	
32-2	5848-5849	,	_	
32-3	5850-5856	recent	_	
32-4	5857-5865	analyses	_	
32-5	5866-5870	from	_	
32-6	5871-5874	the	_	
32-7	5875-5879	same	_	
32-8	5880-5887	dataset	_	
32-9	5888-5898	identified	_	
32-10	5899-5904	seven	_	
32-11	5905-5913	abnormal	_	
32-12	5914-5922	networks	_	
32-13	5923-5933	exhibiting	_	
32-14	5934-5945	significant	_	
32-15	5946-5958	correlations	_	
32-16	5959-5963	with	_	
32-17	5964-5973	cognitive	_	
32-18	5974-5981	control	_	
32-19	5982-5991	including	_	
32-20	5992-5998	visual	_	
32-21	5998-5999	,	_	
32-22	6000-6014	working-memory	_	
32-23	6014-6015	,	_	
32-24	6016-6026	visuomotor	_	
32-25	6027-6038	integration	_	
32-26	6038-6039	,	_	
32-27	6040-6047	default	_	
32-28	6048-6052	mode	_	
32-29	6052-6053	,	_	
32-30	6054-6057	and	_	
32-31	6058-6072	frontoparietal	_	
32-32	6073-6080	control	_	
32-33	6081-6089	networks	_	
32-34	6089-6090	.	_	

#Text=Several studies have examined transdiagnostic alterations in task imaging related to cognitive control.
33-1	6091-6098	Several	_	
33-2	6099-6106	studies	_	
33-3	6107-6111	have	_	
33-4	6112-6120	examined	_	
33-5	6121-6136	transdiagnostic	_	
33-6	6137-6148	alterations	_	
33-7	6149-6151	in	_	
33-8	6152-6156	task	_	
33-9	6157-6164	imaging	_	
33-10	6165-6172	related	_	
33-11	6173-6175	to	_	
33-12	6176-6185	cognitive	_	
33-13	6186-6193	control	_	
33-14	6193-6194	.	_	

#Text=For example, Brandt et al. used ICA decompositions of two-back working memory task and identified nine task-related components.
34-1	6195-6198	For	_	
34-2	6199-6206	example	_	
34-3	6206-6207	,	_	
34-4	6208-6214	Brandt	_	
34-5	6215-6217	et	_	
34-6	6218-6220	al	_	
34-7	6220-6221	.	_	
34-8	6222-6226	used	_	
34-9	6227-6230	ICA	_	
34-10	6231-6245	decompositions	_	
34-11	6246-6248	of	_	
34-12	6249-6257	two-back	_	
34-13	6258-6265	working	_	
34-14	6266-6272	memory	_	
34-15	6273-6277	task	_	
34-16	6278-6281	and	_	
34-17	6282-6292	identified	_	
34-18	6293-6297	nine	_	
34-19	6298-6310	task-related	_	
34-20	6311-6321	components	_	
34-21	6321-6322	.	_	

#Text=Of those, three components with spatial distribution in frontal and parietal regions corresponding to working-memory networks showed significant graded hyperactivation pattern (SZ>BP>HC).
35-1	6323-6325	Of	_	
35-2	6326-6331	those	_	
35-3	6331-6332	,	_	
35-4	6333-6338	three	_	
35-5	6339-6349	components	_	
35-6	6350-6354	with	_	
35-7	6355-6362	spatial	_	
35-8	6363-6375	distribution	_	
35-9	6376-6378	in	_	
35-10	6379-6386	frontal	_	
35-11	6387-6390	and	_	
35-12	6391-6399	parietal	_	
35-13	6400-6407	regions	_	
35-14	6408-6421	corresponding	_	
35-15	6422-6424	to	_	
35-16	6425-6439	working-memory	_	
35-17	6440-6448	networks	_	
35-18	6449-6455	showed	_	
35-19	6456-6467	significant	_	
35-20	6468-6474	graded	_	
35-21	6475-6490	hyperactivation	_	
35-22	6491-6498	pattern	_	
35-23	6499-6500	(	_	
35-24	6500-6502	SZ	_	
35-25	6502-6503	>	_	
35-26	6503-6505	BP	_	
35-27	6505-6506	>	_	
35-28	6506-6508	HC	_	
35-29	6508-6509	)	_	
35-30	6509-6510	.	_	

#Text=Additionally, Smucny et al. used an a priori contrast approach examining activation in dorsolateral prefrontal cortex (DLPFC) and superior parietal cortex (SPC) during the AX-CPT task in a transdiagnostic population.
36-1	6511-6523	Additionally	_	
36-2	6523-6524	,	_	
36-3	6525-6531	Smucny	_	
36-4	6532-6534	et	_	
36-5	6535-6537	al	_	
36-6	6537-6538	.	_	
36-7	6539-6543	used	_	
36-8	6544-6546	an	_	
36-9	6547-6548	a	_	
36-10	6549-6555	priori	_	
36-11	6556-6564	contrast	_	
36-12	6565-6573	approach	_	
36-13	6574-6583	examining	_	
36-14	6584-6594	activation	_	
36-15	6595-6597	in	_	
36-16	6598-6610	dorsolateral	_	
36-17	6611-6621	prefrontal	_	
36-18	6622-6628	cortex	_	
36-19	6629-6630	(	_	
36-20	6630-6635	DLPFC	_	
36-21	6635-6636	)	_	
36-22	6637-6640	and	_	
36-23	6641-6649	superior	_	
36-24	6650-6658	parietal	_	
36-25	6659-6665	cortex	_	
36-26	6666-6667	(	_	
36-27	6667-6670	SPC	_	
36-28	6670-6671	)	_	
36-29	6672-6678	during	_	
36-30	6679-6682	the	_	
36-31	6683-6689	AX-CPT	_	
36-32	6690-6694	task	_	
36-33	6695-6697	in	_	
36-34	6698-6699	a	_	
36-35	6700-6715	transdiagnostic	_	
36-36	6716-6726	population	_	
36-37	6726-6727	.	_	

#Text=They identified significant graded task performance (HC>BP>SZ) and BOLD responses in DLPFC and partially significant responses in SPC.
37-1	6728-6732	They	_	
37-2	6733-6743	identified	_	
37-3	6744-6755	significant	_	
37-4	6756-6762	graded	_	
37-5	6763-6767	task	_	
37-6	6768-6779	performance	_	
37-7	6780-6781	(	_	
37-8	6781-6783	HC	_	
37-9	6783-6784	>	_	
37-10	6784-6786	BP	_	
37-11	6786-6787	>	_	
37-12	6787-6789	SZ	_	
37-13	6789-6790	)	_	
37-14	6791-6794	and	_	
37-15	6795-6799	BOLD	_	
37-16	6800-6809	responses	_	
37-17	6810-6812	in	_	
37-18	6813-6818	DLPFC	_	
37-19	6819-6822	and	_	
37-20	6823-6832	partially	_	
37-21	6833-6844	significant	_	
37-22	6845-6854	responses	_	
37-23	6855-6857	in	_	
37-24	6858-6861	SPC	_	
37-25	6861-6862	.	_	

#Text=As noted, a number of studies have examined neural alterations in psychosis.
38-1	6863-6865	As	_	
38-2	6866-6871	noted	_	
38-3	6871-6872	,	_	
38-4	6873-6874	a	_	
38-5	6875-6881	number	_	
38-6	6882-6884	of	_	
38-7	6885-6892	studies	_	
38-8	6893-6897	have	_	
38-9	6898-6906	examined	_	
38-10	6907-6913	neural	_	
38-11	6914-6925	alterations	_	
38-12	6926-6928	in	_	
38-13	6929-6938	psychosis	_	
38-14	6938-6939	.	_	

#Text=However, much of this literature is unimodal (see for review and fuller motivation for multimodal imaging).
39-1	6940-6947	However	_	
39-2	6947-6948	,	_	
39-3	6949-6953	much	_	
39-4	6954-6956	of	_	
39-5	6957-6961	this	_	
39-6	6962-6972	literature	_	
39-7	6973-6975	is	_	
39-8	6976-6984	unimodal	_	
39-9	6985-6986	(	_	
39-10	6986-6989	see	_	
39-11	6990-6993	for	_	
39-12	6994-7000	review	_	
39-13	7001-7004	and	_	
39-14	7005-7011	fuller	_	
39-15	7012-7022	motivation	_	
39-16	7023-7026	for	_	
39-17	7027-7037	multimodal	_	
39-18	7038-7045	imaging	_	
39-19	7045-7046	)	_	
39-20	7046-7047	.	_	

#Text=Thus, it remains unclear how extant results relate across modalities and across disease state.
40-1	7048-7052	Thus	_	
40-2	7052-7053	,	_	
40-3	7054-7056	it	_	
40-4	7057-7064	remains	_	
40-5	7065-7072	unclear	_	
40-6	7073-7076	how	_	
40-7	7077-7083	extant	_	
40-8	7084-7091	results	_	
40-9	7092-7098	relate	_	
40-10	7099-7105	across	_	
40-11	7106-7116	modalities	_	
40-12	7117-7120	and	_	
40-13	7121-7127	across	_	
40-14	7128-7135	disease	_	
40-15	7136-7141	state	_	
40-16	7141-7142	.	_	

#Text=For example, are the same participants with structural correlates of poor cognitive control performance also the same participants exhibiting resting state correlates of cognitive control performance?
41-1	7143-7146	For	_	
41-2	7147-7154	example	_	
41-3	7154-7155	,	_	
41-4	7156-7159	are	_	
41-5	7160-7163	the	_	
41-6	7164-7168	same	_	
41-7	7169-7181	participants	_	
41-8	7182-7186	with	_	
41-9	7187-7197	structural	_	
41-10	7198-7208	correlates	_	
41-11	7209-7211	of	_	
41-12	7212-7216	poor	_	
41-13	7217-7226	cognitive	_	
41-14	7227-7234	control	_	
41-15	7235-7246	performance	_	
41-16	7247-7251	also	_	
41-17	7252-7255	the	_	
41-18	7256-7260	same	_	
41-19	7261-7273	participants	_	
41-20	7274-7284	exhibiting	_	
41-21	7285-7292	resting	_	
41-22	7293-7298	state	_	
41-23	7299-7309	correlates	_	
41-24	7310-7312	of	_	
41-25	7313-7322	cognitive	_	
41-26	7323-7330	control	_	
41-27	7331-7342	performance	_	
41-28	7342-7343	?	_	

#Text=Multimodal analyses examining structural, resting state, and diffusion imaging and relationships to a cognitive battery in SZ identified a relationship between overall cognitive impairment and variation in cortico-striato-thalamic circuitry.
42-1	7344-7354	Multimodal	_	
42-2	7355-7363	analyses	_	
42-3	7364-7373	examining	_	
42-4	7374-7384	structural	_	
42-5	7384-7385	,	_	
42-6	7386-7393	resting	_	
42-7	7394-7399	state	_	
42-8	7399-7400	,	_	
42-9	7401-7404	and	_	
42-10	7405-7414	diffusion	_	
42-11	7415-7422	imaging	_	
42-12	7423-7426	and	_	
42-13	7427-7440	relationships	_	
42-14	7441-7443	to	_	
42-15	7444-7445	a	_	
42-16	7446-7455	cognitive	_	
42-17	7456-7463	battery	_	
42-18	7464-7466	in	_	
42-19	7467-7469	SZ	_	
42-20	7470-7480	identified	_	
42-21	7481-7482	a	_	
42-22	7483-7495	relationship	_	
42-23	7496-7503	between	_	
42-24	7504-7511	overall	_	
42-25	7512-7521	cognitive	_	
42-26	7522-7532	impairment	_	
42-27	7533-7536	and	_	
42-28	7537-7546	variation	_	
42-29	7547-7549	in	_	
42-30	7550-7574	cortico-striato-thalamic	_	
42-31	7575-7584	circuitry	_	
42-32	7584-7585	.	_	

#Text=Additionally, examination of three modalities derived from structural imaging in a transdiagnostic cohort (HC, BP, and SZ) identified putative associations between gray matter alterations and processing speed, working memory, and attention.
43-1	7586-7598	Additionally	_	
43-2	7598-7599	,	_	
43-3	7600-7611	examination	_	
43-4	7612-7614	of	_	
43-5	7615-7620	three	_	
43-6	7621-7631	modalities	_	
43-7	7632-7639	derived	_	
43-8	7640-7644	from	_	
43-9	7645-7655	structural	_	
43-10	7656-7663	imaging	_	
43-11	7664-7666	in	_	
43-12	7667-7668	a	_	
43-13	7669-7684	transdiagnostic	_	
43-14	7685-7691	cohort	_	
43-15	7692-7693	(	_	
43-16	7693-7695	HC	_	
43-17	7695-7696	,	_	
43-18	7697-7699	BP	_	
43-19	7699-7700	,	_	
43-20	7701-7704	and	_	
43-21	7705-7707	SZ	_	
43-22	7707-7708	)	_	
43-23	7709-7719	identified	_	
43-24	7720-7728	putative	_	
43-25	7729-7741	associations	_	
43-26	7742-7749	between	_	
43-27	7750-7754	gray	_	
43-28	7755-7761	matter	_	
43-29	7762-7773	alterations	_	
43-30	7774-7777	and	_	
43-31	7778-7788	processing	_	
43-32	7789-7794	speed	_	
43-33	7794-7795	,	_	
43-34	7796-7803	working	_	
43-35	7804-7810	memory	_	
43-36	7810-7811	,	_	
43-37	7812-7815	and	_	
43-38	7816-7825	attention	_	
43-39	7825-7826	.	_	

#Text=However, these associations were not significant across multiple diagnostic categories within the same component and did not survive multiple comparison correction.
44-1	7827-7834	However	_	
44-2	7834-7835	,	_	
44-3	7836-7841	these	_	
44-4	7842-7854	associations	_	
44-5	7855-7859	were	_	
44-6	7860-7863	not	_	
44-7	7864-7875	significant	_	
44-8	7876-7882	across	_	
44-9	7883-7891	multiple	_	
44-10	7892-7902	diagnostic	_	
44-11	7903-7913	categories	_	
44-12	7914-7920	within	_	
44-13	7921-7924	the	_	
44-14	7925-7929	same	_	
44-15	7930-7939	component	_	
44-16	7940-7943	and	_	
44-17	7944-7947	did	_	
44-18	7948-7951	not	_	
44-19	7952-7959	survive	_	
44-20	7960-7968	multiple	_	
44-21	7969-7979	comparison	_	
44-22	7980-7990	correction	_	
44-23	7990-7991	.	_	

#Text=Importantly, both studies did not focus specifically on cognitive control.
45-1	7992-8003	Importantly	_	
45-2	8003-8004	,	_	
45-3	8005-8009	both	_	
45-4	8010-8017	studies	_	
45-5	8018-8021	did	_	
45-6	8022-8025	not	_	
45-7	8026-8031	focus	_	
45-8	8032-8044	specifically	_	
45-9	8045-8047	on	_	
45-10	8048-8057	cognitive	_	
45-11	8058-8065	control	_	
45-12	8065-8066	.	_	

#Text=We recently used multiset canonical correlation analysis with joint independent component analysis (mCCA+jICA) to study multimodal neural correlates of cognitive control in the normative population.
46-1	8067-8069	We	_	
46-2	8070-8078	recently	_	
46-3	8079-8083	used	_	
46-4	8084-8092	multiset	_	
46-5	8093-8102	canonical	_	
46-6	8103-8114	correlation	_	
46-7	8115-8123	analysis	_	
46-8	8124-8128	with	_	
46-9	8129-8134	joint	_	
46-10	8135-8146	independent	_	
46-11	8147-8156	component	_	
46-12	8157-8165	analysis	_	
46-13	8166-8167	(	_	
46-14	8167-8171	mCCA	_	
46-15	8171-8172	+	_	
46-16	8172-8176	jICA	_	
46-17	8176-8177	)	_	
46-18	8178-8180	to	_	
46-19	8181-8186	study	_	
46-20	8187-8197	multimodal	_	
46-21	8198-8204	neural	_	
46-22	8205-8215	correlates	_	
46-23	8216-8218	of	_	
46-24	8219-8228	cognitive	_	
46-25	8229-8236	control	_	
46-26	8237-8239	in	_	
46-27	8240-8243	the	_	
46-28	8244-8253	normative	_	
46-29	8254-8264	population	_	
46-30	8264-8265	.	_	

#Text=The mCCA+jICA framework was chosen as it flexibly identifies patterns across modalities and decomposes them into maximally spatially independent sources of variance.
47-1	8266-8269	The	_	
47-2	8270-8274	mCCA	_	
47-3	8274-8275	+	_	
47-4	8275-8279	jICA	_	
47-5	8280-8289	framework	_	
47-6	8290-8293	was	_	
47-7	8294-8300	chosen	_	
47-8	8301-8303	as	_	
47-9	8304-8306	it	_	
47-10	8307-8315	flexibly	_	
47-11	8316-8326	identifies	_	
47-12	8327-8335	patterns	_	
47-13	8336-8342	across	_	
47-14	8343-8353	modalities	_	
47-15	8354-8357	and	_	
47-16	8358-8368	decomposes	_	
47-17	8369-8373	them	_	
47-18	8374-8378	into	_	
47-19	8379-8388	maximally	_	
47-20	8389-8398	spatially	_	
47-21	8399-8410	independent	_	
47-22	8411-8418	sources	_	
47-23	8419-8421	of	_	
47-24	8422-8430	variance	_	
47-25	8430-8431	.	_	

#Text=This has proven to be a powerful analytic framework and has been used to identify abnormalities in SZ and also discriminate between HC, BP, and SZ.
48-1	8432-8436	This	_	
48-2	8437-8440	has	_	
48-3	8441-8447	proven	_	
48-4	8448-8450	to	_	
48-5	8451-8453	be	_	
48-6	8454-8455	a	_	
48-7	8456-8464	powerful	_	
48-8	8465-8473	analytic	_	
48-9	8474-8483	framework	_	
48-10	8484-8487	and	_	
48-11	8488-8491	has	_	
48-12	8492-8496	been	_	
48-13	8497-8501	used	_	
48-14	8502-8504	to	_	
48-15	8505-8513	identify	_	
48-16	8514-8527	abnormalities	_	
48-17	8528-8530	in	_	
48-18	8531-8533	SZ	_	
48-19	8534-8537	and	_	
48-20	8538-8542	also	_	
48-21	8543-8555	discriminate	_	
48-22	8556-8563	between	_	
48-23	8564-8566	HC	_	
48-24	8566-8567	,	_	
48-25	8568-8570	BP	_	
48-26	8570-8571	,	_	
48-27	8572-8575	and	_	
48-28	8576-8578	SZ	_	
48-29	8578-8579	.	_	

#Text=Using a community sample from the Human Connectome Project (HCP), we identified relationships between two mCCA+jICA-derived multimodal patterns and individual differences in cognitive control performance.
49-1	8580-8585	Using	_	
49-2	8586-8587	a	_	
49-3	8588-8597	community	_	
49-4	8598-8604	sample	_	
49-5	8605-8609	from	_	
49-6	8610-8613	the	_	
49-7	8614-8619	Human	_	
49-8	8620-8630	Connectome	_	
49-9	8631-8638	Project	_	
49-10	8639-8640	(	_	
49-11	8640-8643	HCP	_	
49-12	8643-8644	)	_	
49-13	8644-8645	,	_	
49-14	8646-8648	we	_	
49-15	8649-8659	identified	_	
49-16	8660-8673	relationships	_	
49-17	8674-8681	between	_	
49-18	8682-8685	two	_	
49-19	8686-8690	mCCA	_	
49-20	8690-8691	+	_	
49-21	8691-8703	jICA-derived	_	
49-22	8704-8714	multimodal	_	
49-23	8715-8723	patterns	_	
49-24	8724-8727	and	_	
49-25	8728-8738	individual	_	
49-26	8739-8750	differences	_	
49-27	8751-8753	in	_	
49-28	8754-8763	cognitive	_	
49-29	8764-8771	control	_	
49-30	8772-8783	performance	_	
49-31	8783-8784	.	_	

#Text=These two components included structural and functional contributions from the anterior insula, visual, and parietal regions as well canonical resting-state network structures.
50-1	8785-8790	These	_	
50-2	8791-8794	two	_	
50-3	8795-8805	components	_	
50-4	8806-8814	included	_	
50-5	8815-8825	structural	_	
50-6	8826-8829	and	_	
50-7	8830-8840	functional	_	
50-8	8841-8854	contributions	_	
50-9	8855-8859	from	_	
50-10	8860-8863	the	_	
50-11	8864-8872	anterior	_	
50-12	8873-8879	insula	_	
50-13	8879-8880	,	_	
50-14	8881-8887	visual	_	
50-15	8887-8888	,	_	
50-16	8889-8892	and	_	
50-17	8893-8901	parietal	_	
50-18	8902-8909	regions	_	
50-19	8910-8912	as	_	
50-20	8913-8917	well	_	
50-21	8918-8927	canonical	_	
50-22	8928-8941	resting-state	_	
50-23	8942-8949	network	_	
50-24	8950-8960	structures	_	
50-25	8960-8961	.	_	

#Text=Importantly, the findings were replicable in an independent sample of participants from the HCP using both predictive and independent analyses.
51-1	8962-8973	Importantly	_	
51-2	8973-8974	,	_	
51-3	8975-8978	the	_	
51-4	8979-8987	findings	_	
51-5	8988-8992	were	_	
51-6	8993-9003	replicable	_	
51-7	9004-9006	in	_	
51-8	9007-9009	an	_	
51-9	9010-9021	independent	_	
51-10	9022-9028	sample	_	
51-11	9029-9031	of	_	
51-12	9032-9044	participants	_	
51-13	9045-9049	from	_	
51-14	9050-9053	the	_	
51-15	9054-9057	HCP	_	
51-16	9058-9063	using	_	
51-17	9064-9068	both	_	
51-18	9069-9079	predictive	_	
51-19	9080-9083	and	_	
51-20	9084-9095	independent	_	
51-21	9096-9104	analyses	_	
51-22	9104-9105	.	_	

#Text=The goal of the present study was to examine transdiagnostic multimodal neural alterations in psychosis, using the results of our previous work to guide analyses.
52-1	9106-9109	The	_	
52-2	9110-9114	goal	_	
52-3	9115-9117	of	_	
52-4	9118-9121	the	_	
52-5	9122-9129	present	_	
52-6	9130-9135	study	_	
52-7	9136-9139	was	_	
52-8	9140-9142	to	_	
52-9	9143-9150	examine	_	
52-10	9151-9166	transdiagnostic	_	
52-11	9167-9177	multimodal	_	
52-12	9178-9184	neural	_	
52-13	9185-9196	alterations	_	
52-14	9197-9199	in	_	
52-15	9200-9209	psychosis	_	
52-16	9209-9210	,	_	
52-17	9211-9216	using	_	
52-18	9217-9220	the	_	
52-19	9221-9228	results	_	
52-20	9229-9231	of	_	
52-21	9232-9235	our	_	
52-22	9236-9244	previous	_	
52-23	9245-9249	work	_	
52-24	9250-9252	to	_	
52-25	9253-9258	guide	_	
52-26	9259-9267	analyses	_	
52-27	9267-9268	.	_	

#Text=To accomplish this, we recruited a transdiagnostic psychosis cohort comprised of HC, SZ, and BP.
53-1	9269-9271	To	_	
53-2	9272-9282	accomplish	_	
53-3	9283-9287	this	_	
53-4	9287-9288	,	_	
53-5	9289-9291	we	_	
53-6	9292-9301	recruited	_	
53-7	9302-9303	a	_	
53-8	9304-9319	transdiagnostic	_	
53-9	9320-9329	psychosis	_	
53-10	9330-9336	cohort	_	
53-11	9337-9346	comprised	_	
53-12	9347-9349	of	_	
53-13	9350-9352	HC	_	
53-14	9352-9353	,	_	
53-15	9354-9356	SZ	_	
53-16	9356-9357	,	_	
53-17	9358-9361	and	_	
53-18	9362-9364	BP	_	
53-19	9364-9365	.	_	

#Text=Participants were imaged using the same HCP-customized scanner and performed a subset of the same HCP tasks.
54-1	9366-9378	Participants	_	
54-2	9379-9383	were	_	
54-3	9384-9390	imaged	_	
54-4	9391-9396	using	_	
54-5	9397-9400	the	_	
54-6	9401-9405	same	_	
54-7	9406-9420	HCP-customized	_	
54-8	9421-9428	scanner	_	
54-9	9429-9432	and	_	
54-10	9433-9442	performed	_	
54-11	9443-9444	a	_	
54-12	9445-9451	subset	_	
54-13	9452-9454	of	_	
54-14	9455-9458	the	_	
54-15	9459-9463	same	_	
54-16	9464-9467	HCP	_	
54-17	9468-9473	tasks	_	
54-18	9473-9474	.	_	

#Text=We first assessed the replicability of our normative findings by predicting performance in the psychosis participants using the two components from our prior work that were significantly related to cognitive control.
55-1	9475-9477	We	_	
55-2	9478-9483	first	_	
55-3	9484-9492	assessed	_	
55-4	9493-9496	the	_	
55-5	9497-9510	replicability	_	
55-6	9511-9513	of	_	
55-7	9514-9517	our	_	
55-8	9518-9527	normative	_	
55-9	9528-9536	findings	_	
55-10	9537-9539	by	_	
55-11	9540-9550	predicting	_	
55-12	9551-9562	performance	_	
55-13	9563-9565	in	_	
55-14	9566-9569	the	_	
55-15	9570-9579	psychosis	_	
55-16	9580-9592	participants	_	
55-17	9593-9598	using	_	
55-18	9599-9602	the	_	
55-19	9603-9606	two	_	
55-20	9607-9617	components	_	
55-21	9618-9622	from	_	
55-22	9623-9626	our	_	
55-23	9627-9632	prior	_	
55-24	9633-9637	work	_	
55-25	9638-9642	that	_	
55-26	9643-9647	were	_	
55-27	9648-9661	significantly	_	
55-28	9662-9669	related	_	
55-29	9670-9672	to	_	
55-30	9673-9682	cognitive	_	
55-31	9683-9690	control	_	
55-32	9690-9691	.	_	

#Text=We then performed an independent mCCA+jICA decomposition of this new transdiagnostic dataset to identify novel patterns of alteration.
56-1	9692-9694	We	_	
56-2	9695-9699	then	_	
56-3	9700-9709	performed	_	
56-4	9710-9712	an	_	
56-5	9713-9724	independent	_	
56-6	9725-9729	mCCA	_	
56-7	9729-9730	+	_	
56-8	9730-9734	jICA	_	
56-9	9735-9748	decomposition	_	
56-10	9749-9751	of	_	
56-11	9752-9756	this	_	
56-12	9757-9760	new	_	
56-13	9761-9776	transdiagnostic	_	
56-14	9777-9784	dataset	_	
56-15	9785-9787	to	_	
56-16	9788-9796	identify	_	
56-17	9797-9802	novel	_	
56-18	9803-9811	patterns	_	
56-19	9812-9814	of	_	
56-20	9815-9825	alteration	_	
56-21	9825-9826	.	_	

#Text=Methods:
#Text=Participants:
#Text=Participants were recruited from a broader study of neural alterations in psychosis and included healthy controls (HC), schizophrenia or schizoaffective disorder (SZ), and bipolar disorder (BP).
57-1	9827-9834	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
57-2	9834-9835	:	_	
57-3	9836-9848	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-4	9848-9849	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-5	9850-9862	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-6	9863-9867	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-7	9868-9877	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-8	9878-9882	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-9	9883-9884	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-10	9885-9892	broader	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-11	9893-9898	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-12	9899-9901	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-13	9902-9908	neural	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-14	9909-9920	alterations	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-15	9921-9923	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-16	9924-9933	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-17	9934-9937	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-18	9938-9946	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-19	9947-9954	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
57-20	9955-9963	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
57-21	9964-9965	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
57-22	9965-9967	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
57-23	9967-9968	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-24	9968-9969	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-25	9970-9983	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-26	9984-9986	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-27	9987-10002	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-28	10003-10011	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-29	10012-10013	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-30	10013-10015	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-31	10015-10016	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
57-32	10016-10017	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-33	10018-10021	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-34	10022-10029	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[7]	
57-35	10030-10038	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[7]	
57-36	10039-10040	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[7]	
57-37	10040-10042	BP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[7]	
57-38	10042-10043	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
57-39	10043-10044	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=Prior to image pre-processing, there were n=35 HC, n=36 BP, and n=31 SZ available.
58-1	10045-10050	Prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-2	10051-10053	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-3	10054-10059	image	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-4	10060-10074	pre-processing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-5	10074-10075	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-6	10076-10081	there	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-7	10082-10086	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-8	10087-10088	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-9	10088-10089	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-10	10089-10091	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-11	10092-10094	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
58-12	10094-10095	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-13	10096-10097	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-14	10097-10098	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-15	10098-10100	36	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-16	10101-10103	BP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[9]	
58-17	10103-10104	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-18	10105-10108	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-19	10109-10110	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-20	10110-10111	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-21	10111-10113	31	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-22	10114-10116	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[10]	
58-23	10117-10126	available	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
58-24	10126-10127	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=Of this, n=31/30* HC, n=27 BP, and n=23 SZ had the requisite data for inclusion in this study (*see supplement).
59-1	10128-10130	Of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-2	10131-10135	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-3	10135-10136	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-4	10137-10138	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-5	10138-10139	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-6	10139-10141	31	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-7	10141-10142	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-8	10142-10144	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-9	10144-10145	*	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-10	10146-10148	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[11]	
59-11	10148-10149	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-12	10150-10151	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-13	10151-10152	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-14	10152-10154	27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-15	10155-10157	BP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[12]	
59-16	10157-10158	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-17	10159-10162	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-18	10163-10164	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-19	10164-10165	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-20	10165-10167	23	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-21	10168-10170	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[13]	
59-22	10171-10174	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-23	10175-10178	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-24	10179-10188	requisite	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-25	10189-10193	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-26	10194-10197	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-27	10198-10207	inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-28	10208-10210	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-29	10211-10215	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-30	10216-10221	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-31	10222-10223	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-32	10223-10224	*	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-33	10224-10227	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-34	10228-10238	supplement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-35	10238-10239	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
59-36	10239-10240	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=Participants were recruited from clinical and community settings in Saint Louis.
60-1	10241-10253	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-2	10254-10258	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-3	10259-10268	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-4	10269-10273	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-5	10274-10282	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-6	10283-10286	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-7	10287-10296	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-8	10297-10305	settings	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-9	10306-10308	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-10	10309-10314	Saint	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-11	10315-10320	Louis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
60-12	10320-10321	.	_	

#Text=Participants had no substance use disorder in the prior six months, no clinically significant head trauma, and no neurological diseases.
61-1	10322-10334	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-2	10335-10338	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-3	10339-10341	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-4	10342-10351	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-5	10352-10355	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-6	10356-10364	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-7	10365-10367	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-8	10368-10371	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-9	10372-10377	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-10	10378-10381	six	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-11	10382-10388	months	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-12	10388-10389	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-13	10390-10392	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-14	10393-10403	clinically	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-15	10404-10415	significant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-16	10416-10420	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-17	10421-10427	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-18	10427-10428	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-19	10429-10432	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-20	10433-10435	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-21	10436-10448	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-22	10449-10457	diseases	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
61-23	10457-10458	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Patient participation criteria included: DSM-IV diagnosis of BP or SZ, age 18–30, and stable outpatient or partial hospital status.
62-1	10459-10466	Patient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-2	10467-10480	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-3	10481-10489	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-4	10490-10498	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-5	10498-10499	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-6	10500-10506	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-7	10507-10516	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-8	10517-10519	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-9	10520-10522	BP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[15]	
62-10	10523-10525	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-11	10526-10528	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[16]	
62-12	10528-10529	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-13	10530-10533	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-14	10534-10536	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-15	10536-10537	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-16	10537-10539	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-17	10539-10540	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-18	10541-10544	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-19	10545-10551	stable	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-20	10552-10562	outpatient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-21	10563-10565	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-22	10566-10573	partial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-23	10574-10582	hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-24	10583-10589	status	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
62-25	10589-10590	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=HC were recruited to have similar demographics (age, gender, parental level of education) as patients.
63-1	10591-10593	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]	
63-2	10594-10598	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-3	10599-10608	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-4	10609-10611	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-5	10612-10616	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-6	10617-10624	similar	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-7	10625-10637	demographics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-8	10638-10639	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-9	10639-10642	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-10	10642-10643	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-11	10644-10650	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-12	10650-10651	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-13	10652-10660	parental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-14	10661-10666	level	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-15	10667-10669	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-16	10670-10679	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-17	10679-10680	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-18	10681-10683	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-19	10684-10692	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
63-20	10692-10693	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=HC participation criteria included: no history of DSM-IV psychotic disorder and no cognitive enhancing or psychotropic medication for prior three months.
64-1	10694-10696	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]	
64-2	10697-10710	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-3	10711-10719	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-4	10720-10728	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-5	10728-10729	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-6	10730-10732	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-7	10733-10740	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-8	10741-10743	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-9	10744-10750	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-10	10751-10760	psychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-11	10761-10769	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-12	10770-10773	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-13	10774-10776	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-14	10777-10786	cognitive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-15	10787-10796	enhancing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-16	10797-10799	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-17	10800-10812	psychotropic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-18	10813-10823	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-19	10824-10827	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-20	10828-10833	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-21	10834-10839	three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-22	10840-10846	months	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
64-23	10846-10847	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Study procedures were approved by the Washington University Institutional Review Board and all participants gave written informed consent.
65-1	10848-10853	Study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-2	10854-10864	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-3	10865-10869	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-4	10870-10878	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-5	10879-10881	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-6	10882-10885	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-7	10886-10896	Washington	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-8	10897-10907	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-9	10908-10921	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-10	10922-10928	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-11	10929-10934	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-12	10935-10938	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-13	10939-10942	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-14	10943-10955	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-15	10956-10960	gave	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-16	10961-10968	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-17	10969-10977	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-18	10978-10985	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
65-19	10985-10986	.	_	

#Text=Behavioral assessment:
#Text=A composite measure of cognitive control was generated for each participant from their performance on four tasks (see supplement for details on each task): In-scanner N-Back task; 2) Out of scanner letter N-Back task from the Penn Computerized Neuropsychological battery (PennCNP); 3) Progressive matrices from the PennCNP; and, 4) Penn Conditional Exclusion Task accuracy.
66-1	10987-10997	Behavioral	_	
66-2	10998-11008	assessment	_	
66-3	11008-11009	:	_	
66-4	11010-11011	A	_	
66-5	11012-11021	composite	_	
66-6	11022-11029	measure	_	
66-7	11030-11032	of	_	
66-8	11033-11042	cognitive	_	
66-9	11043-11050	control	_	
66-10	11051-11054	was	_	
66-11	11055-11064	generated	_	
66-12	11065-11068	for	_	
66-13	11069-11073	each	_	
66-14	11074-11085	participant	_	
66-15	11086-11090	from	_	
66-16	11091-11096	their	_	
66-17	11097-11108	performance	_	
66-18	11109-11111	on	_	
66-19	11112-11116	four	_	
66-20	11117-11122	tasks	_	
66-21	11123-11124	(	_	
66-22	11124-11127	see	_	
66-23	11128-11138	supplement	_	
66-24	11139-11142	for	_	
66-25	11143-11150	details	_	
66-26	11151-11153	on	_	
66-27	11154-11158	each	_	
66-28	11159-11163	task	_	
66-29	11163-11164	)	_	
66-30	11164-11165	:	_	
66-31	11166-11176	In-scanner	_	
66-32	11177-11183	N-Back	_	
66-33	11184-11188	task	_	
66-34	11188-11189	;	_	
66-35	11190-11191	2	_	
66-36	11191-11192	)	_	
66-37	11193-11196	Out	_	
66-38	11197-11199	of	_	
66-39	11200-11207	scanner	_	
66-40	11208-11214	letter	_	
66-41	11215-11221	N-Back	http://maven.renci.org/NeuroBridge/neurobridge#N-BackTaskTest[19]	
66-42	11222-11226	task	http://maven.renci.org/NeuroBridge/neurobridge#N-BackTaskTest[19]	
66-43	11227-11231	from	_	
66-44	11232-11235	the	_	
66-45	11236-11240	Penn	_	
66-46	11241-11253	Computerized	_	
66-47	11254-11272	Neuropsychological	_	
66-48	11273-11280	battery	_	
66-49	11281-11282	(	_	
66-50	11282-11289	PennCNP	_	
66-51	11289-11290	)	_	
66-52	11290-11291	;	_	
66-53	11292-11293	3	_	
66-54	11293-11294	)	_	
66-55	11295-11306	Progressive	_	
66-56	11307-11315	matrices	_	
66-57	11316-11320	from	_	
66-58	11321-11324	the	_	
66-59	11325-11332	PennCNP	_	
66-60	11332-11333	;	_	
66-61	11334-11337	and	_	
66-62	11337-11338	,	_	
66-63	11339-11340	4	_	
66-64	11340-11341	)	_	
66-65	11342-11346	Penn	_	
66-66	11347-11358	Conditional	_	
66-67	11359-11368	Exclusion	_	
66-68	11369-11373	Task	_	
66-69	11374-11382	accuracy	_	
66-70	11382-11383	.	_	

#Text=Performance on each task was individually Z-scored and averaged to generate the composite measure.
67-1	11384-11395	Performance	_	
67-2	11396-11398	on	_	
67-3	11399-11403	each	_	
67-4	11404-11408	task	_	
67-5	11409-11412	was	_	
67-6	11413-11425	individually	_	
67-7	11426-11434	Z-scored	_	
67-8	11435-11438	and	_	
67-9	11439-11447	averaged	_	
67-10	11448-11450	to	_	
67-11	11451-11459	generate	_	
67-12	11460-11463	the	_	
67-13	11464-11473	composite	_	
67-14	11474-11481	measure	_	
67-15	11481-11482	.	_	

#Text=This composite had a Cronbach’s alpha of 0.75, suggesting good internal consistency.
68-1	11483-11487	This	_	
68-2	11488-11497	composite	_	
68-3	11498-11501	had	_	
68-4	11502-11503	a	_	
68-5	11504-11512	Cronbach	_	
68-6	11512-11513	’	_	
68-7	11513-11514	s	_	
68-8	11515-11520	alpha	_	
68-9	11521-11523	of	_	
68-10	11524-11528	0.75	_	
68-11	11528-11529	,	_	
68-12	11530-11540	suggesting	_	
68-13	11541-11545	good	_	
68-14	11546-11554	internal	_	
68-15	11555-11566	consistency	_	
68-16	11566-11567	.	_	

#Text=Neuroimaging collection and pre-processing
#Text=Participants were scanned at Washington University in St.
69-1	11568-11580	Neuroimaging	_	
69-2	11581-11591	collection	_	
69-3	11592-11595	and	_	
69-4	11596-11610	pre-processing	_	
69-5	11611-11623	Participants	_	
69-6	11624-11628	were	_	
69-7	11629-11636	scanned	_	
69-8	11637-11639	at	_	
69-9	11640-11650	Washington	_	
69-10	11651-11661	University	_	
69-11	11662-11664	in	_	
69-12	11665-11667	St	_	
69-13	11667-11668	.	_	

#Text=Louis using a customized Siemens “Connectome” scanner developed for the HCP.
70-1	11669-11674	Louis	_	
70-2	11675-11680	using	_	
70-3	11681-11682	a	_	
70-4	11683-11693	customized	_	
70-5	11694-11701	Siemens	_	
70-6	11702-11703	“	_	
70-7	11703-11713	Connectome	_	
70-8	11713-11714	”	_	
70-9	11715-11722	scanner	_	
70-10	11723-11732	developed	_	
70-11	11733-11736	for	_	
70-12	11737-11740	the	_	
70-13	11741-11744	HCP	_	
70-14	11744-11745	.	_	

#Text=T1 and T2 were acquired at 0.7mm isotropic resolution and BOLD imaging were collected at 2mm isotropic resolution with 720ms TR.
71-1	11746-11748	T1	_	
71-2	11749-11752	and	_	
71-3	11753-11755	T2	_	
71-4	11756-11760	were	_	
71-5	11761-11769	acquired	_	
71-6	11770-11772	at	_	
71-7	11773-11778	0.7mm	_	
71-8	11779-11788	isotropic	_	
71-9	11789-11799	resolution	_	
71-10	11800-11803	and	_	
71-11	11804-11808	BOLD	_	
71-12	11809-11816	imaging	_	
71-13	11817-11821	were	_	
71-14	11822-11831	collected	_	
71-15	11832-11834	at	_	
71-16	11835-11838	2mm	_	
71-17	11839-11848	isotropic	_	
71-18	11849-11859	resolution	_	
71-19	11860-11864	with	_	
71-20	11865-11870	720ms	_	
71-21	11871-11873	TR	_	
71-22	11873-11874	.	_	

#Text=Data were pre-processed using the HCP pipelines and further processed to generate the final imaging measures used in the present study as was done in.
72-1	11875-11879	Data	_	
72-2	11880-11884	were	_	
72-3	11885-11898	pre-processed	_	
72-4	11899-11904	using	_	
72-5	11905-11908	the	_	
72-6	11909-11912	HCP	_	
72-7	11913-11922	pipelines	_	
72-8	11923-11926	and	_	
72-9	11927-11934	further	_	
72-10	11935-11944	processed	_	
72-11	11945-11947	to	_	
72-12	11948-11956	generate	_	
72-13	11957-11960	the	_	
72-14	11961-11966	final	_	
72-15	11967-11974	imaging	_	
72-16	11975-11983	measures	_	
72-17	11984-11988	used	_	
72-18	11989-11991	in	_	
72-19	11992-11995	the	_	
72-20	11996-12003	present	_	
72-21	12004-12009	study	_	
72-22	12010-12012	as	_	
72-23	12013-12016	was	_	
72-24	12017-12021	done	_	
72-25	12022-12024	in	_	
72-26	12024-12025	.	_	

#Text=Three imaging modalities were used: 1) cortical thickness (sMRI); 2) resting state functional connectivity correlation matrices (rsfcMRI) generated using cortical, cerebellar, and subcortical parcels from Freesurfer; and, 3) the HCP N-back working memory task fMRI (tfMRI) – activation in the 2-back condition (see supplement).
73-1	12026-12031	Three	_	
73-2	12032-12039	imaging	_	
73-3	12040-12050	modalities	_	
73-4	12051-12055	were	_	
73-5	12056-12060	used	_	
73-6	12060-12061	:	_	
73-7	12062-12063	1	_	
73-8	12063-12064	)	_	
73-9	12065-12073	cortical	_	
73-10	12074-12083	thickness	_	
73-11	12084-12085	(	_	
73-12	12085-12089	sMRI	_	
73-13	12089-12090	)	_	
73-14	12090-12091	;	_	
73-15	12092-12093	2	_	
73-16	12093-12094	)	_	
73-17	12095-12102	resting	_	
73-18	12103-12108	state	_	
73-19	12109-12119	functional	_	
73-20	12120-12132	connectivity	_	
73-21	12133-12144	correlation	_	
73-22	12145-12153	matrices	_	
73-23	12154-12155	(	_	
73-24	12155-12162	rsfcMRI	_	
73-25	12162-12163	)	_	
73-26	12164-12173	generated	_	
73-27	12174-12179	using	_	
73-28	12180-12188	cortical	_	
73-29	12188-12189	,	_	
73-30	12190-12200	cerebellar	_	
73-31	12200-12201	,	_	
73-32	12202-12205	and	_	
73-33	12206-12217	subcortical	_	
73-34	12218-12225	parcels	_	
73-35	12226-12230	from	_	
73-36	12231-12241	Freesurfer	_	
73-37	12241-12242	;	_	
73-38	12243-12246	and	_	
73-39	12246-12247	,	_	
73-40	12248-12249	3	_	
73-41	12249-12250	)	_	
73-42	12251-12254	the	_	
73-43	12255-12258	HCP	_	
73-44	12259-12265	N-back	http://maven.renci.org/NeuroBridge/neurobridge#N-BackTaskTest	
73-45	12266-12273	working	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-46	12274-12280	memory	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-47	12281-12285	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-48	12286-12290	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-49	12291-12292	(	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-50	12292-12297	tfMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-51	12297-12298	)	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[20]	
73-52	12299-12300	–	_	
73-53	12301-12311	activation	_	
73-54	12312-12314	in	_	
73-55	12315-12318	the	_	
73-56	12319-12320	2	_	
73-57	12320-12321	-	_	
73-58	12321-12325	back	_	
73-59	12326-12335	condition	_	
73-60	12336-12337	(	_	
73-61	12337-12340	see	_	
73-62	12341-12351	supplement	_	
73-63	12351-12352	)	_	
73-64	12352-12353	.	_	

#Text=Relationship to a priori normative multimodal correlates of cognitive control:
#Text=Our previous work using mCCA+jICA identified replicable multimodal patterns from two mCCA+jICA components that were significantly related to cognitive control in healthy participants in the HCP.
74-1	12354-12366	Relationship	_	
74-2	12367-12369	to	_	
74-3	12370-12371	a	_	
74-4	12372-12378	priori	_	
74-5	12379-12388	normative	_	
74-6	12389-12399	multimodal	_	
74-7	12400-12410	correlates	_	
74-8	12411-12413	of	_	
74-9	12414-12423	cognitive	_	
74-10	12424-12431	control	_	
74-11	12431-12432	:	_	
74-12	12433-12436	Our	_	
74-13	12437-12445	previous	_	
74-14	12446-12450	work	_	
74-15	12451-12456	using	_	
74-16	12457-12461	mCCA	_	
74-17	12461-12462	+	_	
74-18	12462-12466	jICA	_	
74-19	12467-12477	identified	_	
74-20	12478-12488	replicable	_	
74-21	12489-12499	multimodal	_	
74-22	12500-12508	patterns	_	
74-23	12509-12513	from	_	
74-24	12514-12517	two	_	
74-25	12518-12522	mCCA	_	
74-26	12522-12523	+	_	
74-27	12523-12527	jICA	_	
74-28	12528-12538	components	_	
74-29	12539-12543	that	_	
74-30	12544-12548	were	_	
74-31	12549-12562	significantly	_	
74-32	12563-12570	related	_	
74-33	12571-12573	to	_	
74-34	12574-12583	cognitive	_	
74-35	12584-12591	control	_	
74-36	12592-12594	in	_	
74-37	12595-12602	healthy	_	
74-38	12603-12615	participants	_	
74-39	12616-12618	in	_	
74-40	12619-12622	the	_	
74-41	12623-12626	HCP	_	
74-42	12626-12627	.	_	

#Text=We performed an analysis to determine whether patterns from these two components also predicted cognitive control in the present participants.
75-1	12628-12630	We	_	
75-2	12631-12640	performed	_	
75-3	12641-12643	an	_	
75-4	12644-12652	analysis	_	
75-5	12653-12655	to	_	
75-6	12656-12665	determine	_	
75-7	12666-12673	whether	_	
75-8	12674-12682	patterns	_	
75-9	12683-12687	from	_	
75-10	12688-12693	these	_	
75-11	12694-12697	two	_	
75-12	12698-12708	components	_	
75-13	12709-12713	also	_	
75-14	12714-12723	predicted	_	
75-15	12724-12733	cognitive	_	
75-16	12734-12741	control	_	
75-17	12742-12744	in	_	
75-18	12745-12748	the	_	
75-19	12749-12756	present	_	
75-20	12757-12769	participants	_	
75-21	12769-12770	.	_	

#Text=Given that data were collected and processed identically, we directly applied the three relevant modalities from these two components from the prior study to the source data from the present cohort (referred to as HCP_gC1_IC3 and HCP_gC1_IC7, see supplement).
76-1	12771-12776	Given	_	
76-2	12777-12781	that	_	
76-3	12782-12786	data	_	
76-4	12787-12791	were	_	
76-5	12792-12801	collected	_	
76-6	12802-12805	and	_	
76-7	12806-12815	processed	_	
76-8	12816-12827	identically	_	
76-9	12827-12828	,	_	
76-10	12829-12831	we	_	
76-11	12832-12840	directly	_	
76-12	12841-12848	applied	_	
76-13	12849-12852	the	_	
76-14	12853-12858	three	_	
76-15	12859-12867	relevant	_	
76-16	12868-12878	modalities	_	
76-17	12879-12883	from	_	
76-18	12884-12889	these	_	
76-19	12890-12893	two	_	
76-20	12894-12904	components	_	
76-21	12905-12909	from	_	
76-22	12910-12913	the	_	
76-23	12914-12919	prior	_	
76-24	12920-12925	study	_	
76-25	12926-12928	to	_	
76-26	12929-12932	the	_	
76-27	12933-12939	source	_	
76-28	12940-12944	data	_	
76-29	12945-12949	from	_	
76-30	12950-12953	the	_	
76-31	12954-12961	present	_	
76-32	12962-12968	cohort	_	
76-33	12969-12970	(	_	
76-34	12970-12978	referred	_	
76-35	12979-12981	to	_	
76-36	12982-12984	as	_	
76-37	12985-12992	HCP_gC1	_	
76-38	12992-12993	_	_	
76-39	12993-12996	IC3	_	
76-40	12997-13000	and	_	
76-41	13001-13008	HCP_gC1	_	
76-42	13008-13009	_	_	
76-43	13009-13012	IC7	_	
76-44	13012-13013	,	_	
76-45	13014-13017	see	_	
76-46	13018-13028	supplement	_	
76-47	13028-13029	)	_	
76-48	13029-13030	.	_	

#Text=This generated a set of subject-specific weights for the present cohort corresponding to the extent to which a priori components reflected the present data (see supplement).
77-1	13031-13035	This	_	
77-2	13036-13045	generated	_	
77-3	13046-13047	a	_	
77-4	13048-13051	set	_	
77-5	13052-13054	of	_	
77-6	13055-13071	subject-specific	_	
77-7	13072-13079	weights	_	
77-8	13080-13083	for	_	
77-9	13084-13087	the	_	
77-10	13088-13095	present	_	
77-11	13096-13102	cohort	_	
77-12	13103-13116	corresponding	_	
77-13	13117-13119	to	_	
77-14	13120-13123	the	_	
77-15	13124-13130	extent	_	
77-16	13131-13133	to	_	
77-17	13134-13139	which	_	
77-18	13140-13141	a	_	
77-19	13142-13148	priori	_	
77-20	13149-13159	components	_	
77-21	13160-13169	reflected	_	
77-22	13170-13173	the	_	
77-23	13174-13181	present	_	
77-24	13182-13186	data	_	
77-25	13187-13188	(	_	
77-26	13188-13191	see	_	
77-27	13192-13202	supplement	_	
77-28	13202-13203	)	_	
77-29	13203-13204	.	_	

#Text=Resultant weights were correlated with the composite cognitive control measure.
#Text=mCCA+jICA multimodal imaging analysis:
#Text=We also identified mCCA+jICA components de novo in the psychosis data set.
78-1	13205-13214	Resultant	_	
78-2	13215-13222	weights	_	
78-3	13223-13227	were	_	
78-4	13228-13238	correlated	_	
78-5	13239-13243	with	_	
78-6	13244-13247	the	_	
78-7	13248-13257	composite	_	
78-8	13258-13267	cognitive	_	
78-9	13268-13275	control	_	
78-10	13276-13283	measure	_	
78-11	13283-13284	.	_	
78-12	13285-13289	mCCA	_	
78-13	13289-13290	+	_	
78-14	13290-13294	jICA	_	
78-15	13295-13305	multimodal	_	
78-16	13306-13313	imaging	_	
78-17	13314-13322	analysis	_	
78-18	13322-13323	:	_	
78-19	13324-13326	We	_	
78-20	13327-13331	also	_	
78-21	13332-13342	identified	_	
78-22	13343-13347	mCCA	_	
78-23	13347-13348	+	_	
78-24	13348-13352	jICA	_	
78-25	13353-13363	components	_	
78-26	13364-13366	de	_	
78-27	13367-13371	novo	_	
78-28	13372-13374	in	_	
78-29	13375-13378	the	_	
78-30	13379-13388	psychosis	_	
78-31	13389-13393	data	_	
78-32	13394-13397	set	_	
78-33	13397-13398	.	_	

#Text=Multiset canonical correlation analysis with joint independent component analysis (mCCA+jICA) is an unsupervised analysis framework that identifies relationships across modalities and decomposes data to reveal maximally independent latent sources of variance (see supplement).
79-1	13399-13407	Multiset	_	
79-2	13408-13417	canonical	_	
79-3	13418-13429	correlation	_	
79-4	13430-13438	analysis	_	
79-5	13439-13443	with	_	
79-6	13444-13449	joint	_	
79-7	13450-13461	independent	_	
79-8	13462-13471	component	_	
79-9	13472-13480	analysis	_	
79-10	13481-13482	(	_	
79-11	13482-13486	mCCA	_	
79-12	13486-13487	+	_	
79-13	13487-13491	jICA	_	
79-14	13491-13492	)	_	
79-15	13493-13495	is	_	
79-16	13496-13498	an	_	
79-17	13499-13511	unsupervised	_	
79-18	13512-13520	analysis	_	
79-19	13521-13530	framework	_	
79-20	13531-13535	that	_	
79-21	13536-13546	identifies	_	
79-22	13547-13560	relationships	_	
79-23	13561-13567	across	_	
79-24	13568-13578	modalities	_	
79-25	13579-13582	and	_	
79-26	13583-13593	decomposes	_	
79-27	13594-13598	data	_	
79-28	13599-13601	to	_	
79-29	13602-13608	reveal	_	
79-30	13609-13618	maximally	_	
79-31	13619-13630	independent	_	
79-32	13631-13637	latent	_	
79-33	13638-13645	sources	_	
79-34	13646-13648	of	_	
79-35	13649-13657	variance	_	
79-36	13658-13659	(	_	
79-37	13659-13662	see	_	
79-38	13663-13673	supplement	_	
79-39	13673-13674	)	_	
79-40	13674-13675	.	_	

#Text=Briefly, mCCA first aligned the three imaging modalities in order to simplify the correlational structure and maximize inter-subject covariation.
80-1	13676-13683	Briefly	_	
80-2	13683-13684	,	_	
80-3	13685-13689	mCCA	_	
80-4	13690-13695	first	_	
80-5	13696-13703	aligned	_	
80-6	13704-13707	the	_	
80-7	13708-13713	three	_	
80-8	13714-13721	imaging	_	
80-9	13722-13732	modalities	_	
80-10	13733-13735	in	_	
80-11	13736-13741	order	_	
80-12	13742-13744	to	_	
80-13	13745-13753	simplify	_	
80-14	13754-13757	the	_	
80-15	13758-13771	correlational	_	
80-16	13772-13781	structure	_	
80-17	13782-13785	and	_	
80-18	13786-13794	maximize	_	
80-19	13795-13808	inter-subject	_	
80-20	13809-13820	covariation	_	
80-21	13820-13821	.	_	

#Text=Next, jICA maximized spatial independence yielding a set of 9 independent components (ICs).
81-1	13822-13826	Next	_	
81-2	13826-13827	,	_	
81-3	13828-13832	jICA	_	
81-4	13833-13842	maximized	_	
81-5	13843-13850	spatial	_	
81-6	13851-13863	independence	_	
81-7	13864-13872	yielding	_	
81-8	13873-13874	a	_	
81-9	13875-13878	set	_	
81-10	13879-13881	of	_	
81-11	13882-13883	9	_	
81-12	13884-13895	independent	_	
81-13	13896-13906	components	_	
81-14	13907-13908	(	_	
81-15	13908-13911	ICs	_	
81-16	13911-13912	)	_	
81-17	13912-13913	.	_	

#Text=Each IC contained a set of linked modalities including maps of cortical thickness (sMRI) and working memory task activation (tfMRI), and a parcel-wise correlation matrix (rsfcMRI).
82-1	13914-13918	Each	_	
82-2	13919-13921	IC	_	
82-3	13922-13931	contained	_	
82-4	13932-13933	a	_	
82-5	13934-13937	set	_	
82-6	13938-13940	of	_	
82-7	13941-13947	linked	_	
82-8	13948-13958	modalities	_	
82-9	13959-13968	including	_	
82-10	13969-13973	maps	_	
82-11	13974-13976	of	_	
82-12	13977-13985	cortical	_	
82-13	13986-13995	thickness	_	
82-14	13996-13997	(	_	
82-15	13997-14001	sMRI	_	
82-16	14001-14002	)	_	
82-17	14003-14006	and	_	
82-18	14007-14014	working	_	
82-19	14015-14021	memory	_	
82-20	14022-14026	task	_	
82-21	14027-14037	activation	_	
82-22	14038-14039	(	_	
82-23	14039-14044	tfMRI	_	
82-24	14044-14045	)	_	
82-25	14045-14046	,	_	
82-26	14047-14050	and	_	
82-27	14051-14052	a	_	
82-28	14053-14064	parcel-wise	_	
82-29	14065-14076	correlation	_	
82-30	14077-14083	matrix	_	
82-31	14084-14085	(	_	
82-32	14085-14092	rsfcMRI	_	
82-33	14092-14093	)	_	
82-34	14093-14094	.	_	

#Text=Each IC had a corresponding set of subject-specific weights that reflected the extent to which a given IC comprised the participant’s original data.
83-1	14095-14099	Each	_	
83-2	14100-14102	IC	_	
83-3	14103-14106	had	_	
83-4	14107-14108	a	_	
83-5	14109-14122	corresponding	_	
83-6	14123-14126	set	_	
83-7	14127-14129	of	_	
83-8	14130-14146	subject-specific	_	
83-9	14147-14154	weights	_	
83-10	14155-14159	that	_	
83-11	14160-14169	reflected	_	
83-12	14170-14173	the	_	
83-13	14174-14180	extent	_	
83-14	14181-14183	to	_	
83-15	14184-14189	which	_	
83-16	14190-14191	a	_	
83-17	14192-14197	given	_	
83-18	14198-14200	IC	_	
83-19	14201-14210	comprised	_	
83-20	14211-14214	the	_	
83-21	14215-14226	participant	_	
83-22	14226-14227	’	_	
83-23	14227-14228	s	_	
83-24	14229-14237	original	_	
83-25	14238-14242	data	_	
83-26	14242-14243	.	_	

#Text=These weights were then used for statistical analyses to identify brain-behavior relationships and assess group discriminability (see supplement).
84-1	14244-14249	These	_	
84-2	14250-14257	weights	_	
84-3	14258-14262	were	_	
84-4	14263-14267	then	_	
84-5	14268-14272	used	_	
84-6	14273-14276	for	_	
84-7	14277-14288	statistical	_	
84-8	14289-14297	analyses	_	
84-9	14298-14300	to	_	
84-10	14301-14309	identify	_	
84-11	14310-14324	brain-behavior	_	
84-12	14325-14338	relationships	_	
84-13	14339-14342	and	_	
84-14	14343-14349	assess	_	
84-15	14350-14355	group	_	
84-16	14356-14372	discriminability	_	
84-17	14373-14374	(	_	
84-18	14374-14377	see	_	
84-19	14378-14388	supplement	_	
84-20	14388-14389	)	_	
84-21	14389-14390	.	_	

#Text=Statistical analyses:
#Text=Statistical analyses were performed in SPSS and MATLAB with multiple comparison correction using FDR.
85-1	14391-14402	Statistical	_	
85-2	14403-14411	analyses	_	
85-3	14411-14412	:	_	
85-4	14413-14424	Statistical	_	
85-5	14425-14433	analyses	_	
85-6	14434-14438	were	_	
85-7	14439-14448	performed	_	
85-8	14449-14451	in	_	
85-9	14452-14456	SPSS	_	
85-10	14457-14460	and	_	
85-11	14461-14467	MATLAB	_	
85-12	14468-14472	with	_	
85-13	14473-14481	multiple	_	
85-14	14482-14492	comparison	_	
85-15	14493-14503	correction	_	
85-16	14504-14509	using	_	
85-17	14510-14513	FDR	_	
85-18	14513-14514	.	_	

#Text=For correlations between subject-specific weights and cognitive control performance, partial correlation was used to correct for differences in group means.
86-1	14515-14518	For	_	
86-2	14519-14531	correlations	_	
86-3	14532-14539	between	_	
86-4	14540-14556	subject-specific	_	
86-5	14557-14564	weights	_	
86-6	14565-14568	and	_	
86-7	14569-14578	cognitive	_	
86-8	14579-14586	control	_	
86-9	14587-14598	performance	_	
86-10	14598-14599	,	_	
86-11	14600-14607	partial	_	
86-12	14608-14619	correlation	_	
86-13	14620-14623	was	_	
86-14	14624-14628	used	_	
86-15	14629-14631	to	_	
86-16	14632-14639	correct	_	
86-17	14640-14643	for	_	
86-18	14644-14655	differences	_	
86-19	14656-14658	in	_	
86-20	14659-14664	group	_	
86-21	14665-14670	means	_	
86-22	14670-14671	.	_	

#Text=We assessed group discrimination performance of each IC using multivariate analysis of variance (MANOVA) in which group was used to predict all three imaging weights (one per modality) related to each IC.
87-1	14672-14674	We	_	
87-2	14675-14683	assessed	_	
87-3	14684-14689	group	_	
87-4	14690-14704	discrimination	_	
87-5	14705-14716	performance	_	
87-6	14717-14719	of	_	
87-7	14720-14724	each	_	
87-8	14725-14727	IC	_	
87-9	14728-14733	using	_	
87-10	14734-14746	multivariate	_	
87-11	14747-14755	analysis	_	
87-12	14756-14758	of	_	
87-13	14759-14767	variance	_	
87-14	14768-14769	(	_	
87-15	14769-14775	MANOVA	_	
87-16	14775-14776	)	_	
87-17	14777-14779	in	_	
87-18	14780-14785	which	_	
87-19	14786-14791	group	_	
87-20	14792-14795	was	_	
87-21	14796-14800	used	_	
87-22	14801-14803	to	_	
87-23	14804-14811	predict	_	
87-24	14812-14815	all	_	
87-25	14816-14821	three	_	
87-26	14822-14829	imaging	_	
87-27	14830-14837	weights	_	
87-28	14838-14839	(	_	
87-29	14839-14842	one	_	
87-30	14843-14846	per	_	
87-31	14847-14855	modality	_	
87-32	14855-14856	)	_	
87-33	14857-14864	related	_	
87-34	14865-14867	to	_	
87-35	14868-14872	each	_	
87-36	14873-14875	IC	_	
87-37	14875-14876	.	_	

#Text=Significant MANOVA omnibus tests were followed up with planned contrasts.
88-1	14877-14888	Significant	_	
88-2	14889-14895	MANOVA	_	
88-3	14896-14903	omnibus	_	
88-4	14904-14909	tests	_	
88-5	14910-14914	were	_	
88-6	14915-14923	followed	_	
88-7	14924-14926	up	_	
88-8	14927-14931	with	_	
88-9	14932-14939	planned	_	
88-10	14940-14949	contrasts	_	
88-11	14949-14950	.	_	

#Text=Results:
#Text=Behavioral and demographics
#Text=There were no significant group differences in gender or parental education\\SES.
89-1	14951-14958	Results	_	
89-2	14958-14959	:	_	
89-3	14960-14970	Behavioral	_	
89-4	14971-14974	and	_	
89-5	14975-14987	demographics	_	
89-6	14988-14993	There	_	
89-7	14994-14998	were	_	
89-8	14999-15001	no	_	
89-9	15002-15013	significant	_	
89-10	15014-15019	group	_	
89-11	15020-15031	differences	_	
89-12	15032-15034	in	_	
89-13	15035-15041	gender	_	
89-14	15042-15044	or	_	
89-15	15045-15053	parental	_	
89-16	15054-15063	education	_	
89-17	15063-15064	\	_	
89-18	15064-15067	SES	_	
89-19	15067-15068	.	_	

#Text=Groups differed significantly on age, ethnicity, education, symptoms, and cognitive control performance.
90-1	15069-15075	Groups	_	
90-2	15076-15084	differed	_	
90-3	15085-15098	significantly	_	
90-4	15099-15101	on	_	
90-5	15102-15105	age	_	
90-6	15105-15106	,	_	
90-7	15107-15116	ethnicity	_	
90-8	15116-15117	,	_	
90-9	15118-15127	education	_	
90-10	15127-15128	,	_	
90-11	15129-15137	symptoms	_	
90-12	15137-15138	,	_	
90-13	15139-15142	and	_	
90-14	15143-15152	cognitive	_	
90-15	15153-15160	control	_	
90-16	15161-15172	performance	_	
90-17	15172-15173	.	_	

#Text=SZ had significantly impaired cognitive control performance as compared to HC and BP, with no difference between HC and BP (table 1).
91-1	15174-15176	SZ	_	
91-2	15177-15180	had	_	
91-3	15181-15194	significantly	_	
91-4	15195-15203	impaired	_	
91-5	15204-15213	cognitive	_	
91-6	15214-15221	control	_	
91-7	15222-15233	performance	_	
91-8	15234-15236	as	_	
91-9	15237-15245	compared	_	
91-10	15246-15248	to	_	
91-11	15249-15251	HC	_	
91-12	15252-15255	and	_	
91-13	15256-15258	BP	_	
91-14	15258-15259	,	_	
91-15	15260-15264	with	_	
91-16	15265-15267	no	_	
91-17	15268-15278	difference	_	
91-18	15279-15286	between	_	
91-19	15287-15289	HC	_	
91-20	15290-15293	and	_	
91-21	15294-15296	BP	_	
91-22	15297-15298	(	_	
91-23	15298-15303	table	_	
91-24	15304-15305	1	_	
91-25	15305-15306	)	_	
91-26	15306-15307	.	_	

#Text=Dichotomizing BP participants by psychosis severity revealed that low-psychosis BP performed significantly better than SZ and high-psychosis BP exhibited performance indistinguishable from SZ (table S13).
92-1	15308-15321	Dichotomizing	_	
92-2	15322-15324	BP	_	
92-3	15325-15337	participants	_	
92-4	15338-15340	by	_	
92-5	15341-15350	psychosis	_	
92-6	15351-15359	severity	_	
92-7	15360-15368	revealed	_	
92-8	15369-15373	that	_	
92-9	15374-15387	low-psychosis	_	
92-10	15388-15390	BP	_	
92-11	15391-15400	performed	_	
92-12	15401-15414	significantly	_	
92-13	15415-15421	better	_	
92-14	15422-15426	than	_	
92-15	15427-15429	SZ	_	
92-16	15430-15433	and	_	
92-17	15434-15448	high-psychosis	_	
92-18	15449-15451	BP	_	
92-19	15452-15461	exhibited	_	
92-20	15462-15473	performance	_	
92-21	15474-15491	indistinguishable	_	
92-22	15492-15496	from	_	
92-23	15497-15499	SZ	_	
92-24	15500-15501	(	_	
92-25	15501-15506	table	_	
92-26	15507-15510	S13	_	
92-27	15510-15511	)	_	
92-28	15511-15512	.	_	

#Text=Prediction using a priori ICs
#Text=Two ICs from (figs.
93-1	15513-15523	Prediction	_	
93-2	15524-15529	using	_	
93-3	15530-15531	a	_	
93-4	15532-15538	priori	_	
93-5	15539-15542	ICs	_	
93-6	15543-15546	Two	_	
93-7	15547-15550	ICs	_	
93-8	15551-15555	from	_	
93-9	15556-15557	(	_	
93-10	15557-15561	figs	_	
93-11	15561-15562	.	_	

#Text=S1–2) were applied to the present dataset and resultant weights partially correlated with cognitive control in order to identify whether a priori ICs predicted cognitive control in the present dataset (table 2, fig. 1, and fig.
94-1	15563-15565	S1	_	
94-2	15565-15566	–	_	
94-3	15566-15567	2	_	
94-4	15567-15568	)	_	
94-5	15569-15573	were	_	
94-6	15574-15581	applied	_	
94-7	15582-15584	to	_	
94-8	15585-15588	the	_	
94-9	15589-15596	present	_	
94-10	15597-15604	dataset	_	
94-11	15605-15608	and	_	
94-12	15609-15618	resultant	_	
94-13	15619-15626	weights	_	
94-14	15627-15636	partially	_	
94-15	15637-15647	correlated	_	
94-16	15648-15652	with	_	
94-17	15653-15662	cognitive	_	
94-18	15663-15670	control	_	
94-19	15671-15673	in	_	
94-20	15674-15679	order	_	
94-21	15680-15682	to	_	
94-22	15683-15691	identify	_	
94-23	15692-15699	whether	_	
94-24	15700-15701	a	_	
94-25	15702-15708	priori	_	
94-26	15709-15712	ICs	_	
94-27	15713-15722	predicted	_	
94-28	15723-15732	cognitive	_	
94-29	15733-15740	control	_	
94-30	15741-15743	in	_	
94-31	15744-15747	the	_	
94-32	15748-15755	present	_	
94-33	15756-15763	dataset	_	
94-34	15764-15765	(	_	
94-35	15765-15770	table	_	
94-36	15771-15772	2	_	
94-37	15772-15773	,	_	
94-38	15774-15777	fig	_	
94-39	15777-15778	.	_	
94-40	15779-15780	1	_	
94-41	15780-15781	,	_	
94-42	15782-15785	and	_	
94-43	15786-15789	fig	_	
94-44	15789-15790	.	_	

#Text=S3; see supplementary results for individual group correlations).
95-1	15791-15793	S3	_	
95-2	15793-15794	;	_	
95-3	15795-15798	see	_	
95-4	15799-15812	supplementary	_	
95-5	15813-15820	results	_	
95-6	15821-15824	for	_	
95-7	15825-15835	individual	_	
95-8	15836-15841	group	_	
95-9	15842-15854	correlations	_	
95-10	15854-15855	)	_	
95-11	15855-15856	.	_	

#Text=This identified significant predictions from a priori HCP_gC1_IC3 working memory tfMRI and HCP_gC1_IC7 cortical thickness.
96-1	15857-15861	This	_	
96-2	15862-15872	identified	_	
96-3	15873-15884	significant	_	
96-4	15885-15896	predictions	_	
96-5	15897-15901	from	_	
96-6	15902-15903	a	_	
96-7	15904-15910	priori	_	
96-8	15911-15918	HCP_gC1	_	
96-9	15918-15919	_	_	
96-10	15919-15922	IC3	_	
96-11	15923-15930	working	_	
96-12	15931-15937	memory	_	
96-13	15938-15943	tfMRI	_	
96-14	15944-15947	and	_	
96-15	15948-15955	HCP_gC1	_	
96-16	15955-15956	_	_	
96-17	15956-15959	IC7	_	
96-18	15960-15968	cortical	_	
96-19	15969-15978	thickness	_	
96-20	15978-15979	.	_	

#Text=Follow-up analyses (figs. 1, S3; tables S3–S8) identified a significant interaction driven by correlations between these weights and the cognitive control composite for SZ in HCP_gC1_IC3 tfMRI.
97-1	15980-15989	Follow-up	_	
97-2	15990-15998	analyses	_	
97-3	15999-16000	(	_	
97-4	16000-16004	figs	_	
97-5	16004-16005	.	_	
97-6	16006-16007	1	_	
97-7	16007-16008	,	_	
97-8	16009-16011	S3	_	
97-9	16011-16012	;	_	
97-10	16013-16019	tables	_	
97-11	16020-16022	S3	_	
97-12	16022-16023	–	_	
97-13	16023-16025	S8	_	
97-14	16025-16026	)	_	
97-15	16027-16037	identified	_	
97-16	16038-16039	a	_	
97-17	16040-16051	significant	_	
97-18	16052-16063	interaction	_	
97-19	16064-16070	driven	_	
97-20	16071-16073	by	_	
97-21	16074-16086	correlations	_	
97-22	16087-16094	between	_	
97-23	16095-16100	these	_	
97-24	16101-16108	weights	_	
97-25	16109-16112	and	_	
97-26	16113-16116	the	_	
97-27	16117-16126	cognitive	_	
97-28	16127-16134	control	_	
97-29	16135-16144	composite	_	
97-30	16145-16148	for	_	
97-31	16149-16151	SZ	_	
97-32	16152-16154	in	_	
97-33	16155-16162	HCP_gC1	_	
97-34	16162-16163	_	_	
97-35	16163-16166	IC3	_	
97-36	16167-16172	tfMRI	_	
97-37	16172-16173	.	_	

#Text=There were no significant interactions with group for HCP_gC1_IC7 sMRI.
98-1	16174-16179	There	_	
98-2	16180-16184	were	_	
98-3	16185-16187	no	_	
98-4	16188-16199	significant	_	
98-5	16200-16212	interactions	_	
98-6	16213-16217	with	_	
98-7	16218-16223	group	_	
98-8	16224-16227	for	_	
98-9	16228-16235	HCP_gC1	_	
98-10	16235-16236	_	_	
98-11	16236-16239	IC7	_	
98-12	16240-16244	sMRI	_	
98-13	16244-16245	.	_	

#Text=Neither HCP_gC1_IC3 or HCP_gC1_IC7 were group discriminative (tables S16–S17).
99-1	16246-16253	Neither	_	
99-2	16254-16261	HCP_gC1	_	
99-3	16261-16262	_	_	
99-4	16262-16265	IC3	_	
99-5	16266-16268	or	_	
99-6	16269-16276	HCP_gC1	_	
99-7	16276-16277	_	_	
99-8	16277-16280	IC7	_	
99-9	16281-16285	were	_	
99-10	16286-16291	group	_	
99-11	16292-16306	discriminative	_	
99-12	16307-16308	(	_	
99-13	16308-16314	tables	_	
99-14	16315-16318	S16	_	
99-15	16318-16319	–	_	
99-16	16319-16322	S17	_	
99-17	16322-16323	)	_	
99-18	16323-16324	.	_	

#Text=De novo mCCA+jICA
#Text=mCCA+jICA was also performed de novo to identify novel domains of variation in the psychosis cohort.
100-1	16325-16327	De	_	
100-2	16328-16332	novo	_	
100-3	16333-16337	mCCA	_	
100-4	16337-16338	+	_	
100-5	16338-16342	jICA	_	
100-6	16343-16347	mCCA	_	
100-7	16347-16348	+	_	
100-8	16348-16352	jICA	_	
100-9	16353-16356	was	_	
100-10	16357-16361	also	_	
100-11	16362-16371	performed	_	
100-12	16372-16374	de	_	
100-13	16375-16379	novo	_	
100-14	16380-16382	to	_	
100-15	16383-16391	identify	_	
100-16	16392-16397	novel	_	
100-17	16398-16405	domains	_	
100-18	16406-16408	of	_	
100-19	16409-16418	variation	_	
100-20	16419-16421	in	_	
100-21	16422-16425	the	_	
100-22	16426-16435	psychosis	_	
100-23	16436-16442	cohort	_	
100-24	16442-16443	.	_	

#Text=This identified a single component, IC3, that significantly correlated with cognitive control for all three modalities after FDR correction.
101-1	16444-16448	This	_	
101-2	16449-16459	identified	_	
101-3	16460-16461	a	_	
101-4	16462-16468	single	_	
101-5	16469-16478	component	_	
101-6	16478-16479	,	_	
101-7	16480-16483	IC3	_	
101-8	16483-16484	,	_	
101-9	16485-16489	that	_	
101-10	16490-16503	significantly	_	
101-11	16504-16514	correlated	_	
101-12	16515-16519	with	_	
101-13	16520-16529	cognitive	_	
101-14	16530-16537	control	_	
101-15	16538-16541	for	_	
101-16	16542-16545	all	_	
101-17	16546-16551	three	_	
101-18	16552-16562	modalities	_	
101-19	16563-16568	after	_	
101-20	16569-16572	FDR	_	
101-21	16573-16583	correction	_	
101-22	16583-16584	.	_	

#Text=Follow-up partial correlations correcting for group were performed, indicating that all three modalities still significantly correlated with cognitive control (table 2).
102-1	16585-16594	Follow-up	_	
102-2	16595-16602	partial	_	
102-3	16603-16615	correlations	_	
102-4	16616-16626	correcting	_	
102-5	16627-16630	for	_	
102-6	16631-16636	group	_	
102-7	16637-16641	were	_	
102-8	16642-16651	performed	_	
102-9	16651-16652	,	_	
102-10	16653-16663	indicating	_	
102-11	16664-16668	that	_	
102-12	16669-16672	all	_	
102-13	16673-16678	three	_	
102-14	16679-16689	modalities	_	
102-15	16690-16695	still	_	
102-16	16696-16709	significantly	_	
102-17	16710-16720	correlated	_	
102-18	16721-16725	with	_	
102-19	16726-16735	cognitive	_	
102-20	16736-16743	control	_	
102-21	16744-16745	(	_	
102-22	16745-16750	table	_	
102-23	16751-16752	2	_	
102-24	16752-16753	)	_	
102-25	16753-16754	.	_	

#Text=Follow-up analyses (Figs. 2, S3; tables S9–11) identified significant interactions in all three modalities such that SZ were responsible for the significant correlations between imaging and cognitive control.
103-1	16755-16764	Follow-up	_	
103-2	16765-16773	analyses	_	
103-3	16774-16775	(	_	
103-4	16775-16779	Figs	_	
103-5	16779-16780	.	_	
103-6	16781-16782	2	_	
103-7	16782-16783	,	_	
103-8	16784-16786	S3	_	
103-9	16786-16787	;	_	
103-10	16788-16794	tables	_	
103-11	16795-16797	S9	_	
103-12	16797-16798	–	_	
103-13	16798-16800	11	_	
103-14	16800-16801	)	_	
103-15	16802-16812	identified	_	
103-16	16813-16824	significant	_	
103-17	16825-16837	interactions	_	
103-18	16838-16840	in	_	
103-19	16841-16844	all	_	
103-20	16845-16850	three	_	
103-21	16851-16861	modalities	_	
103-22	16862-16866	such	_	
103-23	16867-16871	that	_	
103-24	16872-16874	SZ	_	
103-25	16875-16879	were	_	
103-26	16880-16891	responsible	_	
103-27	16892-16895	for	_	
103-28	16896-16899	the	_	
103-29	16900-16911	significant	_	
103-30	16912-16924	correlations	_	
103-31	16925-16932	between	_	
103-32	16933-16940	imaging	_	
103-33	16941-16944	and	_	
103-34	16945-16954	cognitive	_	
103-35	16955-16962	control	_	
103-36	16962-16963	.	_	

#Text=Spatial distributions of de novo IC3
#Text=The modalities in de novo IC3 (figs. 3–5) were visually inspected and bore strong visual resemblances to a priori HCP_gC1_IC3 (fig.
104-1	16964-16971	Spatial	_	
104-2	16972-16985	distributions	_	
104-3	16986-16988	of	_	
104-4	16989-16991	de	_	
104-5	16992-16996	novo	_	
104-6	16997-17000	IC3	_	
104-7	17001-17004	The	_	
104-8	17005-17015	modalities	_	
104-9	17016-17018	in	_	
104-10	17019-17021	de	_	
104-11	17022-17026	novo	_	
104-12	17027-17030	IC3	_	
104-13	17031-17032	(	_	
104-14	17032-17036	figs	_	
104-15	17036-17037	.	_	
104-16	17038-17039	3	_	
104-17	17039-17040	–	_	
104-18	17040-17041	5	_	
104-19	17041-17042	)	_	
104-20	17043-17047	were	_	
104-21	17048-17056	visually	_	
104-22	17057-17066	inspected	_	
104-23	17067-17070	and	_	
104-24	17071-17075	bore	_	
104-25	17076-17082	strong	_	
104-26	17083-17089	visual	_	
104-27	17090-17102	resemblances	_	
104-28	17103-17105	to	_	
104-29	17106-17107	a	_	
104-30	17108-17114	priori	_	
104-31	17115-17122	HCP_gC1	_	
104-32	17122-17123	_	_	
104-33	17123-17126	IC3	_	
104-34	17127-17128	(	_	
104-35	17128-17131	fig	_	
104-36	17131-17132	.	_	

#Text=S1).
105-1	17133-17135	S1	_	
105-2	17135-17136	)	_	
105-3	17136-17137	.	_	

#Text=Algorithmic matching using η2 confirmed visual similarity by pairing IC3 with HCP_gC1_IC3 as the strongest match across all ICs with 91.5% shared variance across the two ICs (table S1).
106-1	17138-17149	Algorithmic	_	
106-2	17150-17158	matching	_	
106-3	17159-17164	using	_	
106-4	17165-17167	η2	_	
106-5	17168-17177	confirmed	_	
106-6	17178-17184	visual	_	
106-7	17185-17195	similarity	_	
106-8	17196-17198	by	_	
106-9	17199-17206	pairing	_	
106-10	17207-17210	IC3	_	
106-11	17211-17215	with	_	
106-12	17216-17223	HCP_gC1	_	
106-13	17223-17224	_	_	
106-14	17224-17227	IC3	_	
106-15	17228-17230	as	_	
106-16	17231-17234	the	_	
106-17	17235-17244	strongest	_	
106-18	17245-17250	match	_	
106-19	17251-17257	across	_	
106-20	17258-17261	all	_	
106-21	17262-17265	ICs	_	
106-22	17266-17270	with	_	
106-23	17271-17276	91.5%	_	
106-24	17277-17283	shared	_	
106-25	17284-17292	variance	_	
106-26	17293-17299	across	_	
106-27	17300-17303	the	_	
106-28	17304-17307	two	_	
106-29	17308-17311	ICs	_	
106-30	17312-17313	(	_	
106-31	17313-17318	table	_	
106-32	17319-17321	S1	_	
106-33	17321-17322	)	_	
106-34	17322-17323	.	_	

#Text=Matching analyses using individual modalities were also performed (see supplement).
107-1	17324-17332	Matching	_	
107-2	17333-17341	analyses	_	
107-3	17342-17347	using	_	
107-4	17348-17358	individual	_	
107-5	17359-17369	modalities	_	
107-6	17370-17374	were	_	
107-7	17375-17379	also	_	
107-8	17380-17389	performed	_	
107-9	17390-17391	(	_	
107-10	17391-17394	see	_	
107-11	17395-17405	supplement	_	
107-12	17405-17406	)	_	
107-13	17406-17407	.	_	

#Text=For sMRI data in IC3 (fig. 3), the strongest positive contributing areas were in bilateral anterior and posterior insula, temporal pole, cingulate, frontal superior cortex, and temporal gyrus.
108-1	17408-17411	For	_	
108-2	17412-17416	sMRI	_	
108-3	17417-17421	data	_	
108-4	17422-17424	in	_	
108-5	17425-17428	IC3	_	
108-6	17429-17430	(	_	
108-7	17430-17433	fig	_	
108-8	17433-17434	.	_	
108-9	17435-17436	3	_	
108-10	17436-17437	)	_	
108-11	17437-17438	,	_	
108-12	17439-17442	the	_	
108-13	17443-17452	strongest	_	
108-14	17453-17461	positive	_	
108-15	17462-17474	contributing	_	
108-16	17475-17480	areas	_	
108-17	17481-17485	were	_	
108-18	17486-17488	in	_	
108-19	17489-17498	bilateral	_	
108-20	17499-17507	anterior	_	
108-21	17508-17511	and	_	
108-22	17512-17521	posterior	_	
108-23	17522-17528	insula	_	
108-24	17528-17529	,	_	
108-25	17530-17538	temporal	_	
108-26	17539-17543	pole	_	
108-27	17543-17544	,	_	
108-28	17545-17554	cingulate	_	
108-29	17554-17555	,	_	
108-30	17556-17563	frontal	_	
108-31	17564-17572	superior	_	
108-32	17573-17579	cortex	_	
108-33	17579-17580	,	_	
108-34	17581-17584	and	_	
108-35	17585-17593	temporal	_	
108-36	17594-17599	gyrus	_	
108-37	17599-17600	.	_	

#Text=Thus, improved cognitive control performance was related to greater thickness in these areas.
109-1	17601-17605	Thus	_	
109-2	17605-17606	,	_	
109-3	17607-17615	improved	_	
109-4	17616-17625	cognitive	_	
109-5	17626-17633	control	_	
109-6	17634-17645	performance	_	
109-7	17646-17649	was	_	
109-8	17650-17657	related	_	
109-9	17658-17660	to	_	
109-10	17661-17668	greater	_	
109-11	17669-17678	thickness	_	
109-12	17679-17681	in	_	
109-13	17682-17687	these	_	
109-14	17688-17693	areas	_	
109-15	17693-17694	.	_	

#Text=For rsfcMRI data in IC3 (Fig. 4), the strongest positive contributions were concentrated in within-network connectivity, the diagonal of the correlation matrix, with improved cognitive control performance related to stronger within network connectivity.
110-1	17695-17698	For	_	
110-2	17699-17706	rsfcMRI	_	
110-3	17707-17711	data	_	
110-4	17712-17714	in	_	
110-5	17715-17718	IC3	_	
110-6	17719-17720	(	_	
110-7	17720-17723	Fig	_	
110-8	17723-17724	.	_	
110-9	17725-17726	4	_	
110-10	17726-17727	)	_	
110-11	17727-17728	,	_	
110-12	17729-17732	the	_	
110-13	17733-17742	strongest	_	
110-14	17743-17751	positive	_	
110-15	17752-17765	contributions	_	
110-16	17766-17770	were	_	
110-17	17771-17783	concentrated	_	
110-18	17784-17786	in	_	
110-19	17787-17801	within-network	_	
110-20	17802-17814	connectivity	_	
110-21	17814-17815	,	_	
110-22	17816-17819	the	_	
110-23	17820-17828	diagonal	_	
110-24	17829-17831	of	_	
110-25	17832-17835	the	_	
110-26	17836-17847	correlation	_	
110-27	17848-17854	matrix	_	
110-28	17854-17855	,	_	
110-29	17856-17860	with	_	
110-30	17861-17869	improved	_	
110-31	17870-17879	cognitive	_	
110-32	17880-17887	control	_	
110-33	17888-17899	performance	_	
110-34	17900-17907	related	_	
110-35	17908-17910	to	_	
110-36	17911-17919	stronger	_	
110-37	17920-17926	within	_	
110-38	17927-17934	network	_	
110-39	17935-17947	connectivity	_	
110-40	17947-17948	.	_	

#Text=Negative contributions were predominantly concentrated off-diagonal and between the default mode network (DMN) and the task positive networks, including the fronto-parietal, cingulo-opercular, parietal encoding and retrieval, dorsal attention, and ventral attention networks.
111-1	17949-17957	Negative	_	
111-2	17958-17971	contributions	_	
111-3	17972-17976	were	_	
111-4	17977-17990	predominantly	_	
111-5	17991-18003	concentrated	_	
111-6	18004-18016	off-diagonal	_	
111-7	18017-18020	and	_	
111-8	18021-18028	between	_	
111-9	18029-18032	the	_	
111-10	18033-18040	default	_	
111-11	18041-18045	mode	_	
111-12	18046-18053	network	_	
111-13	18054-18055	(	_	
111-14	18055-18058	DMN	_	
111-15	18058-18059	)	_	
111-16	18060-18063	and	_	
111-17	18064-18067	the	_	
111-18	18068-18072	task	_	
111-19	18073-18081	positive	_	
111-20	18082-18090	networks	_	
111-21	18090-18091	,	_	
111-22	18092-18101	including	_	
111-23	18102-18105	the	_	
111-24	18106-18121	fronto-parietal	_	
111-25	18121-18122	,	_	
111-26	18123-18140	cingulo-opercular	_	
111-27	18140-18141	,	_	
111-28	18142-18150	parietal	_	
111-29	18151-18159	encoding	_	
111-30	18160-18163	and	_	
111-31	18164-18173	retrieval	_	
111-32	18173-18174	,	_	
111-33	18175-18181	dorsal	_	
111-34	18182-18191	attention	_	
111-35	18191-18192	,	_	
111-36	18193-18196	and	_	
111-37	18197-18204	ventral	_	
111-38	18205-18214	attention	_	
111-39	18215-18223	networks	_	
111-40	18223-18224	.	_	

#Text=Thus, improved cognitive control performance was related to stronger negative connections between networks.
112-1	18225-18229	Thus	_	
112-2	18229-18230	,	_	
112-3	18231-18239	improved	_	
112-4	18240-18249	cognitive	_	
112-5	18250-18257	control	_	
112-6	18258-18269	performance	_	
112-7	18270-18273	was	_	
112-8	18274-18281	related	_	
112-9	18282-18284	to	_	
112-10	18285-18293	stronger	_	
112-11	18294-18302	negative	_	
112-12	18303-18314	connections	_	
112-13	18315-18322	between	_	
112-14	18323-18331	networks	_	
112-15	18331-18332	.	_	

#Text=For tfMRI data in IC3 (Fig. 5), the strongest positive contributing areas were in bilateral visual cortex, intraparietal sulcus, superior parietal gyrus, precentral sulcus and right middle cingulate, and inferior frontal sulcus, with improved cognitive control performance related to greater activation in these regions.
113-1	18333-18336	For	_	
113-2	18337-18342	tfMRI	_	
113-3	18343-18347	data	_	
113-4	18348-18350	in	_	
113-5	18351-18354	IC3	_	
113-6	18355-18356	(	_	
113-7	18356-18359	Fig	_	
113-8	18359-18360	.	_	
113-9	18361-18362	5	_	
113-10	18362-18363	)	_	
113-11	18363-18364	,	_	
113-12	18365-18368	the	_	
113-13	18369-18378	strongest	_	
113-14	18379-18387	positive	_	
113-15	18388-18400	contributing	_	
113-16	18401-18406	areas	_	
113-17	18407-18411	were	_	
113-18	18412-18414	in	_	
113-19	18415-18424	bilateral	_	
113-20	18425-18431	visual	_	
113-21	18432-18438	cortex	_	
113-22	18438-18439	,	_	
113-23	18440-18453	intraparietal	_	
113-24	18454-18460	sulcus	_	
113-25	18460-18461	,	_	
113-26	18462-18470	superior	_	
113-27	18471-18479	parietal	_	
113-28	18480-18485	gyrus	_	
113-29	18485-18486	,	_	
113-30	18487-18497	precentral	_	
113-31	18498-18504	sulcus	_	
113-32	18505-18508	and	_	
113-33	18509-18514	right	_	
113-34	18515-18521	middle	_	
113-35	18522-18531	cingulate	_	
113-36	18531-18532	,	_	
113-37	18533-18536	and	_	
113-38	18537-18545	inferior	_	
113-39	18546-18553	frontal	_	
113-40	18554-18560	sulcus	_	
113-41	18560-18561	,	_	
113-42	18562-18566	with	_	
113-43	18567-18575	improved	_	
113-44	18576-18585	cognitive	_	
113-45	18586-18593	control	_	
113-46	18594-18605	performance	_	
113-47	18606-18613	related	_	
113-48	18614-18616	to	_	
113-49	18617-18624	greater	_	
113-50	18625-18635	activation	_	
113-51	18636-18638	in	_	
113-52	18639-18644	these	_	
113-53	18645-18652	regions	_	
113-54	18652-18653	.	_	

#Text=The strongest negative contributions were seen in bilateral isthmus of the cingulate, left supramarginal gyrus, precuneus, and inferior parietal gyrus.
114-1	18654-18657	The	_	
114-2	18658-18667	strongest	_	
114-3	18668-18676	negative	_	
114-4	18677-18690	contributions	_	
114-5	18691-18695	were	_	
114-6	18696-18700	seen	_	
114-7	18701-18703	in	_	
114-8	18704-18713	bilateral	_	
114-9	18714-18721	isthmus	_	
114-10	18722-18724	of	_	
114-11	18725-18728	the	_	
114-12	18729-18738	cingulate	_	
114-13	18738-18739	,	_	
114-14	18740-18744	left	_	
114-15	18745-18758	supramarginal	_	
114-16	18759-18764	gyrus	_	
114-17	18764-18765	,	_	
114-18	18766-18775	precuneus	_	
114-19	18775-18776	,	_	
114-20	18777-18780	and	_	
114-21	18781-18789	inferior	_	
114-22	18790-18798	parietal	_	
114-23	18799-18804	gyrus	_	
114-24	18804-18805	.	_	

#Text=Thus, improved cognitive control performance was related to lower activation in these regions.
115-1	18806-18810	Thus	_	
115-2	18810-18811	,	_	
115-3	18812-18820	improved	_	
115-4	18821-18830	cognitive	_	
115-5	18831-18838	control	_	
115-6	18839-18850	performance	_	
115-7	18851-18854	was	_	
115-8	18855-18862	related	_	
115-9	18863-18865	to	_	
115-10	18866-18871	lower	_	
115-11	18872-18882	activation	_	
115-12	18883-18885	in	_	
115-13	18886-18891	these	_	
115-14	18892-18899	regions	_	
115-15	18899-18900	.	_	

#Text=Group-discrimination
#Text=MANOVAs were performed for each IC to assess whether imaging weights were group discriminative.
116-1	18901-18921	Group-discrimination	_	
116-2	18922-18929	MANOVAs	_	
116-3	18930-18934	were	_	
116-4	18935-18944	performed	_	
116-5	18945-18948	for	_	
116-6	18949-18953	each	_	
116-7	18954-18956	IC	_	
116-8	18957-18959	to	_	
116-9	18960-18966	assess	_	
116-10	18967-18974	whether	_	
116-11	18975-18982	imaging	_	
116-12	18983-18990	weights	_	
116-13	18991-18995	were	_	
116-14	18996-19001	group	_	
116-15	19002-19016	discriminative	_	
116-16	19016-19017	.	_	

#Text=Omnibus MANOVA results were significant with FDR correction only for IC3, the only component significantly related to cognitive control (table 3); all other ICs were not group-discriminative (table S2).
117-1	19018-19025	Omnibus	_	
117-2	19026-19032	MANOVA	_	
117-3	19033-19040	results	_	
117-4	19041-19045	were	_	
117-5	19046-19057	significant	_	
117-6	19058-19062	with	_	
117-7	19063-19066	FDR	_	
117-8	19067-19077	correction	_	
117-9	19078-19082	only	_	
117-10	19083-19086	for	_	
117-11	19087-19090	IC3	_	
117-12	19090-19091	,	_	
117-13	19092-19095	the	_	
117-14	19096-19100	only	_	
117-15	19101-19110	component	_	
117-16	19111-19124	significantly	_	
117-17	19125-19132	related	_	
117-18	19133-19135	to	_	
117-19	19136-19145	cognitive	_	
117-20	19146-19153	control	_	
117-21	19154-19155	(	_	
117-22	19155-19160	table	_	
117-23	19161-19162	3	_	
117-24	19162-19163	)	_	
117-25	19163-19164	;	_	
117-26	19165-19168	all	_	
117-27	19169-19174	other	_	
117-28	19175-19178	ICs	_	
117-29	19179-19183	were	_	
117-30	19184-19187	not	_	
117-31	19188-19208	group-discriminative	_	
117-32	19209-19210	(	_	
117-33	19210-19215	table	_	
117-34	19216-19218	S2	_	
117-35	19218-19219	)	_	
117-36	19219-19220	.	_	

#Text=Between subjects effects were significant for tfMRI and trended significant for sMRI.
118-1	19221-19228	Between	_	
118-2	19229-19237	subjects	_	
118-3	19238-19245	effects	_	
118-4	19246-19250	were	_	
118-5	19251-19262	significant	_	
118-6	19263-19266	for	_	
118-7	19267-19272	tfMRI	_	
118-8	19273-19276	and	_	
118-9	19277-19284	trended	_	
118-10	19285-19296	significant	_	
118-11	19297-19300	for	_	
118-12	19301-19305	sMRI	_	
118-13	19305-19306	.	_	

#Text=Post-hoc tests between groups were significant for group differences between HC and SZ for sMRI and tfMRI, trend-level significant for differences between BP and SZ for all three modalities, and no differences between HC and BP.
119-1	19307-19315	Post-hoc	_	
119-2	19316-19321	tests	_	
119-3	19322-19329	between	_	
119-4	19330-19336	groups	_	
119-5	19337-19341	were	_	
119-6	19342-19353	significant	_	
119-7	19354-19357	for	_	
119-8	19358-19363	group	_	
119-9	19364-19375	differences	_	
119-10	19376-19383	between	_	
119-11	19384-19386	HC	_	
119-12	19387-19390	and	_	
119-13	19391-19393	SZ	_	
119-14	19394-19397	for	_	
119-15	19398-19402	sMRI	_	
119-16	19403-19406	and	_	
119-17	19407-19412	tfMRI	_	
119-18	19412-19413	,	_	
119-19	19414-19425	trend-level	_	
119-20	19426-19437	significant	_	
119-21	19438-19441	for	_	
119-22	19442-19453	differences	_	
119-23	19454-19461	between	_	
119-24	19462-19464	BP	_	
119-25	19465-19468	and	_	
119-26	19469-19471	SZ	_	
119-27	19472-19475	for	_	
119-28	19476-19479	all	_	
119-29	19480-19485	three	_	
119-30	19486-19496	modalities	_	
119-31	19496-19497	,	_	
119-32	19498-19501	and	_	
119-33	19502-19504	no	_	
119-34	19505-19516	differences	_	
119-35	19517-19524	between	_	
119-36	19525-19527	HC	_	
119-37	19528-19531	and	_	
119-38	19532-19534	BP	_	
119-39	19534-19535	.	_	

#Text=Although groups did not significantly differ on parental SES, inclusion of parental SES as a covariate improved the model such that there were trend or significant effects for all modalities (table S9).
120-1	19536-19544	Although	_	
120-2	19545-19551	groups	_	
120-3	19552-19555	did	_	
120-4	19556-19559	not	_	
120-5	19560-19573	significantly	_	
120-6	19574-19580	differ	_	
120-7	19581-19583	on	_	
120-8	19584-19592	parental	_	
120-9	19593-19596	SES	_	
120-10	19596-19597	,	_	
120-11	19598-19607	inclusion	_	
120-12	19608-19610	of	_	
120-13	19611-19619	parental	_	
120-14	19620-19623	SES	_	
120-15	19624-19626	as	_	
120-16	19627-19628	a	_	
120-17	19629-19638	covariate	_	
120-18	19639-19647	improved	_	
120-19	19648-19651	the	_	
120-20	19652-19657	model	_	
120-21	19658-19662	such	_	
120-22	19663-19667	that	_	
120-23	19668-19673	there	_	
120-24	19674-19678	were	_	
120-25	19679-19684	trend	_	
120-26	19685-19687	or	_	
120-27	19688-19699	significant	_	
120-28	19700-19707	effects	_	
120-29	19708-19711	for	_	
120-30	19712-19715	all	_	
120-31	19716-19726	modalities	_	
120-32	19727-19728	(	_	
120-33	19728-19733	table	_	
120-34	19734-19736	S9	_	
120-35	19736-19737	)	_	
120-36	19737-19738	.	_	

#Text=Discussion:
#Text=The goal of the present study was to examine transdiagnostic multimodal neural alterations in psychosis related to cognitive control.
121-1	19739-19749	Discussion	_	
121-2	19749-19750	:	_	
121-3	19751-19754	The	_	
121-4	19755-19759	goal	_	
121-5	19760-19762	of	_	
121-6	19763-19766	the	_	
121-7	19767-19774	present	_	
121-8	19775-19780	study	_	
121-9	19781-19784	was	_	
121-10	19785-19787	to	_	
121-11	19788-19795	examine	_	
121-12	19796-19811	transdiagnostic	_	
121-13	19812-19822	multimodal	_	
121-14	19823-19829	neural	_	
121-15	19830-19841	alterations	_	
121-16	19842-19844	in	_	
121-17	19845-19854	psychosis	_	
121-18	19855-19862	related	_	
121-19	19863-19865	to	_	
121-20	19866-19875	cognitive	_	
121-21	19876-19883	control	_	
121-22	19883-19884	.	_	

#Text=Application of a priori ICs identified in the HCP to the psychosis dataset significantly predicted cognitive control performance in a cortical thickness map for all groups and in a working memory map for SZ participants.
122-1	19885-19896	Application	_	
122-2	19897-19899	of	_	
122-3	19900-19901	a	_	
122-4	19902-19908	priori	_	
122-5	19909-19912	ICs	_	
122-6	19913-19923	identified	_	
122-7	19924-19926	in	_	
122-8	19927-19930	the	_	
122-9	19931-19934	HCP	_	
122-10	19935-19937	to	_	
122-11	19938-19941	the	_	
122-12	19942-19951	psychosis	_	
122-13	19952-19959	dataset	_	
122-14	19960-19973	significantly	_	
122-15	19974-19983	predicted	_	
122-16	19984-19993	cognitive	_	
122-17	19994-20001	control	_	
122-18	20002-20013	performance	_	
122-19	20014-20016	in	_	
122-20	20017-20018	a	_	
122-21	20019-20027	cortical	_	
122-22	20028-20037	thickness	_	
122-23	20038-20041	map	_	
122-24	20042-20045	for	_	
122-25	20046-20049	all	_	
122-26	20050-20056	groups	_	
122-27	20057-20060	and	_	
122-28	20061-20063	in	_	
122-29	20064-20065	a	_	
122-30	20066-20073	working	_	
122-31	20074-20080	memory	_	
122-32	20081-20084	map	_	
122-33	20085-20088	for	_	
122-34	20089-20091	SZ	_	
122-35	20092-20104	participants	_	
122-36	20104-20105	.	_	

#Text=De novo mCCA+jICA analysis of the psychosis dataset identified a single IC that significantly correlated with cognitive control performance in SZ.
123-1	20106-20108	De	_	
123-2	20109-20113	novo	_	
123-3	20114-20118	mCCA	_	
123-4	20118-20119	+	_	
123-5	20119-20123	jICA	_	
123-6	20124-20132	analysis	_	
123-7	20133-20135	of	_	
123-8	20136-20139	the	_	
123-9	20140-20149	psychosis	_	
123-10	20150-20157	dataset	_	
123-11	20158-20168	identified	_	
123-12	20169-20170	a	_	
123-13	20171-20177	single	_	
123-14	20178-20180	IC	_	
123-15	20181-20185	that	_	
123-16	20186-20199	significantly	_	
123-17	20200-20210	correlated	_	
123-18	20211-20215	with	_	
123-19	20216-20225	cognitive	_	
123-20	20226-20233	control	_	
123-21	20234-20245	performance	_	
123-22	20246-20248	in	_	
123-23	20249-20251	SZ	_	
123-24	20251-20252	.	_	

#Text=This IC exhibited highly similar spatial distribution to an a priori IC and was the sole group-discriminative IC from the de novo mCCA+jICA results.
124-1	20253-20257	This	_	
124-2	20258-20260	IC	_	
124-3	20261-20270	exhibited	_	
124-4	20271-20277	highly	_	
124-5	20278-20285	similar	_	
124-6	20286-20293	spatial	_	
124-7	20294-20306	distribution	_	
124-8	20307-20309	to	_	
124-9	20310-20312	an	_	
124-10	20313-20314	a	_	
124-11	20315-20321	priori	_	
124-12	20322-20324	IC	_	
124-13	20325-20328	and	_	
124-14	20329-20332	was	_	
124-15	20333-20336	the	_	
124-16	20337-20341	sole	_	
124-17	20342-20362	group-discriminative	_	
124-18	20363-20365	IC	_	
124-19	20366-20370	from	_	
124-20	20371-20374	the	_	
124-21	20375-20377	de	_	
124-22	20378-20382	novo	_	
124-23	20383-20387	mCCA	_	
124-24	20387-20388	+	_	
124-25	20388-20392	jICA	_	
124-26	20393-20400	results	_	
124-27	20400-20401	.	_	

#Text=Importantly, as described below, our multi-modal analyses illustrate the ways in which there are both deficits in the same regions/networks that cut across modalities, as well as deficits that are modality specific, though contributing to joint prediction of cognitive control.
125-1	20402-20413	Importantly	_	
125-2	20413-20414	,	_	
125-3	20415-20417	as	_	
125-4	20418-20427	described	_	
125-5	20428-20433	below	_	
125-6	20433-20434	,	_	
125-7	20435-20438	our	_	
125-8	20439-20450	multi-modal	_	
125-9	20451-20459	analyses	_	
125-10	20460-20470	illustrate	_	
125-11	20471-20474	the	_	
125-12	20475-20479	ways	_	
125-13	20480-20482	in	_	
125-14	20483-20488	which	_	
125-15	20489-20494	there	_	
125-16	20495-20498	are	_	
125-17	20499-20503	both	_	
125-18	20504-20512	deficits	_	
125-19	20513-20515	in	_	
125-20	20516-20519	the	_	
125-21	20520-20524	same	_	
125-22	20525-20532	regions	_	
125-23	20532-20533	/	_	
125-24	20533-20541	networks	_	
125-25	20542-20546	that	_	
125-26	20547-20550	cut	_	
125-27	20551-20557	across	_	
125-28	20558-20568	modalities	_	
125-29	20568-20569	,	_	
125-30	20570-20572	as	_	
125-31	20573-20577	well	_	
125-32	20578-20580	as	_	
125-33	20581-20589	deficits	_	
125-34	20590-20594	that	_	
125-35	20595-20598	are	_	
125-36	20599-20607	modality	_	
125-37	20608-20616	specific	_	
125-38	20616-20617	,	_	
125-39	20618-20624	though	_	
125-40	20625-20637	contributing	_	
125-41	20638-20640	to	_	
125-42	20641-20646	joint	_	
125-43	20647-20657	prediction	_	
125-44	20658-20660	of	_	
125-45	20661-20670	cognitive	_	
125-46	20671-20678	control	_	
125-47	20678-20679	.	_	

#Text=Such results help to link findings in individual modalities of neural structure/function into an associated pattern that is correlated with a central domain of cognitive impairment in psychosis.
126-1	20680-20684	Such	_	
126-2	20685-20692	results	_	
126-3	20693-20697	help	_	
126-4	20698-20700	to	_	
126-5	20701-20705	link	_	
126-6	20706-20714	findings	_	
126-7	20715-20717	in	_	
126-8	20718-20728	individual	_	
126-9	20729-20739	modalities	_	
126-10	20740-20742	of	_	
126-11	20743-20749	neural	_	
126-12	20750-20759	structure	_	
126-13	20759-20760	/	_	
126-14	20760-20768	function	_	
126-15	20769-20773	into	_	
126-16	20774-20776	an	_	
126-17	20777-20787	associated	_	
126-18	20788-20795	pattern	_	
126-19	20796-20800	that	_	
126-20	20801-20803	is	_	
126-21	20804-20814	correlated	_	
126-22	20815-20819	with	_	
126-23	20820-20821	a	_	
126-24	20822-20829	central	_	
126-25	20830-20836	domain	_	
126-26	20837-20839	of	_	
126-27	20840-20849	cognitive	_	
126-28	20850-20860	impairment	_	
126-29	20861-20863	in	_	
126-30	20864-20873	psychosis	_	
126-31	20873-20874	.	_	

#Text=Our previous multimodal work studying cognitive control in healthy individuals identified a working memory map in HCP_gC1_IC3 which exhibited predominantly posterior cortical contributions in the tfMRI data from the fronto-parietal (FP), dorsal attention (DA), and visual networks which are hypothesized to support rapid-timescale cognitive control functionality.
127-1	20875-20878	Our	_	
127-2	20879-20887	previous	_	
127-3	20888-20898	multimodal	_	
127-4	20899-20903	work	_	
127-5	20904-20912	studying	_	
127-6	20913-20922	cognitive	_	
127-7	20923-20930	control	_	
127-8	20931-20933	in	_	
127-9	20934-20941	healthy	_	
127-10	20942-20953	individuals	_	
127-11	20954-20964	identified	_	
127-12	20965-20966	a	_	
127-13	20967-20974	working	_	
127-14	20975-20981	memory	_	
127-15	20982-20985	map	_	
127-16	20986-20988	in	_	
127-17	20989-20996	HCP_gC1	_	
127-18	20996-20997	_	_	
127-19	20997-21000	IC3	_	
127-20	21001-21006	which	_	
127-21	21007-21016	exhibited	_	
127-22	21017-21030	predominantly	_	
127-23	21031-21040	posterior	_	
127-24	21041-21049	cortical	_	
127-25	21050-21063	contributions	_	
127-26	21064-21066	in	_	
127-27	21067-21070	the	_	
127-28	21071-21076	tfMRI	_	
127-29	21077-21081	data	_	
127-30	21082-21086	from	_	
127-31	21087-21090	the	_	
127-32	21091-21106	fronto-parietal	_	
127-33	21107-21108	(	_	
127-34	21108-21110	FP	_	
127-35	21110-21111	)	_	
127-36	21111-21112	,	_	
127-37	21113-21119	dorsal	_	
127-38	21120-21129	attention	_	
127-39	21130-21131	(	_	
127-40	21131-21133	DA	_	
127-41	21133-21134	)	_	
127-42	21134-21135	,	_	
127-43	21136-21139	and	_	
127-44	21140-21146	visual	_	
127-45	21147-21155	networks	_	
127-46	21156-21161	which	_	
127-47	21162-21165	are	_	
127-48	21166-21178	hypothesized	_	
127-49	21179-21181	to	_	
127-50	21182-21189	support	_	
127-51	21190-21205	rapid-timescale	_	
127-52	21206-21215	cognitive	_	
127-53	21216-21223	control	_	
127-54	21224-21237	functionality	_	
127-55	21237-21238	.	_	

#Text=It was surprising that this pattern significantly predicted cognitive control in SZ but not BP or HC even though it was derived from and significantly correlated with cognitive control in healthy participants in the HCP (see limitations).
128-1	21239-21241	It	_	
128-2	21242-21245	was	_	
128-3	21246-21256	surprising	_	
128-4	21257-21261	that	_	
128-5	21262-21266	this	_	
128-6	21267-21274	pattern	_	
128-7	21275-21288	significantly	_	
128-8	21289-21298	predicted	_	
128-9	21299-21308	cognitive	_	
128-10	21309-21316	control	_	
128-11	21317-21319	in	_	
128-12	21320-21322	SZ	_	
128-13	21323-21326	but	_	
128-14	21327-21330	not	_	
128-15	21331-21333	BP	_	
128-16	21334-21336	or	_	
128-17	21337-21339	HC	_	
128-18	21340-21344	even	_	
128-19	21345-21351	though	_	
128-20	21352-21354	it	_	
128-21	21355-21358	was	_	
128-22	21359-21366	derived	_	
128-23	21367-21371	from	_	
128-24	21372-21375	and	_	
128-25	21376-21389	significantly	_	
128-26	21390-21400	correlated	_	
128-27	21401-21405	with	_	
128-28	21406-21415	cognitive	_	
128-29	21416-21423	control	_	
128-30	21424-21426	in	_	
128-31	21427-21434	healthy	_	
128-32	21435-21447	participants	_	
128-33	21448-21450	in	_	
128-34	21451-21454	the	_	
128-35	21455-21458	HCP	_	
128-36	21459-21460	(	_	
128-37	21460-21463	see	_	
128-38	21464-21475	limitations	_	
128-39	21475-21476	)	_	
128-40	21476-21477	.	_	

#Text=A second component identified in our prior work, HCP_gC1_IC7, contained an sMRI map with positive contributions in the cingulo-opercular, salience, and ventral attention networks and negative contributions in the default mode and visual networks, which are hypothesized to support stable-timescale cognitive control functionality.
129-1	21478-21479	A	_	
129-2	21480-21486	second	_	
129-3	21487-21496	component	_	
129-4	21497-21507	identified	_	
129-5	21508-21510	in	_	
129-6	21511-21514	our	_	
129-7	21515-21520	prior	_	
129-8	21521-21525	work	_	
129-9	21525-21526	,	_	
129-10	21527-21534	HCP_gC1	_	
129-11	21534-21535	_	_	
129-12	21535-21538	IC7	_	
129-13	21538-21539	,	_	
129-14	21540-21549	contained	_	
129-15	21550-21552	an	_	
129-16	21553-21557	sMRI	_	
129-17	21558-21561	map	_	
129-18	21562-21566	with	_	
129-19	21567-21575	positive	_	
129-20	21576-21589	contributions	_	
129-21	21590-21592	in	_	
129-22	21593-21596	the	_	
129-23	21597-21614	cingulo-opercular	_	
129-24	21614-21615	,	_	
129-25	21616-21624	salience	_	
129-26	21624-21625	,	_	
129-27	21626-21629	and	_	
129-28	21630-21637	ventral	_	
129-29	21638-21647	attention	_	
129-30	21648-21656	networks	_	
129-31	21657-21660	and	_	
129-32	21661-21669	negative	_	
129-33	21670-21683	contributions	_	
129-34	21684-21686	in	_	
129-35	21687-21690	the	_	
129-36	21691-21698	default	_	
129-37	21699-21703	mode	_	
129-38	21704-21707	and	_	
129-39	21708-21714	visual	_	
129-40	21715-21723	networks	_	
129-41	21723-21724	,	_	
129-42	21725-21730	which	_	
129-43	21731-21734	are	_	
129-44	21735-21747	hypothesized	_	
129-45	21748-21750	to	_	
129-46	21751-21758	support	_	
129-47	21759-21775	stable-timescale	_	
129-48	21776-21785	cognitive	_	
129-49	21786-21793	control	_	
129-50	21794-21807	functionality	_	
129-51	21807-21808	.	_	

#Text=Interestingly, this component significantly predicted cognitive control in the psychosis cohort for all groups.
130-1	21809-21822	Interestingly	_	
130-2	21822-21823	,	_	
130-3	21824-21828	this	_	
130-4	21829-21838	component	_	
130-5	21839-21852	significantly	_	
130-6	21853-21862	predicted	_	
130-7	21863-21872	cognitive	_	
130-8	21873-21880	control	_	
130-9	21881-21883	in	_	
130-10	21884-21887	the	_	
130-11	21888-21897	psychosis	_	
130-12	21898-21904	cohort	_	
130-13	21905-21908	for	_	
130-14	21909-21912	all	_	
130-15	21913-21919	groups	_	
130-16	21919-21920	.	_	

#Text=Together, these a priori patterns were partially predictive of cognitive control in the general population as well as individuals with varying levels of psychosis and may provide clues towards localization of deficits in psychosis.
131-1	21921-21929	Together	_	
131-2	21929-21930	,	_	
131-3	21931-21936	these	_	
131-4	21937-21938	a	_	
131-5	21939-21945	priori	_	
131-6	21946-21954	patterns	_	
131-7	21955-21959	were	_	
131-8	21960-21969	partially	_	
131-9	21970-21980	predictive	_	
131-10	21981-21983	of	_	
131-11	21984-21993	cognitive	_	
131-12	21994-22001	control	_	
131-13	22002-22004	in	_	
131-14	22005-22008	the	_	
131-15	22009-22016	general	_	
131-16	22017-22027	population	_	
131-17	22028-22030	as	_	
131-18	22031-22035	well	_	
131-19	22036-22038	as	_	
131-20	22039-22050	individuals	_	
131-21	22051-22055	with	_	
131-22	22056-22063	varying	_	
131-23	22064-22070	levels	_	
131-24	22071-22073	of	_	
131-25	22074-22083	psychosis	_	
131-26	22084-22087	and	_	
131-27	22088-22091	may	_	
131-28	22092-22099	provide	_	
131-29	22100-22105	clues	_	
131-30	22106-22113	towards	_	
131-31	22114-22126	localization	_	
131-32	22127-22129	of	_	
131-33	22130-22138	deficits	_	
131-34	22139-22141	in	_	
131-35	22142-22151	psychosis	_	
131-36	22151-22152	.	_	

#Text=De novo application of mCCA+jICA to the psychosis dataset identified an IC that was both 91.5% similar to a priori HCP_gC1_IC3 and also significantly correlated with cognitive control performance.
132-1	22153-22155	De	_	
132-2	22156-22160	novo	_	
132-3	22161-22172	application	_	
132-4	22173-22175	of	_	
132-5	22176-22180	mCCA	_	
132-6	22180-22181	+	_	
132-7	22181-22185	jICA	_	
132-8	22186-22188	to	_	
132-9	22189-22192	the	_	
132-10	22193-22202	psychosis	_	
132-11	22203-22210	dataset	_	
132-12	22211-22221	identified	_	
132-13	22222-22224	an	_	
132-14	22225-22227	IC	_	
132-15	22228-22232	that	_	
132-16	22233-22236	was	_	
132-17	22237-22241	both	_	
132-18	22242-22247	91.5%	_	
132-19	22248-22255	similar	_	
132-20	22256-22258	to	_	
132-21	22259-22260	a	_	
132-22	22261-22267	priori	_	
132-23	22268-22275	HCP_gC1	_	
132-24	22275-22276	_	_	
132-25	22276-22279	IC3	_	
132-26	22280-22283	and	_	
132-27	22284-22288	also	_	
132-28	22289-22302	significantly	_	
132-29	22303-22313	correlated	_	
132-30	22314-22318	with	_	
132-31	22319-22328	cognitive	_	
132-32	22329-22336	control	_	
132-33	22337-22348	performance	_	
132-34	22348-22349	.	_	

#Text=However, it was surprising that the de novo correlations with cognitive control were significant only for SZ participants even though the a priori IC was significant in healthy controls.
133-1	22350-22357	However	_	
133-2	22357-22358	,	_	
133-3	22359-22361	it	_	
133-4	22362-22365	was	_	
133-5	22366-22376	surprising	_	
133-6	22377-22381	that	_	
133-7	22382-22385	the	_	
133-8	22386-22388	de	_	
133-9	22389-22393	novo	_	
133-10	22394-22406	correlations	_	
133-11	22407-22411	with	_	
133-12	22412-22421	cognitive	_	
133-13	22422-22429	control	_	
133-14	22430-22434	were	_	
133-15	22435-22446	significant	_	
133-16	22447-22451	only	_	
133-17	22452-22455	for	_	
133-18	22456-22458	SZ	_	
133-19	22459-22471	participants	_	
133-20	22472-22476	even	_	
133-21	22477-22483	though	_	
133-22	22484-22487	the	_	
133-23	22488-22489	a	_	
133-24	22490-22496	priori	_	
133-25	22497-22499	IC	_	
133-26	22500-22503	was	_	
133-27	22504-22515	significant	_	
133-28	22516-22518	in	_	
133-29	22519-22526	healthy	_	
133-30	22527-22535	controls	_	
133-31	22535-22536	.	_	

#Text=Thus, we discuss below the interpretations of these findings in SZ and address the group-specificity of correlations later in the discussion.
134-1	22537-22541	Thus	_	
134-2	22541-22542	,	_	
134-3	22543-22545	we	_	
134-4	22546-22553	discuss	_	
134-5	22554-22559	below	_	
134-6	22560-22563	the	_	
134-7	22564-22579	interpretations	_	
134-8	22580-22582	of	_	
134-9	22583-22588	these	_	
134-10	22589-22597	findings	_	
134-11	22598-22600	in	_	
134-12	22601-22603	SZ	_	
134-13	22604-22607	and	_	
134-14	22608-22615	address	_	
134-15	22616-22619	the	_	
134-16	22620-22637	group-specificity	_	
134-17	22638-22640	of	_	
134-18	22641-22653	correlations	_	
134-19	22654-22659	later	_	
134-20	22660-22662	in	_	
134-21	22663-22666	the	_	
134-22	22667-22677	discussion	_	
134-23	22677-22678	.	_	

#Text=Nonetheless, the independent identification of two highly similar ICs using data-driven methods suggests these imaging patterns may be robust features in the broader population, though identifying relationships between these patterns and cognitive control performance requires further study.
135-1	22679-22690	Nonetheless	_	
135-2	22690-22691	,	_	
135-3	22692-22695	the	_	
135-4	22696-22707	independent	_	
135-5	22708-22722	identification	_	
135-6	22723-22725	of	_	
135-7	22726-22729	two	_	
135-8	22730-22736	highly	_	
135-9	22737-22744	similar	_	
135-10	22745-22748	ICs	_	
135-11	22749-22754	using	_	
135-12	22755-22766	data-driven	_	
135-13	22767-22774	methods	_	
135-14	22775-22783	suggests	_	
135-15	22784-22789	these	_	
135-16	22790-22797	imaging	_	
135-17	22798-22806	patterns	_	
135-18	22807-22810	may	_	
135-19	22811-22813	be	_	
135-20	22814-22820	robust	_	
135-21	22821-22829	features	_	
135-22	22830-22832	in	_	
135-23	22833-22836	the	_	
135-24	22837-22844	broader	_	
135-25	22845-22855	population	_	
135-26	22855-22856	,	_	
135-27	22857-22863	though	_	
135-28	22864-22875	identifying	_	
135-29	22876-22889	relationships	_	
135-30	22890-22897	between	_	
135-31	22898-22903	these	_	
135-32	22904-22912	patterns	_	
135-33	22913-22916	and	_	
135-34	22917-22926	cognitive	_	
135-35	22927-22934	control	_	
135-36	22935-22946	performance	_	
135-37	22947-22955	requires	_	
135-38	22956-22963	further	_	
135-39	22964-22969	study	_	
135-40	22969-22970	.	_	

#Text=For tfMRI data, a priori HCP_gC1_IC3 and de novo IC3 were both predictive of cognitive control in SZ.
136-1	22971-22974	For	_	
136-2	22975-22980	tfMRI	_	
136-3	22981-22985	data	_	
136-4	22985-22986	,	_	
136-5	22987-22988	a	_	
136-6	22989-22995	priori	_	
136-7	22996-23003	HCP_gC1	_	
136-8	23003-23004	_	_	
136-9	23004-23007	IC3	_	
136-10	23008-23011	and	_	
136-11	23012-23014	de	_	
136-12	23015-23019	novo	_	
136-13	23020-23023	IC3	_	
136-14	23024-23028	were	_	
136-15	23029-23033	both	_	
136-16	23034-23044	predictive	_	
136-17	23045-23047	of	_	
136-18	23048-23057	cognitive	_	
136-19	23058-23065	control	_	
136-20	23066-23068	in	_	
136-21	23069-23071	SZ	_	
136-22	23071-23072	.	_	

#Text=We previously postulated that strong visual contributions may be due to top-down modulation of visual regions, especially given that the working memory tfMRI task was highly visually demanding.
137-1	23073-23075	We	_	
137-2	23076-23086	previously	_	
137-3	23087-23097	postulated	_	
137-4	23098-23102	that	_	
137-5	23103-23109	strong	_	
137-6	23110-23116	visual	_	
137-7	23117-23130	contributions	_	
137-8	23131-23134	may	_	
137-9	23135-23137	be	_	
137-10	23138-23141	due	_	
137-11	23142-23144	to	_	
137-12	23145-23153	top-down	_	
137-13	23154-23164	modulation	_	
137-14	23165-23167	of	_	
137-15	23168-23174	visual	_	
137-16	23175-23182	regions	_	
137-17	23182-23183	,	_	
137-18	23184-23194	especially	_	
137-19	23195-23200	given	_	
137-20	23201-23205	that	_	
137-21	23206-23209	the	_	
137-22	23210-23217	working	_	
137-23	23218-23224	memory	_	
137-24	23225-23230	tfMRI	_	
137-25	23231-23235	task	_	
137-26	23236-23239	was	_	
137-27	23240-23246	highly	_	
137-28	23247-23255	visually	_	
137-29	23256-23265	demanding	_	
137-30	23265-23266	.	_	

#Text=Independent identification of this pattern de novo may provide intriguing clues towards the source of cognitive control dysfunction in SZ.
138-1	23267-23278	Independent	_	
138-2	23279-23293	identification	_	
138-3	23294-23296	of	_	
138-4	23297-23301	this	_	
138-5	23302-23309	pattern	_	
138-6	23310-23312	de	_	
138-7	23313-23317	novo	_	
138-8	23318-23321	may	_	
138-9	23322-23329	provide	_	
138-10	23330-23340	intriguing	_	
138-11	23341-23346	clues	_	
138-12	23347-23354	towards	_	
138-13	23355-23358	the	_	
138-14	23359-23365	source	_	
138-15	23366-23368	of	_	
138-16	23369-23378	cognitive	_	
138-17	23379-23386	control	_	
138-18	23387-23398	dysfunction	_	
138-19	23399-23401	in	_	
138-20	23402-23404	SZ	_	
138-21	23404-23405	.	_	

#Text=A number of reports have identified visual system dysfunction in SZ, though the literature is more mixed for BP.
139-1	23406-23407	A	_	
139-2	23408-23414	number	_	
139-3	23415-23417	of	_	
139-4	23418-23425	reports	_	
139-5	23426-23430	have	_	
139-6	23431-23441	identified	_	
139-7	23442-23448	visual	_	
139-8	23449-23455	system	_	
139-9	23456-23467	dysfunction	_	
139-10	23468-23470	in	_	
139-11	23471-23473	SZ	_	
139-12	23473-23474	,	_	
139-13	23475-23481	though	_	
139-14	23482-23485	the	_	
139-15	23486-23496	literature	_	
139-16	23497-23499	is	_	
139-17	23500-23504	more	_	
139-18	23505-23510	mixed	_	
139-19	23511-23514	for	_	
139-20	23515-23517	BP	_	
139-21	23517-23518	.	_	

#Text=Theories generated from these lines of research postulate that alterations in visual system functionality leads to aberrant integration of information in higher order cortical areas and lead to dysfunction in cognitive control.
140-1	23519-23527	Theories	_	
140-2	23528-23537	generated	_	
140-3	23538-23542	from	_	
140-4	23543-23548	these	_	
140-5	23549-23554	lines	_	
140-6	23555-23557	of	_	
140-7	23558-23566	research	_	
140-8	23567-23576	postulate	_	
140-9	23577-23581	that	_	
140-10	23582-23593	alterations	_	
140-11	23594-23596	in	_	
140-12	23597-23603	visual	_	
140-13	23604-23610	system	_	
140-14	23611-23624	functionality	_	
140-15	23625-23630	leads	_	
140-16	23631-23633	to	_	
140-17	23634-23642	aberrant	_	
140-18	23643-23654	integration	_	
140-19	23655-23657	of	_	
140-20	23658-23669	information	_	
140-21	23670-23672	in	_	
140-22	23673-23679	higher	_	
140-23	23680-23685	order	_	
140-24	23686-23694	cortical	_	
140-25	23695-23700	areas	_	
140-26	23701-23704	and	_	
140-27	23705-23709	lead	_	
140-28	23710-23712	to	_	
140-29	23713-23724	dysfunction	_	
140-30	23725-23727	in	_	
140-31	23728-23737	cognitive	_	
140-32	23738-23745	control	_	
140-33	23745-23746	.	_	

#Text=Thus, the present work could be seen as consistent with the hypothesis that impairments in the function and/or structure of visual cortex may disrupt higher order processing leading to deficits in cognitive control.
141-1	23747-23751	Thus	_	
141-2	23751-23752	,	_	
141-3	23753-23756	the	_	
141-4	23757-23764	present	_	
141-5	23765-23769	work	_	
141-6	23770-23775	could	_	
141-7	23776-23778	be	_	
141-8	23779-23783	seen	_	
141-9	23784-23786	as	_	
141-10	23787-23797	consistent	_	
141-11	23798-23802	with	_	
141-12	23803-23806	the	_	
141-13	23807-23817	hypothesis	_	
141-14	23818-23822	that	_	
141-15	23823-23834	impairments	_	
141-16	23835-23837	in	_	
141-17	23838-23841	the	_	
141-18	23842-23850	function	_	
141-19	23851-23854	and	_	
141-20	23854-23855	/	_	
141-21	23855-23857	or	_	
141-22	23858-23867	structure	_	
141-23	23868-23870	of	_	
141-24	23871-23877	visual	_	
141-25	23878-23884	cortex	_	
141-26	23885-23888	may	_	
141-27	23889-23896	disrupt	_	
141-28	23897-23903	higher	_	
141-29	23904-23909	order	_	
141-30	23910-23920	processing	_	
141-31	23921-23928	leading	_	
141-32	23929-23931	to	_	
141-33	23932-23940	deficits	_	
141-34	23941-23943	in	_	
141-35	23944-23953	cognitive	_	
141-36	23954-23961	control	_	
141-37	23961-23962	.	_	

#Text=In the present data, SZ participants who exhibited greater visual region contributions in IC3 tfMRI data had significantly better cognitive control performance.
142-1	23963-23965	In	_	
142-2	23966-23969	the	_	
142-3	23970-23977	present	_	
142-4	23978-23982	data	_	
142-5	23982-23983	,	_	
142-6	23984-23986	SZ	_	
142-7	23987-23999	participants	_	
142-8	24000-24003	who	_	
142-9	24004-24013	exhibited	_	
142-10	24014-24021	greater	_	
142-11	24022-24028	visual	_	
142-12	24029-24035	region	_	
142-13	24036-24049	contributions	_	
142-14	24050-24052	in	_	
142-15	24053-24056	IC3	_	
142-16	24057-24062	tfMRI	_	
142-17	24063-24067	data	_	
142-18	24068-24071	had	_	
142-19	24072-24085	significantly	_	
142-20	24086-24092	better	_	
142-21	24093-24102	cognitive	_	
142-22	24103-24110	control	_	
142-23	24111-24122	performance	_	
142-24	24122-24123	.	_	

#Text=Importantly, the de novo data for HC and BP trended in the same direction as SZ, though this trend was not significant (fig. 2).
143-1	24124-24135	Importantly	_	
143-2	24135-24136	,	_	
143-3	24137-24140	the	_	
143-4	24141-24143	de	_	
143-5	24144-24148	novo	_	
143-6	24149-24153	data	_	
143-7	24154-24157	for	_	
143-8	24158-24160	HC	_	
143-9	24161-24164	and	_	
143-10	24165-24167	BP	_	
143-11	24168-24175	trended	_	
143-12	24176-24178	in	_	
143-13	24179-24182	the	_	
143-14	24183-24187	same	_	
143-15	24188-24197	direction	_	
143-16	24198-24200	as	_	
143-17	24201-24203	SZ	_	
143-18	24203-24204	,	_	
143-19	24205-24211	though	_	
143-20	24212-24216	this	_	
143-21	24217-24222	trend	_	
143-22	24223-24226	was	_	
143-23	24227-24230	not	_	
143-24	24231-24242	significant	_	
143-25	24243-24244	(	_	
143-26	24244-24247	fig	_	
143-27	24247-24248	.	_	
143-28	24249-24250	2	_	
143-29	24250-24251	)	_	
143-30	24251-24252	.	_	

#Text=While the present work is not a direct assessment of the relationship between visual system integrity and cognition, the findings are consistent with these models of psychosis in SZ and thus warrant further study.
144-1	24253-24258	While	_	
144-2	24259-24262	the	_	
144-3	24263-24270	present	_	
144-4	24271-24275	work	_	
144-5	24276-24278	is	_	
144-6	24279-24282	not	_	
144-7	24283-24284	a	_	
144-8	24285-24291	direct	_	
144-9	24292-24302	assessment	_	
144-10	24303-24305	of	_	
144-11	24306-24309	the	_	
144-12	24310-24322	relationship	_	
144-13	24323-24330	between	_	
144-14	24331-24337	visual	_	
144-15	24338-24344	system	_	
144-16	24345-24354	integrity	_	
144-17	24355-24358	and	_	
144-18	24359-24368	cognition	_	
144-19	24368-24369	,	_	
144-20	24370-24373	the	_	
144-21	24374-24382	findings	_	
144-22	24383-24386	are	_	
144-23	24387-24397	consistent	_	
144-24	24398-24402	with	_	
144-25	24403-24408	these	_	
144-26	24409-24415	models	_	
144-27	24416-24418	of	_	
144-28	24419-24428	psychosis	_	
144-29	24429-24431	in	_	
144-30	24432-24434	SZ	_	
144-31	24435-24438	and	_	
144-32	24439-24443	thus	_	
144-33	24444-24451	warrant	_	
144-34	24452-24459	further	_	
144-35	24460-24465	study	_	
144-36	24465-24466	.	_	

#Text=For sMRI data, de novo IC3 significantly correlated with cognitive control in SZ and exhibited contributions similar to HCP_gC1_IC3 including the insula, medial prefrontal cortex, and cingulate.
145-1	24467-24470	For	_	
145-2	24471-24475	sMRI	_	
145-3	24476-24480	data	_	
145-4	24480-24481	,	_	
145-5	24482-24484	de	_	
145-6	24485-24489	novo	_	
145-7	24490-24493	IC3	_	
145-8	24494-24507	significantly	_	
145-9	24508-24518	correlated	_	
145-10	24519-24523	with	_	
145-11	24524-24533	cognitive	_	
145-12	24534-24541	control	_	
145-13	24542-24544	in	_	
145-14	24545-24547	SZ	_	
145-15	24548-24551	and	_	
145-16	24552-24561	exhibited	_	
145-17	24562-24575	contributions	_	
145-18	24576-24583	similar	_	
145-19	24584-24586	to	_	
145-20	24587-24594	HCP_gC1	_	
145-21	24594-24595	_	_	
145-22	24595-24598	IC3	_	
145-23	24599-24608	including	_	
145-24	24609-24612	the	_	
145-25	24613-24619	insula	_	
145-26	24619-24620	,	_	
145-27	24621-24627	medial	_	
145-28	24628-24638	prefrontal	_	
145-29	24639-24645	cortex	_	
145-30	24645-24646	,	_	
145-31	24647-24650	and	_	
145-32	24651-24660	cingulate	_	
145-33	24660-24661	.	_	

#Text=Transdiagnostic gray matter volume variability in these regions has been identified in these regions, but relationships with cognitive control in psychosis were not tested.
146-1	24662-24677	Transdiagnostic	_	
146-2	24678-24682	gray	_	
146-3	24683-24689	matter	_	
146-4	24690-24696	volume	_	
146-5	24697-24708	variability	_	
146-6	24709-24711	in	_	
146-7	24712-24717	these	_	
146-8	24718-24725	regions	_	
146-9	24726-24729	has	_	
146-10	24730-24734	been	_	
146-11	24735-24745	identified	_	
146-12	24746-24748	in	_	
146-13	24749-24754	these	_	
146-14	24755-24762	regions	_	
146-15	24762-24763	,	_	
146-16	24764-24767	but	_	
146-17	24768-24781	relationships	_	
146-18	24782-24786	with	_	
146-19	24787-24796	cognitive	_	
146-20	24797-24804	control	_	
146-21	24805-24807	in	_	
146-22	24808-24817	psychosis	_	
146-23	24818-24822	were	_	
146-24	24823-24826	not	_	
146-25	24827-24833	tested	_	
146-26	24833-24834	.	_	

#Text=However, did identify a positive relationship between volume in these regions and cognitive control in HC.
147-1	24835-24842	However	_	
147-2	24842-24843	,	_	
147-3	24844-24847	did	_	
147-4	24848-24856	identify	_	
147-5	24857-24858	a	_	
147-6	24859-24867	positive	_	
147-7	24868-24880	relationship	_	
147-8	24881-24888	between	_	
147-9	24889-24895	volume	_	
147-10	24896-24898	in	_	
147-11	24899-24904	these	_	
147-12	24905-24912	regions	_	
147-13	24913-24916	and	_	
147-14	24917-24926	cognitive	_	
147-15	24927-24934	control	_	
147-16	24935-24937	in	_	
147-17	24938-24940	HC	_	
147-18	24940-24941	.	_	

#Text=Interestingly, small portions of these regions were also present in a priori HCP_gC1_IC7, although contributions were more scattershot with smaller clusters exceeding the visualization threshold.
148-1	24942-24955	Interestingly	_	
148-2	24955-24956	,	_	
148-3	24957-24962	small	_	
148-4	24963-24971	portions	_	
148-5	24972-24974	of	_	
148-6	24975-24980	these	_	
148-7	24981-24988	regions	_	
148-8	24989-24993	were	_	
148-9	24994-24998	also	_	
148-10	24999-25006	present	_	
148-11	25007-25009	in	_	
148-12	25010-25011	a	_	
148-13	25012-25018	priori	_	
148-14	25019-25026	HCP_gC1	_	
148-15	25026-25027	_	_	
148-16	25027-25030	IC7	_	
148-17	25030-25031	,	_	
148-18	25032-25040	although	_	
148-19	25041-25054	contributions	_	
148-20	25055-25059	were	_	
148-21	25060-25064	more	_	
148-22	25065-25076	scattershot	_	
148-23	25077-25081	with	_	
148-24	25082-25089	smaller	_	
148-25	25090-25098	clusters	_	
148-26	25099-25108	exceeding	_	
148-27	25109-25112	the	_	
148-28	25113-25126	visualization	_	
148-29	25127-25136	threshold	_	
148-30	25136-25137	.	_	

#Text=Importantly, correlations between HCP_gC1_IC7 and cognitive control were significant for all three groups.
149-1	25138-25149	Importantly	_	
149-2	25149-25150	,	_	
149-3	25151-25163	correlations	_	
149-4	25164-25171	between	_	
149-5	25172-25179	HCP_gC1	_	
149-6	25179-25180	_	_	
149-7	25180-25183	IC7	_	
149-8	25184-25187	and	_	
149-9	25188-25197	cognitive	_	
149-10	25198-25205	control	_	
149-11	25206-25210	were	_	
149-12	25211-25222	significant	_	
149-13	25223-25226	for	_	
149-14	25227-25230	all	_	
149-15	25231-25236	three	_	
149-16	25237-25243	groups	_	
149-17	25243-25244	.	_	

#Text=Thus, the data suggest this finding may indeed be transdiagnostic, though further study is clearly warranted.
150-1	25245-25249	Thus	_	
150-2	25249-25250	,	_	
150-3	25251-25254	the	_	
150-4	25255-25259	data	_	
150-5	25260-25267	suggest	_	
150-6	25268-25272	this	_	
150-7	25273-25280	finding	_	
150-8	25281-25284	may	_	
150-9	25285-25291	indeed	_	
150-10	25292-25294	be	_	
150-11	25295-25310	transdiagnostic	_	
150-12	25310-25311	,	_	
150-13	25312-25318	though	_	
150-14	25319-25326	further	_	
150-15	25327-25332	study	_	
150-16	25333-25335	is	_	
150-17	25336-25343	clearly	_	
150-18	25344-25353	warranted	_	
150-19	25353-25354	.	_	

#Text=For rsfcMRI data, de novo IC3 significantly correlated with cognitive control in SZ and exhibited similar contributions to a priori HCP_gC1_IC3.
151-1	25355-25358	For	_	
151-2	25359-25366	rsfcMRI	_	
151-3	25367-25371	data	_	
151-4	25371-25372	,	_	
151-5	25373-25375	de	_	
151-6	25376-25380	novo	_	
151-7	25381-25384	IC3	_	
151-8	25385-25398	significantly	_	
151-9	25399-25409	correlated	_	
151-10	25410-25414	with	_	
151-11	25415-25424	cognitive	_	
151-12	25425-25432	control	_	
151-13	25433-25435	in	_	
151-14	25436-25438	SZ	_	
151-15	25439-25442	and	_	
151-16	25443-25452	exhibited	_	
151-17	25453-25460	similar	_	
151-18	25461-25474	contributions	_	
151-19	25475-25477	to	_	
151-20	25478-25479	a	_	
151-21	25480-25486	priori	_	
151-22	25487-25494	HCP_gC1	_	
151-23	25494-25495	_	_	
151-24	25495-25498	IC3	_	
151-25	25498-25499	.	_	

#Text=Both a priori HCP_gC1_IC3 and de novo IC3 rsfcMRI maps exhibited modular network structures comprised of high within-network connectivity and anti-correlated activity between the task-positive and task-negative networks, and resembled a canonical resting state matrix.
152-1	25500-25504	Both	_	
152-2	25505-25506	a	_	
152-3	25507-25513	priori	_	
152-4	25514-25521	HCP_gC1	_	
152-5	25521-25522	_	_	
152-6	25522-25525	IC3	_	
152-7	25526-25529	and	_	
152-8	25530-25532	de	_	
152-9	25533-25537	novo	_	
152-10	25538-25541	IC3	_	
152-11	25542-25549	rsfcMRI	_	
152-12	25550-25554	maps	_	
152-13	25555-25564	exhibited	_	
152-14	25565-25572	modular	_	
152-15	25573-25580	network	_	
152-16	25581-25591	structures	_	
152-17	25592-25601	comprised	_	
152-18	25602-25604	of	_	
152-19	25605-25609	high	_	
152-20	25610-25624	within-network	_	
152-21	25625-25637	connectivity	_	
152-22	25638-25641	and	_	
152-23	25642-25657	anti-correlated	_	
152-24	25658-25666	activity	_	
152-25	25667-25674	between	_	
152-26	25675-25678	the	_	
152-27	25679-25692	task-positive	_	
152-28	25693-25696	and	_	
152-29	25697-25710	task-negative	_	
152-30	25711-25719	networks	_	
152-31	25719-25720	,	_	
152-32	25721-25724	and	_	
152-33	25725-25734	resembled	_	
152-34	25735-25736	a	_	
152-35	25737-25746	canonical	_	
152-36	25747-25754	resting	_	
152-37	25755-25760	state	_	
152-38	25761-25767	matrix	_	
152-39	25767-25768	.	_	

#Text=Thus, we draw the same general conclusion as in our prior work, namely that there is some evidence that greater presence of canonical resting state networks may be associated with improved cognitive control.
153-1	25769-25773	Thus	_	
153-2	25773-25774	,	_	
153-3	25775-25777	we	_	
153-4	25778-25782	draw	_	
153-5	25783-25786	the	_	
153-6	25787-25791	same	_	
153-7	25792-25799	general	_	
153-8	25800-25810	conclusion	_	
153-9	25811-25813	as	_	
153-10	25814-25816	in	_	
153-11	25817-25820	our	_	
153-12	25821-25826	prior	_	
153-13	25827-25831	work	_	
153-14	25831-25832	,	_	
153-15	25833-25839	namely	_	
153-16	25840-25844	that	_	
153-17	25845-25850	there	_	
153-18	25851-25853	is	_	
153-19	25854-25858	some	_	
153-20	25859-25867	evidence	_	
153-21	25868-25872	that	_	
153-22	25873-25880	greater	_	
153-23	25881-25889	presence	_	
153-24	25890-25892	of	_	
153-25	25893-25902	canonical	_	
153-26	25903-25910	resting	_	
153-27	25911-25916	state	_	
153-28	25917-25925	networks	_	
153-29	25926-25929	may	_	
153-30	25930-25932	be	_	
153-31	25933-25943	associated	_	
153-32	25944-25948	with	_	
153-33	25949-25957	improved	_	
153-34	25958-25967	cognitive	_	
153-35	25968-25975	control	_	
153-36	25975-25976	.	_	

#Text=It was surprising that correlations between imaging and cognitive control were significantly driven by SZ in all analyses except a priori HCP_gC1_IC7 sMRI.
154-1	25977-25979	It	_	
154-2	25980-25983	was	_	
154-3	25984-25994	surprising	_	
154-4	25995-25999	that	_	
154-5	26000-26012	correlations	_	
154-6	26013-26020	between	_	
154-7	26021-26028	imaging	_	
154-8	26029-26032	and	_	
154-9	26033-26042	cognitive	_	
154-10	26043-26050	control	_	
154-11	26051-26055	were	_	
154-12	26056-26069	significantly	_	
154-13	26070-26076	driven	_	
154-14	26077-26079	by	_	
154-15	26080-26082	SZ	_	
154-16	26083-26085	in	_	
154-17	26086-26089	all	_	
154-18	26090-26098	analyses	_	
154-19	26099-26105	except	_	
154-20	26106-26107	a	_	
154-21	26108-26114	priori	_	
154-22	26115-26122	HCP_gC1	_	
154-23	26122-26123	_	_	
154-24	26123-26126	IC7	_	
154-25	26127-26131	sMRI	_	
154-26	26131-26132	.	_	

#Text=This may be due to a variety of factors.
155-1	26133-26137	This	_	
155-2	26138-26141	may	_	
155-3	26142-26144	be	_	
155-4	26145-26148	due	_	
155-5	26149-26151	to	_	
155-6	26152-26153	a	_	
155-7	26154-26161	variety	_	
155-8	26162-26164	of	_	
155-9	26165-26172	factors	_	
155-10	26172-26173	.	_	

#Text=First, there was a graded, trend-significant inhomogeneity of variance in cognitive control performance, such that SZ had greater variance than BP, who had greater variance than HC.
156-1	26174-26179	First	_	
156-2	26179-26180	,	_	
156-3	26181-26186	there	_	
156-4	26187-26190	was	_	
156-5	26191-26192	a	_	
156-6	26193-26199	graded	_	
156-7	26199-26200	,	_	
156-8	26201-26218	trend-significant	_	
156-9	26219-26232	inhomogeneity	_	
156-10	26233-26235	of	_	
156-11	26236-26244	variance	_	
156-12	26245-26247	in	_	
156-13	26248-26257	cognitive	_	
156-14	26258-26265	control	_	
156-15	26266-26277	performance	_	
156-16	26277-26278	,	_	
156-17	26279-26283	such	_	
156-18	26284-26288	that	_	
156-19	26289-26291	SZ	_	
156-20	26292-26295	had	_	
156-21	26296-26303	greater	_	
156-22	26304-26312	variance	_	
156-23	26313-26317	than	_	
156-24	26318-26320	BP	_	
156-25	26320-26321	,	_	
156-26	26322-26325	who	_	
156-27	26326-26329	had	_	
156-28	26330-26337	greater	_	
156-29	26338-26346	variance	_	
156-30	26347-26351	than	_	
156-31	26352-26354	HC	_	
156-32	26354-26355	.	_	

#Text=This may have hampered our ability to identify relationships with cognitive control within the other groups.
157-1	26356-26360	This	_	
157-2	26361-26364	may	_	
157-3	26365-26369	have	_	
157-4	26370-26378	hampered	_	
157-5	26379-26382	our	_	
157-6	26383-26390	ability	_	
157-7	26391-26393	to	_	
157-8	26394-26402	identify	_	
157-9	26403-26416	relationships	_	
157-10	26417-26421	with	_	
157-11	26422-26431	cognitive	_	
157-12	26432-26439	control	_	
157-13	26440-26446	within	_	
157-14	26447-26450	the	_	
157-15	26451-26456	other	_	
157-16	26457-26463	groups	_	
157-17	26463-26464	.	_	

#Text=Indeed, for all correlations between imaging and cognitive control (except HCP_gC1_IC7 rsfcMRI, which was not significant in original HCP data), the direction of trendlines were concordant for patients, suggesting the presence of a relationship that we were underpowered to detect.
158-1	26465-26471	Indeed	_	
158-2	26471-26472	,	_	
158-3	26473-26476	for	_	
158-4	26477-26480	all	_	
158-5	26481-26493	correlations	_	
158-6	26494-26501	between	_	
158-7	26502-26509	imaging	_	
158-8	26510-26513	and	_	
158-9	26514-26523	cognitive	_	
158-10	26524-26531	control	_	
158-11	26532-26533	(	_	
158-12	26533-26539	except	_	
158-13	26540-26547	HCP_gC1	_	
158-14	26547-26548	_	_	
158-15	26548-26551	IC7	_	
158-16	26552-26559	rsfcMRI	_	
158-17	26559-26560	,	_	
158-18	26561-26566	which	_	
158-19	26567-26570	was	_	
158-20	26571-26574	not	_	
158-21	26575-26586	significant	_	
158-22	26587-26589	in	_	
158-23	26590-26598	original	_	
158-24	26599-26602	HCP	_	
158-25	26603-26607	data	_	
158-26	26607-26608	)	_	
158-27	26608-26609	,	_	
158-28	26610-26613	the	_	
158-29	26614-26623	direction	_	
158-30	26624-26626	of	_	
158-31	26627-26637	trendlines	_	
158-32	26638-26642	were	_	
158-33	26643-26653	concordant	_	
158-34	26654-26657	for	_	
158-35	26658-26666	patients	_	
158-36	26666-26667	,	_	
158-37	26668-26678	suggesting	_	
158-38	26679-26682	the	_	
158-39	26683-26691	presence	_	
158-40	26692-26694	of	_	
158-41	26695-26696	a	_	
158-42	26697-26709	relationship	_	
158-43	26710-26714	that	_	
158-44	26715-26717	we	_	
158-45	26718-26722	were	_	
158-46	26723-26735	underpowered	_	
158-47	26736-26738	to	_	
158-48	26739-26745	detect	_	
158-49	26745-26746	.	_	

#Text=Second, BP inclusion was not limited to individuals with psychosis and BP endorsed significantly less history of psychotic symptoms than SZ (table 1).
159-1	26747-26753	Second	_	
159-2	26753-26754	,	_	
159-3	26755-26757	BP	_	
159-4	26758-26767	inclusion	_	
159-5	26768-26771	was	_	
159-6	26772-26775	not	_	
159-7	26776-26783	limited	_	
159-8	26784-26786	to	_	
159-9	26787-26798	individuals	_	
159-10	26799-26803	with	_	
159-11	26804-26813	psychosis	_	
159-12	26814-26817	and	_	
159-13	26818-26820	BP	_	
159-14	26821-26829	endorsed	_	
159-15	26830-26843	significantly	_	
159-16	26844-26848	less	_	
159-17	26849-26856	history	_	
159-18	26857-26859	of	_	
159-19	26860-26869	psychotic	_	
159-20	26870-26878	symptoms	_	
159-21	26879-26883	than	_	
159-22	26884-26886	SZ	_	
159-23	26887-26888	(	_	
159-24	26888-26893	table	_	
159-25	26894-26895	1	_	
159-26	26895-26896	)	_	
159-27	26896-26897	.	_	

#Text=Importantly, the literature suggests variability in cognitive performance in BP with poorer working memory and executive function performance in psychotic BP, which was also observed in the present study (table S10).
160-1	26898-26909	Importantly	_	
160-2	26909-26910	,	_	
160-3	26911-26914	the	_	
160-4	26915-26925	literature	_	
160-5	26926-26934	suggests	_	
160-6	26935-26946	variability	_	
160-7	26947-26949	in	_	
160-8	26950-26959	cognitive	_	
160-9	26960-26971	performance	_	
160-10	26972-26974	in	_	
160-11	26975-26977	BP	_	
160-12	26978-26982	with	_	
160-13	26983-26989	poorer	_	
160-14	26990-26997	working	_	
160-15	26998-27004	memory	_	
160-16	27005-27008	and	_	
160-17	27009-27018	executive	_	
160-18	27019-27027	function	_	
160-19	27028-27039	performance	_	
160-20	27040-27042	in	_	
160-21	27043-27052	psychotic	_	
160-22	27053-27055	BP	_	
160-23	27055-27056	,	_	
160-24	27057-27062	which	_	
160-25	27063-27066	was	_	
160-26	27067-27071	also	_	
160-27	27072-27080	observed	_	
160-28	27081-27083	in	_	
160-29	27084-27087	the	_	
160-30	27088-27095	present	_	
160-31	27096-27101	study	_	
160-32	27102-27103	(	_	
160-33	27103-27108	table	_	
160-34	27109-27112	S10	_	
160-35	27112-27113	)	_	
160-36	27113-27114	.	_	

#Text=Thus, future work with larger BP samples with psychosis are needed to better determine similarity to schizophrenia in multimodal correlates of cognitive control.
161-1	27115-27119	Thus	_	
161-2	27119-27120	,	_	
161-3	27121-27127	future	_	
161-4	27128-27132	work	_	
161-5	27133-27137	with	_	
161-6	27138-27144	larger	_	
161-7	27145-27147	BP	_	
161-8	27148-27155	samples	_	
161-9	27156-27160	with	_	
161-10	27161-27170	psychosis	_	
161-11	27171-27174	are	_	
161-12	27175-27181	needed	_	
161-13	27182-27184	to	_	
161-14	27185-27191	better	_	
161-15	27192-27201	determine	_	
161-16	27202-27212	similarity	_	
161-17	27213-27215	to	_	
161-18	27216-27229	schizophrenia	_	
161-19	27230-27232	in	_	
161-20	27233-27243	multimodal	_	
161-21	27244-27254	correlates	_	
161-22	27255-27257	of	_	
161-23	27258-27267	cognitive	_	
161-24	27268-27275	control	_	
161-25	27275-27276	.	_	

#Text=There are several additional limitations to the present study.
162-1	27277-27282	There	_	
162-2	27283-27286	are	_	
162-3	27287-27294	several	_	
162-4	27295-27305	additional	_	
162-5	27306-27317	limitations	_	
162-6	27318-27320	to	_	
162-7	27321-27324	the	_	
162-8	27325-27332	present	_	
162-9	27333-27338	study	_	
162-10	27338-27339	.	_	

#Text=First, de novo mCCA+jICA was a data-driven explorative analysis and must be interpreted with caution.
163-1	27340-27345	First	_	
163-2	27345-27346	,	_	
163-3	27347-27349	de	_	
163-4	27350-27354	novo	_	
163-5	27355-27359	mCCA	_	
163-6	27359-27360	+	_	
163-7	27360-27364	jICA	_	
163-8	27365-27368	was	_	
163-9	27369-27370	a	_	
163-10	27371-27382	data-driven	_	
163-11	27383-27394	explorative	_	
163-12	27395-27403	analysis	_	
163-13	27404-27407	and	_	
163-14	27408-27412	must	_	
163-15	27413-27415	be	_	
163-16	27416-27427	interpreted	_	
163-17	27428-27432	with	_	
163-18	27433-27440	caution	_	
163-19	27440-27441	.	_	

#Text=However, given similarity between a priori ICs and the present results, the differences across datasets provide intriguing possibilities for further hypothesis-driven study.
164-1	27442-27449	However	_	
164-2	27449-27450	,	_	
164-3	27451-27456	given	_	
164-4	27457-27467	similarity	_	
164-5	27468-27475	between	_	
164-6	27476-27477	a	_	
164-7	27478-27484	priori	_	
164-8	27485-27488	ICs	_	
164-9	27489-27492	and	_	
164-10	27493-27496	the	_	
164-11	27497-27504	present	_	
164-12	27505-27512	results	_	
164-13	27512-27513	,	_	
164-14	27514-27517	the	_	
164-15	27518-27529	differences	_	
164-16	27530-27536	across	_	
164-17	27537-27545	datasets	_	
164-18	27546-27553	provide	_	
164-19	27554-27564	intriguing	_	
164-20	27565-27578	possibilities	_	
164-21	27579-27582	for	_	
164-22	27583-27590	further	_	
164-23	27591-27608	hypothesis-driven	_	
164-24	27609-27614	study	_	
164-25	27614-27615	.	_	

#Text=Second, the present cognitive control metric was not identical to the HCP metric due to study design differences, potentially limiting our ability to detect all of the same relationships identified in our prior work (see supplement).
165-1	27616-27622	Second	_	
165-2	27622-27623	,	_	
165-3	27624-27627	the	_	
165-4	27628-27635	present	_	
165-5	27636-27645	cognitive	_	
165-6	27646-27653	control	_	
165-7	27654-27660	metric	_	
165-8	27661-27664	was	_	
165-9	27665-27668	not	_	
165-10	27669-27678	identical	_	
165-11	27679-27681	to	_	
165-12	27682-27685	the	_	
165-13	27686-27689	HCP	_	
165-14	27690-27696	metric	_	
165-15	27697-27700	due	_	
165-16	27701-27703	to	_	
165-17	27704-27709	study	_	
165-18	27710-27716	design	_	
165-19	27717-27728	differences	_	
165-20	27728-27729	,	_	
165-21	27730-27741	potentially	_	
165-22	27742-27750	limiting	_	
165-23	27751-27754	our	_	
165-24	27755-27762	ability	_	
165-25	27763-27765	to	_	
165-26	27766-27772	detect	_	
165-27	27773-27776	all	_	
165-28	27777-27779	of	_	
165-29	27780-27783	the	_	
165-30	27784-27788	same	_	
165-31	27789-27802	relationships	_	
165-32	27803-27813	identified	_	
165-33	27814-27816	in	_	
165-34	27817-27820	our	_	
165-35	27821-27826	prior	_	
165-36	27827-27831	work	_	
165-37	27832-27833	(	_	
165-38	27833-27836	see	_	
165-39	27837-27847	supplement	_	
165-40	27847-27848	)	_	
165-41	27848-27849	.	_	

#Text=Third, while IC3 was group discriminative overall, we were unable to detect significant post-hoc differences between HC and BP, though differences between HC and SZ were significant and differences between SZ and BP were trend-level, which may be due to medications or a relatively unimpaired BP group.
166-1	27850-27855	Third	_	
166-2	27855-27856	,	_	
166-3	27857-27862	while	_	
166-4	27863-27866	IC3	_	
166-5	27867-27870	was	_	
166-6	27871-27876	group	_	
166-7	27877-27891	discriminative	_	
166-8	27892-27899	overall	_	
166-9	27899-27900	,	_	
166-10	27901-27903	we	_	
166-11	27904-27908	were	_	
166-12	27909-27915	unable	_	
166-13	27916-27918	to	_	
166-14	27919-27925	detect	_	
166-15	27926-27937	significant	_	
166-16	27938-27946	post-hoc	_	
166-17	27947-27958	differences	_	
166-18	27959-27966	between	_	
166-19	27967-27969	HC	_	
166-20	27970-27973	and	_	
166-21	27974-27976	BP	_	
166-22	27976-27977	,	_	
166-23	27978-27984	though	_	
166-24	27985-27996	differences	_	
166-25	27997-28004	between	_	
166-26	28005-28007	HC	_	
166-27	28008-28011	and	_	
166-28	28012-28014	SZ	_	
166-29	28015-28019	were	_	
166-30	28020-28031	significant	_	
166-31	28032-28035	and	_	
166-32	28036-28047	differences	_	
166-33	28048-28055	between	_	
166-34	28056-28058	SZ	_	
166-35	28059-28062	and	_	
166-36	28063-28065	BP	_	
166-37	28066-28070	were	_	
166-38	28071-28082	trend-level	_	
166-39	28082-28083	,	_	
166-40	28084-28089	which	_	
166-41	28090-28093	may	_	
166-42	28094-28096	be	_	
166-43	28097-28100	due	_	
166-44	28101-28103	to	_	
166-45	28104-28115	medications	_	
166-46	28116-28118	or	_	
166-47	28119-28120	a	_	
166-48	28121-28131	relatively	_	
166-49	28132-28142	unimpaired	_	
166-50	28143-28145	BP	_	
166-51	28146-28151	group	_	
166-52	28151-28152	.	_	

#Text=Fourth, it was surprising that a priori HCP_gC1_IC3 rsfcMRI did not significantly predict cognitive control in the entire psychosis sample or any of the individual subgroups.
167-1	28153-28159	Fourth	_	
167-2	28159-28160	,	_	
167-3	28161-28163	it	_	
167-4	28164-28167	was	_	
167-5	28168-28178	surprising	_	
167-6	28179-28183	that	_	
167-7	28184-28185	a	_	
167-8	28186-28192	priori	_	
167-9	28193-28200	HCP_gC1	_	
167-10	28200-28201	_	_	
167-11	28201-28204	IC3	_	
167-12	28205-28212	rsfcMRI	_	
167-13	28213-28216	did	_	
167-14	28217-28220	not	_	
167-15	28221-28234	significantly	_	
167-16	28235-28242	predict	_	
167-17	28243-28252	cognitive	_	
167-18	28253-28260	control	_	
167-19	28261-28263	in	_	
167-20	28264-28267	the	_	
167-21	28268-28274	entire	_	
167-22	28275-28284	psychosis	_	
167-23	28285-28291	sample	_	
167-24	28292-28294	or	_	
167-25	28295-28298	any	_	
167-26	28299-28301	of	_	
167-27	28302-28305	the	_	
167-28	28306-28316	individual	_	
167-29	28317-28326	subgroups	_	
167-30	28326-28327	.	_	

#Text=This could be due to differences in the behavioral composite across the studies or, alternatively, it is possible that sum of numerous small but subtle differences in the two maps were sufficient to reduce predictive performance.
168-1	28328-28332	This	_	
168-2	28333-28338	could	_	
168-3	28339-28341	be	_	
168-4	28342-28345	due	_	
168-5	28346-28348	to	_	
168-6	28349-28360	differences	_	
168-7	28361-28363	in	_	
168-8	28364-28367	the	_	
168-9	28368-28378	behavioral	_	
168-10	28379-28388	composite	_	
168-11	28389-28395	across	_	
168-12	28396-28399	the	_	
168-13	28400-28407	studies	_	
168-14	28408-28410	or	_	
168-15	28410-28411	,	_	
168-16	28412-28425	alternatively	_	
168-17	28425-28426	,	_	
168-18	28427-28429	it	_	
168-19	28430-28432	is	_	
168-20	28433-28441	possible	_	
168-21	28442-28446	that	_	
168-22	28447-28450	sum	_	
168-23	28451-28453	of	_	
168-24	28454-28462	numerous	_	
168-25	28463-28468	small	_	
168-26	28469-28472	but	_	
168-27	28473-28479	subtle	_	
168-28	28480-28491	differences	_	
168-29	28492-28494	in	_	
168-30	28495-28498	the	_	
168-31	28499-28502	two	_	
168-32	28503-28507	maps	_	
168-33	28508-28512	were	_	
168-34	28513-28523	sufficient	_	
168-35	28524-28526	to	_	
168-36	28527-28533	reduce	_	
168-37	28534-28544	predictive	_	
168-38	28545-28556	performance	_	
168-39	28556-28557	.	_	

#Text=Finally, sample size may have limited our ability to detect group discrimination of a priori ICs, relationships between imaging and cognitive control given that we only had behavioral data for 30 HC, 27 BP, and 23 SZ participants.
169-1	28558-28565	Finally	_	
169-2	28565-28566	,	_	
169-3	28567-28573	sample	_	
169-4	28574-28578	size	_	
169-5	28579-28582	may	_	
169-6	28583-28587	have	_	
169-7	28588-28595	limited	_	
169-8	28596-28599	our	_	
169-9	28600-28607	ability	_	
169-10	28608-28610	to	_	
169-11	28611-28617	detect	_	
169-12	28618-28623	group	_	
169-13	28624-28638	discrimination	_	
169-14	28639-28641	of	_	
169-15	28642-28643	a	_	
169-16	28644-28650	priori	_	
169-17	28651-28654	ICs	_	
169-18	28654-28655	,	_	
169-19	28656-28669	relationships	_	
169-20	28670-28677	between	_	
169-21	28678-28685	imaging	_	
169-22	28686-28689	and	_	
169-23	28690-28699	cognitive	_	
169-24	28700-28707	control	_	
169-25	28708-28713	given	_	
169-26	28714-28718	that	_	
169-27	28719-28721	we	_	
169-28	28722-28726	only	_	
169-29	28727-28730	had	_	
169-30	28731-28741	behavioral	_	
169-31	28742-28746	data	_	
169-32	28747-28750	for	_	
169-33	28751-28753	30	_	
169-34	28754-28756	HC	_	
169-35	28756-28757	,	_	
169-36	28758-28760	27	_	
169-37	28761-28763	BP	_	
169-38	28763-28764	,	_	
169-39	28765-28768	and	_	
169-40	28769-28771	23	_	
169-41	28772-28774	SZ	_	
169-42	28775-28787	participants	_	
169-43	28787-28788	.	_	

#Text=However, the de novo identification of IC3 which was 91.5% similar to HCP_gC1_IC3 suggests that this pattern is indeed a durable feature in the data and that limited variance in the cognitive control composite was the primary driver of our inability to detect some effects.
170-1	28789-28796	However	_	
170-2	28796-28797	,	_	
170-3	28798-28801	the	_	
170-4	28802-28804	de	_	
170-5	28805-28809	novo	_	
170-6	28810-28824	identification	_	
170-7	28825-28827	of	_	
170-8	28828-28831	IC3	_	
170-9	28832-28837	which	_	
170-10	28838-28841	was	_	
170-11	28842-28847	91.5%	_	
170-12	28848-28855	similar	_	
170-13	28856-28858	to	_	
170-14	28859-28866	HCP_gC1	_	
170-15	28866-28867	_	_	
170-16	28867-28870	IC3	_	
170-17	28871-28879	suggests	_	
170-18	28880-28884	that	_	
170-19	28885-28889	this	_	
170-20	28890-28897	pattern	_	
170-21	28898-28900	is	_	
170-22	28901-28907	indeed	_	
170-23	28908-28909	a	_	
170-24	28910-28917	durable	_	
170-25	28918-28925	feature	_	
170-26	28926-28928	in	_	
170-27	28929-28932	the	_	
170-28	28933-28937	data	_	
170-29	28938-28941	and	_	
170-30	28942-28946	that	_	
170-31	28947-28954	limited	_	
170-32	28955-28963	variance	_	
170-33	28964-28966	in	_	
170-34	28967-28970	the	_	
170-35	28971-28980	cognitive	_	
170-36	28981-28988	control	_	
170-37	28989-28998	composite	_	
170-38	28999-29002	was	_	
170-39	29003-29006	the	_	
170-40	29007-29014	primary	_	
170-41	29015-29021	driver	_	
170-42	29022-29024	of	_	
170-43	29025-29028	our	_	
170-44	29029-29038	inability	_	
170-45	29039-29041	to	_	
170-46	29042-29048	detect	_	
170-47	29049-29053	some	_	
170-48	29054-29061	effects	_	
170-49	29061-29062	.	_	

#Text=In conclusion, the present study employed multimodal methods to examine transdiagnostic alterations in cognitive control in psychosis.
171-1	29063-29065	In	_	
171-2	29066-29076	conclusion	_	
171-3	29076-29077	,	_	
171-4	29078-29081	the	_	
171-5	29082-29089	present	_	
171-6	29090-29095	study	_	
171-7	29096-29104	employed	_	
171-8	29105-29115	multimodal	_	
171-9	29116-29123	methods	_	
171-10	29124-29126	to	_	
171-11	29127-29134	examine	_	
171-12	29135-29150	transdiagnostic	_	
171-13	29151-29162	alterations	_	
171-14	29163-29165	in	_	
171-15	29166-29175	cognitive	_	
171-16	29176-29183	control	_	
171-17	29184-29186	in	_	
171-18	29187-29196	psychosis	_	
171-19	29196-29197	.	_	

#Text=Two modalities from a priori ICs from the normative population significantly predicted cognitive control in psychosis for two of six modalities tested.
172-1	29198-29201	Two	_	
172-2	29202-29212	modalities	_	
172-3	29213-29217	from	_	
172-4	29218-29219	a	_	
172-5	29220-29226	priori	_	
172-6	29227-29230	ICs	_	
172-7	29231-29235	from	_	
172-8	29236-29239	the	_	
172-9	29240-29249	normative	_	
172-10	29250-29260	population	_	
172-11	29261-29274	significantly	_	
172-12	29275-29284	predicted	_	
172-13	29285-29294	cognitive	_	
172-14	29295-29302	control	_	
172-15	29303-29305	in	_	
172-16	29306-29315	psychosis	_	
172-17	29316-29319	for	_	
172-18	29320-29323	two	_	
172-19	29324-29326	of	_	
172-20	29327-29330	six	_	
172-21	29331-29341	modalities	_	
172-22	29342-29348	tested	_	
172-23	29348-29349	.	_	

#Text=De novo mCCA+jICA identified a group-discriminative IC that significantly correlated with cognitive control for sMRI, rsfcMRI, and tfMRI data.
173-1	29350-29352	De	_	
173-2	29353-29357	novo	_	
173-3	29358-29362	mCCA	_	
173-4	29362-29363	+	_	
173-5	29363-29367	jICA	_	
173-6	29368-29378	identified	_	
173-7	29379-29380	a	_	
173-8	29381-29401	group-discriminative	_	
173-9	29402-29404	IC	_	
173-10	29405-29409	that	_	
173-11	29410-29423	significantly	_	
173-12	29424-29434	correlated	_	
173-13	29435-29439	with	_	
173-14	29440-29449	cognitive	_	
173-15	29450-29457	control	_	
173-16	29458-29461	for	_	
173-17	29462-29466	sMRI	_	
173-18	29466-29467	,	_	
173-19	29468-29475	rsfcMRI	_	
173-20	29475-29476	,	_	
173-21	29477-29480	and	_	
173-22	29481-29486	tfMRI	_	
173-23	29487-29491	data	_	
173-24	29491-29492	.	_	

#Text=De novo analyses suggest joint associations between cognitive control and tfMRI contributions from the posterior frontoparietal, dorsal attention, and visual networks, sMRI contributions from the insula, medial PFC, and cingulate, and rsfcMRI contributions from canonical resting-state network organization.
174-1	29493-29495	De	_	
174-2	29496-29500	novo	_	
174-3	29501-29509	analyses	_	
174-4	29510-29517	suggest	_	
174-5	29518-29523	joint	_	
174-6	29524-29536	associations	_	
174-7	29537-29544	between	_	
174-8	29545-29554	cognitive	_	
174-9	29555-29562	control	_	
174-10	29563-29566	and	_	
174-11	29567-29572	tfMRI	_	
174-12	29573-29586	contributions	_	
174-13	29587-29591	from	_	
174-14	29592-29595	the	_	
174-15	29596-29605	posterior	_	
174-16	29606-29620	frontoparietal	_	
174-17	29620-29621	,	_	
174-18	29622-29628	dorsal	_	
174-19	29629-29638	attention	_	
174-20	29638-29639	,	_	
174-21	29640-29643	and	_	
174-22	29644-29650	visual	_	
174-23	29651-29659	networks	_	
174-24	29659-29660	,	_	
174-25	29661-29665	sMRI	_	
174-26	29666-29679	contributions	_	
174-27	29680-29684	from	_	
174-28	29685-29688	the	_	
174-29	29689-29695	insula	_	
174-30	29695-29696	,	_	
174-31	29697-29703	medial	_	
174-32	29704-29707	PFC	_	
174-33	29707-29708	,	_	
174-34	29709-29712	and	_	
174-35	29713-29722	cingulate	_	
174-36	29722-29723	,	_	
174-37	29724-29727	and	_	
174-38	29728-29735	rsfcMRI	_	
174-39	29736-29749	contributions	_	
174-40	29750-29754	from	_	
174-41	29755-29764	canonical	_	
174-42	29765-29778	resting-state	_	
174-43	29779-29786	network	_	
174-44	29787-29799	organization	_	
174-45	29799-29800	.	_	

#Text=However, significant effects were predominantly driven by SZ with little evidence for effects in BP or HC.
175-1	29801-29808	However	_	
175-2	29808-29809	,	_	
175-3	29810-29821	significant	_	
175-4	29822-29829	effects	_	
175-5	29830-29834	were	_	
175-6	29835-29848	predominantly	_	
175-7	29849-29855	driven	_	
175-8	29856-29858	by	_	
175-9	29859-29861	SZ	_	
175-10	29862-29866	with	_	
175-11	29867-29873	little	_	
175-12	29874-29882	evidence	_	
175-13	29883-29886	for	_	
175-14	29887-29894	effects	_	
175-15	29895-29897	in	_	
175-16	29898-29900	BP	_	
175-17	29901-29903	or	_	
175-18	29904-29906	HC	_	
175-19	29906-29907	.	_	

#Text=Given psychotic symptom heterogeneity in BP, results suggest that shared symptomatology, e.g. psychosis, may be key to identification of transdiagnostic relationships with cognitive control.
176-1	29908-29913	Given	_	
176-2	29914-29923	psychotic	_	
176-3	29924-29931	symptom	_	
176-4	29932-29945	heterogeneity	_	
176-5	29946-29948	in	_	
176-6	29949-29951	BP	_	
176-7	29951-29952	,	_	
176-8	29953-29960	results	_	
176-9	29961-29968	suggest	_	
176-10	29969-29973	that	_	
176-11	29974-29980	shared	_	
176-12	29981-29995	symptomatology	_	
176-13	29995-29996	,	_	
176-14	29997-30000	e.g	_	
176-15	30000-30001	.	_	
176-16	30002-30011	psychosis	_	
176-17	30011-30012	,	_	
176-18	30013-30016	may	_	
176-19	30017-30019	be	_	
176-20	30020-30023	key	_	
176-21	30024-30026	to	_	
176-22	30027-30041	identification	_	
176-23	30042-30044	of	_	
176-24	30045-30060	transdiagnostic	_	
176-25	30061-30074	relationships	_	
176-26	30075-30079	with	_	
176-27	30080-30089	cognitive	_	
176-28	30090-30097	control	_	
176-29	30097-30098	.	_	

#Text=Together, these results identified significant and replicable relationships across modalities and the psychosis spectrum, providing targets across modalities of neural structure and function for future research.
177-1	30099-30107	Together	_	
177-2	30107-30108	,	_	
177-3	30109-30114	these	_	
177-4	30115-30122	results	_	
177-5	30123-30133	identified	_	
177-6	30134-30145	significant	_	
177-7	30146-30149	and	_	
177-8	30150-30160	replicable	_	
177-9	30161-30174	relationships	_	
177-10	30175-30181	across	_	
177-11	30182-30192	modalities	_	
177-12	30193-30196	and	_	
177-13	30197-30200	the	_	
177-14	30201-30210	psychosis	_	
177-15	30211-30219	spectrum	_	
177-16	30219-30220	,	_	
177-17	30221-30230	providing	_	
177-18	30231-30238	targets	_	
177-19	30239-30245	across	_	
177-20	30246-30256	modalities	_	
177-21	30257-30259	of	_	
177-22	30260-30266	neural	_	
177-23	30267-30276	structure	_	
177-24	30277-30280	and	_	
177-25	30281-30289	function	_	
177-26	30290-30293	for	_	
177-27	30294-30300	future	_	
177-28	30301-30309	research	_	
177-29	30309-30310	.	_	

#Text=Supplementary Material
#Text=Disclosures:
#Text=SK, VDC, and DTM have no biomedical financial interests or potential conflicts of interest.
178-1	30311-30324	Supplementary	_	
178-2	30325-30333	Material	_	
178-3	30334-30345	Disclosures	_	
178-4	30345-30346	:	_	
178-5	30347-30349	SK	_	
178-6	30349-30350	,	_	
178-7	30351-30354	VDC	_	
178-8	30354-30355	,	_	
178-9	30356-30359	and	_	
178-10	30360-30363	DTM	_	
178-11	30364-30368	have	_	
178-12	30369-30371	no	_	
178-13	30372-30382	biomedical	_	
178-14	30383-30392	financial	_	
178-15	30393-30402	interests	_	
178-16	30403-30405	or	_	
178-17	30406-30415	potential	_	
178-18	30416-30425	conflicts	_	
178-19	30426-30428	of	_	
178-20	30429-30437	interest	_	
178-21	30437-30438	.	_	

#Text=DMB has consulted for Pfizer in the prior two years.
179-1	30439-30442	DMB	_	
179-2	30443-30446	has	_	
179-3	30447-30456	consulted	_	
179-4	30457-30460	for	_	
179-5	30461-30467	Pfizer	_	
179-6	30468-30470	in	_	
179-7	30471-30474	the	_	
179-8	30475-30480	prior	_	
179-9	30481-30484	two	_	
179-10	30485-30490	years	_	
179-11	30490-30491	.	_	

#Text=DBLS has received payment from an unrelated pharmaceutical company for use of his pet in veterinary product advertisements.
180-1	30492-30496	DBLS	_	
180-2	30497-30500	has	_	
180-3	30501-30509	received	_	
180-4	30510-30517	payment	_	
180-5	30518-30522	from	_	
180-6	30523-30525	an	_	
180-7	30526-30535	unrelated	_	
180-8	30536-30550	pharmaceutical	_	
180-9	30551-30558	company	_	
180-10	30559-30562	for	_	
180-11	30563-30566	use	_	
180-12	30567-30569	of	_	
180-13	30570-30573	his	_	
180-14	30574-30577	pet	_	
180-15	30578-30580	in	_	
180-16	30581-30591	veterinary	_	
180-17	30592-30599	product	_	
180-18	30600-30614	advertisements	_	
180-19	30614-30615	.	_	

#Text=References:
#Text=Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia
#Text=Cognitive variability in psychotic disorders: a cross-diagnostic cluster analysis
#Text=Cognition in schizophrenia: core psychological and neural mechanisms
#Text=Cognitive impairments in psychotic disorders: common mechanisms and measurement
#Text=Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function
#Text=Cognitive control deficits in schizophrenia: mechanisms and meaning
#Text=Levels of Cognitive Control: A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia
#Text=Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls
#Text=Transdiagnostic impairment of cognitive control in mental illness
#Text=Attentional control activation relates to working memory in attention-deficit/hyperactivity disorder
#Text=Inverted-U-shaped dopamine actions on human working memory and cognitive control
#Text=Annual Research Review: On the relations among self-regulation, self-control, executive functioning, effortful control, cognitive control, impulsivity, risk-taking, and inhibition for developmental psychopathology
#Text=Developing constructs for psychopathology research: research domain criteria
#Text=The computational and neural basis of cognitive control: charted territory and new frontiers
#Text=Motivation and cognitive control: from behavior to neural mechanism
#Text=An integrative theory of prefrontal cortex function
#Text=
#Text=Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences
#Text=Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence?
181-1	30616-30626	References	_	
181-2	30626-30627	:	_	
181-3	30628-30637	Psychosis	_	
181-4	30638-30640	as	_	
181-5	30641-30642	a	_	
181-6	30643-30648	state	_	
181-7	30649-30651	of	_	
181-8	30652-30660	aberrant	_	
181-9	30661-30669	salience	_	
181-10	30669-30670	:	_	
181-11	30671-30672	a	_	
181-12	30673-30682	framework	_	
181-13	30683-30690	linking	_	
181-14	30691-30698	biology	_	
181-15	30698-30699	,	_	
181-16	30700-30713	phenomenology	_	
181-17	30713-30714	,	_	
181-18	30715-30718	and	_	
181-19	30719-30731	pharmacology	_	
181-20	30732-30734	in	_	
181-21	30735-30748	schizophrenia	_	
181-22	30749-30758	Cognitive	_	
181-23	30759-30770	variability	_	
181-24	30771-30773	in	_	
181-25	30774-30783	psychotic	_	
181-26	30784-30793	disorders	_	
181-27	30793-30794	:	_	
181-28	30795-30796	a	_	
181-29	30797-30813	cross-diagnostic	_	
181-30	30814-30821	cluster	_	
181-31	30822-30830	analysis	_	
181-32	30831-30840	Cognition	_	
181-33	30841-30843	in	_	
181-34	30844-30857	schizophrenia	_	
181-35	30857-30858	:	_	
181-36	30859-30863	core	_	
181-37	30864-30877	psychological	_	
181-38	30878-30881	and	_	
181-39	30882-30888	neural	_	
181-40	30889-30899	mechanisms	_	
181-41	30900-30909	Cognitive	_	
181-42	30910-30921	impairments	_	
181-43	30922-30924	in	_	
181-44	30925-30934	psychotic	_	
181-45	30935-30944	disorders	_	
181-46	30944-30945	:	_	
181-47	30946-30952	common	_	
181-48	30953-30963	mechanisms	_	
181-49	30964-30967	and	_	
181-50	30968-30979	measurement	_	
181-51	30980-30989	Cognition	_	
181-52	30990-30993	and	_	
181-53	30994-31001	control	_	
181-54	31002-31004	in	_	
181-55	31005-31018	schizophrenia	_	
181-56	31018-31019	:	_	
181-57	31020-31021	a	_	
181-58	31022-31035	computational	_	
181-59	31036-31041	model	_	
181-60	31042-31044	of	_	
181-61	31045-31053	dopamine	_	
181-62	31054-31057	and	_	
181-63	31058-31068	prefrontal	_	
181-64	31069-31077	function	_	
181-65	31078-31087	Cognitive	_	
181-66	31088-31095	control	_	
181-67	31096-31104	deficits	_	
181-68	31105-31107	in	_	
181-69	31108-31121	schizophrenia	_	
181-70	31121-31122	:	_	
181-71	31123-31133	mechanisms	_	
181-72	31134-31137	and	_	
181-73	31138-31145	meaning	_	
181-74	31146-31152	Levels	_	
181-75	31153-31155	of	_	
181-76	31156-31165	Cognitive	_	
181-77	31166-31173	Control	_	
181-78	31173-31174	:	_	
181-79	31175-31176	A	_	
181-80	31177-31187	Functional	_	
181-81	31188-31196	Magnetic	_	
181-82	31197-31206	Resonance	_	
181-83	31207-31220	Imaging-Based	_	
181-84	31221-31225	Test	_	
181-85	31226-31228	of	_	
181-86	31229-31231	an	_	
181-87	31232-31236	RDoC	_	
181-88	31237-31243	Domain	_	
181-89	31244-31250	Across	_	
181-90	31251-31258	Bipolar	_	
181-91	31259-31267	Disorder	_	
181-92	31268-31271	and	_	
181-93	31272-31285	Schizophrenia	_	
181-94	31286-31299	Meta-analysis	_	
181-95	31300-31302	of	_	
181-96	31303-31312	Cognitive	_	
181-97	31313-31323	Impairment	_	
181-98	31324-31326	in	_	
181-99	31327-31340	First-Episode	_	
181-100	31341-31348	Bipolar	_	
181-101	31349-31357	Disorder	_	
181-102	31357-31358	:	_	
181-103	31359-31369	Comparison	_	
181-104	31370-31374	With	_	
181-105	31375-31388	First-Episode	_	
181-106	31389-31402	Schizophrenia	_	
181-107	31403-31406	and	_	
181-108	31407-31414	Healthy	_	
181-109	31415-31423	Controls	_	
181-110	31424-31439	Transdiagnostic	_	
181-111	31440-31450	impairment	_	
181-112	31451-31453	of	_	
181-113	31454-31463	cognitive	_	
181-114	31464-31471	control	_	
181-115	31472-31474	in	_	
181-116	31475-31481	mental	_	
181-117	31482-31489	illness	_	
181-118	31490-31501	Attentional	_	
181-119	31502-31509	control	_	
181-120	31510-31520	activation	_	
181-121	31521-31528	relates	_	
181-122	31529-31531	to	_	
181-123	31532-31539	working	_	
181-124	31540-31546	memory	_	
181-125	31547-31549	in	_	
181-126	31550-31567	attention-deficit	_	
181-127	31567-31568	/	_	
181-128	31568-31581	hyperactivity	_	
181-129	31582-31590	disorder	_	
181-130	31591-31608	Inverted-U-shaped	_	
181-131	31609-31617	dopamine	_	
181-132	31618-31625	actions	_	
181-133	31626-31628	on	_	
181-134	31629-31634	human	_	
181-135	31635-31642	working	_	
181-136	31643-31649	memory	_	
181-137	31650-31653	and	_	
181-138	31654-31663	cognitive	_	
181-139	31664-31671	control	_	
181-140	31672-31678	Annual	_	
181-141	31679-31687	Research	_	
181-142	31688-31694	Review	_	
181-143	31694-31695	:	_	
181-144	31696-31698	On	_	
181-145	31699-31702	the	_	
181-146	31703-31712	relations	_	
181-147	31713-31718	among	_	
181-148	31719-31734	self-regulation	_	
181-149	31734-31735	,	_	
181-150	31736-31748	self-control	_	
181-151	31748-31749	,	_	
181-152	31750-31759	executive	_	
181-153	31760-31771	functioning	_	
181-154	31771-31772	,	_	
181-155	31773-31782	effortful	_	
181-156	31783-31790	control	_	
181-157	31790-31791	,	_	
181-158	31792-31801	cognitive	_	
181-159	31802-31809	control	_	
181-160	31809-31810	,	_	
181-161	31811-31822	impulsivity	_	
181-162	31822-31823	,	_	
181-163	31824-31835	risk-taking	_	
181-164	31835-31836	,	_	
181-165	31837-31840	and	_	
181-166	31841-31851	inhibition	_	
181-167	31852-31855	for	_	
181-168	31856-31869	developmental	_	
181-169	31870-31885	psychopathology	_	
181-170	31886-31896	Developing	_	
181-171	31897-31907	constructs	_	
181-172	31908-31911	for	_	
181-173	31912-31927	psychopathology	_	
181-174	31928-31936	research	_	
181-175	31936-31937	:	_	
181-176	31938-31946	research	_	
181-177	31947-31953	domain	_	
181-178	31954-31962	criteria	_	
181-179	31963-31966	The	_	
181-180	31967-31980	computational	_	
181-181	31981-31984	and	_	
181-182	31985-31991	neural	_	
181-183	31992-31997	basis	_	
181-184	31998-32000	of	_	
181-185	32001-32010	cognitive	_	
181-186	32011-32018	control	_	
181-187	32018-32019	:	_	
181-188	32020-32027	charted	_	
181-189	32028-32037	territory	_	
181-190	32038-32041	and	_	
181-191	32042-32045	new	_	
181-192	32046-32055	frontiers	_	
181-193	32056-32066	Motivation	_	
181-194	32067-32070	and	_	
181-195	32071-32080	cognitive	_	
181-196	32081-32088	control	_	
181-197	32088-32089	:	_	
181-198	32090-32094	from	_	
181-199	32095-32103	behavior	_	
181-200	32104-32106	to	_	
181-201	32107-32113	neural	_	
181-202	32114-32123	mechanism	_	
181-203	32124-32126	An	_	
181-204	32127-32138	integrative	_	
181-205	32139-32145	theory	_	
181-206	32146-32148	of	_	
181-207	32149-32159	prefrontal	_	
181-208	32160-32166	cortex	_	
181-209	32167-32175	function	_	
181-210	32177-32195	Neuropsychological	_	
181-211	32196-32209	abnormalities	_	
181-212	32210-32212	in	_	
181-213	32213-32226	schizophrenia	_	
181-214	32227-32230	and	_	
181-215	32231-32236	major	_	
181-216	32237-32241	mood	_	
181-217	32242-32251	disorders	_	
181-218	32251-32252	:	_	
181-219	32253-32265	similarities	_	
181-220	32266-32269	and	_	
181-221	32270-32281	differences	_	
181-222	32282-32288	Shared	_	
181-223	32289-32292	and	_	
181-224	32293-32302	divergent	_	
181-225	32303-32317	neurocognitive	_	
181-226	32318-32329	impairments	_	
181-227	32330-32332	in	_	
181-228	32333-32338	adult	_	
181-229	32339-32347	patients	_	
181-230	32348-32352	with	_	
181-231	32353-32366	schizophrenia	_	
181-232	32367-32370	and	_	
181-233	32371-32378	bipolar	_	
181-234	32379-32387	disorder	_	
181-235	32387-32388	:	_	
181-236	32389-32396	Whither	_	
181-237	32397-32400	the	_	
181-238	32401-32409	evidence	_	
181-239	32409-32410	?	_	

#Text=Brain cortical thickness and surface area correlates of neurocognitive performance in patients with schizophrenia, bipolar disorder, and healthy adults
#Text=Identification of a common neurobiological substrate for mental illness
#Text=Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction
#Text=Identifying dynamic functional connectivity biomarkers using GIG-ICA: Application to schizophrenia, schizoaffective disorder, and psychotic bipolar disorder
#Text=A group ICA based framework for evaluating resting fMRI markers when disease categories are unclear: application to schizophrenia, bipolar, and schizoaffective disorders
#Text=Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder
#Text=Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition
#Text=Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives
#Text=Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort
#Text=Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition
#Text=Working memory networks and activation patterns in schizophrenia and bipolar disorder: comparison with healthy controls
#Text=Multimodal fusion of brain imaging data: A key to finding the missing link(s) in complex mental illness
#Text=In search of multimodal neuroimaging biomarkers of cognitive deficits in schizophrenia
#Text=Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders
#Text=Multimodal neural correlates of cognitive control in the Human Connectome Project
#Text=A review of multivariate methods for multimodal fusion of brain imaging data
#Text=Three-way FMRI-DTI-methylation data fusion based on mCCA+jICA and its application to schizophrenia
#Text=Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCA+ joint ICA model
#Text=The WU-Minn Human Connectome Project: an overview
#Text=A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation
#Text=The minimal preprocessing pipelines for the Human Connectome Project
#Text=Generation and Evaluation of a Cortical Area Parcellation from Resting-State Correlations
#Text=
#Text=Canonical Correlation Analysis for Feature-Based Fusion of Biomedical Imaging Modalities and Its Application to Detection of Associative Networks in Schizophrenia
#Text=Joint Blind Source Separation by Multi-set Canonical Correlation Analysis
#Text=A method for multitask fMRI data fusion applied to schizophrenia
#Text=Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
#Text=Distinct brain networks for adaptive and stable task control in humans
#Text=Function in the human connectome: Task-fMRI and individual differences in behavior
#Text=Vision in schizophrenia: why it matters
#Text=
#Text=Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia
#Text=When doors of perception close: bottom-up models of disrupted cognition in schizophrenia
#Text=Bipolar and schizophrenic patients differ in patterns of visual motion discrimination
#Text=Visual motion integration in schizophrenia patients, their first-degree relatives, and patients with bipolar disorder
#Text=Visual sensory processing deficits in patients with bipolar disorder revealed through high-density electrical mapping
#Text=Cross-diagnostic comparison of visual processing in bipolar disorder and schizophrenia
#Text=Altered visual information processing systems in bipolar disorder: evidence from visual MMN and P3
#Text=Abnormal early brain responses during visual search are evident in schizophrenia but not bipolar affective disorder
#Text=The coherent organization of mental life depends on mechanisms for context-sensitive gain-control that are impaired in schizophrenia
#Text=Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysis
#Text=Scatter plots of cognitive control and a priori ICs applied to psychosis cohort
#Text=Two out of six modalities in HCP_gC1_IC3 and HCP_gC1_IC7 significantly predicted cognitive control performance in the psychosis cohort.
182-1	32411-32416	Brain	_	
182-2	32417-32425	cortical	_	
182-3	32426-32435	thickness	_	
182-4	32436-32439	and	_	
182-5	32440-32447	surface	_	
182-6	32448-32452	area	_	
182-7	32453-32463	correlates	_	
182-8	32464-32466	of	_	
182-9	32467-32481	neurocognitive	_	
182-10	32482-32493	performance	_	
182-11	32494-32496	in	_	
182-12	32497-32505	patients	_	
182-13	32506-32510	with	_	
182-14	32511-32524	schizophrenia	_	
182-15	32524-32525	,	_	
182-16	32526-32533	bipolar	_	
182-17	32534-32542	disorder	_	
182-18	32542-32543	,	_	
182-19	32544-32547	and	_	
182-20	32548-32555	healthy	_	
182-21	32556-32562	adults	_	
182-22	32563-32577	Identification	_	
182-23	32578-32580	of	_	
182-24	32581-32582	a	_	
182-25	32583-32589	common	_	
182-26	32590-32605	neurobiological	_	
182-27	32606-32615	substrate	_	
182-28	32616-32619	for	_	
182-29	32620-32626	mental	_	
182-30	32627-32634	illness	_	
182-31	32635-32641	Shared	_	
182-32	32642-32654	intermediate	_	
182-33	32655-32665	phenotypes	_	
182-34	32666-32669	for	_	
182-35	32670-32683	schizophrenia	_	
182-36	32684-32687	and	_	
182-37	32688-32695	bipolar	_	
182-38	32696-32704	disorder	_	
182-39	32704-32705	:	_	
182-40	32706-32721	neuroanatomical	_	
182-41	32722-32730	features	_	
182-42	32731-32733	of	_	
182-43	32734-32742	subtypes	_	
182-44	32743-32756	distinguished	_	
182-45	32757-32759	by	_	
182-46	32760-32769	executive	_	
182-47	32770-32781	dysfunction	_	
182-48	32782-32793	Identifying	_	
182-49	32794-32801	dynamic	_	
182-50	32802-32812	functional	_	
182-51	32813-32825	connectivity	_	
182-52	32826-32836	biomarkers	_	
182-53	32837-32842	using	_	
182-54	32843-32850	GIG-ICA	_	
182-55	32850-32851	:	_	
182-56	32852-32863	Application	_	
182-57	32864-32866	to	_	
182-58	32867-32880	schizophrenia	_	
182-59	32880-32881	,	_	
182-60	32882-32897	schizoaffective	_	
182-61	32898-32906	disorder	_	
182-62	32906-32907	,	_	
182-63	32908-32911	and	_	
182-64	32912-32921	psychotic	_	
182-65	32922-32929	bipolar	_	
182-66	32930-32938	disorder	_	
182-67	32939-32940	A	_	
182-68	32941-32946	group	_	
182-69	32947-32950	ICA	_	
182-70	32951-32956	based	_	
182-71	32957-32966	framework	_	
182-72	32967-32970	for	_	
182-73	32971-32981	evaluating	_	
182-74	32982-32989	resting	_	
182-75	32990-32994	fMRI	_	
182-76	32995-33002	markers	_	
182-77	33003-33007	when	_	
182-78	33008-33015	disease	_	
182-79	33016-33026	categories	_	
182-80	33027-33030	are	_	
182-81	33031-33038	unclear	_	
182-82	33038-33039	:	_	
182-83	33040-33051	application	_	
182-84	33052-33054	to	_	
182-85	33055-33068	schizophrenia	_	
182-86	33068-33069	,	_	
182-87	33070-33077	bipolar	_	
182-88	33077-33078	,	_	
182-89	33079-33082	and	_	
182-90	33083-33098	schizoaffective	_	
182-91	33099-33108	disorders	_	
182-92	33109-33122	Resting-state	_	
182-93	33123-33127	fMRI	_	
182-94	33128-33140	connectivity	_	
182-95	33141-33151	impairment	_	
182-96	33152-33154	in	_	
182-97	33155-33168	schizophrenia	_	
182-98	33169-33172	and	_	
182-99	33173-33180	bipolar	_	
182-100	33181-33189	disorder	_	
182-101	33190-33205	Transdiagnostic	_	
182-102	33206-33218	Associations	_	
182-103	33219-33226	Between	_	
182-104	33227-33237	Functional	_	
182-105	33238-33243	Brain	_	
182-106	33244-33251	Network	_	
182-107	33252-33261	Integrity	_	
182-108	33262-33265	and	_	
182-109	33266-33275	Cognition	_	
182-110	33276-33287	Differences	_	
182-111	33288-33290	in	_	
182-112	33291-33304	resting-state	_	
182-113	33305-33315	functional	_	
182-114	33316-33324	magnetic	_	
182-115	33325-33334	resonance	_	
182-116	33335-33342	imaging	_	
182-117	33343-33353	functional	_	
182-118	33354-33361	network	_	
182-119	33362-33374	connectivity	_	
182-120	33375-33382	between	_	
182-121	33383-33396	schizophrenia	_	
182-122	33397-33400	and	_	
182-123	33401-33410	psychotic	_	
182-124	33411-33418	bipolar	_	
182-125	33419-33427	probands	_	
182-126	33428-33431	and	_	
182-127	33432-33437	their	_	
182-128	33438-33448	unaffected	_	
182-129	33449-33461	first-degree	_	
182-130	33462-33471	relatives	_	
182-131	33472-33481	Examining	_	
182-132	33482-33492	Functional	_	
182-133	33493-33506	Resting-State	_	
182-134	33507-33519	Connectivity	_	
182-135	33520-33522	in	_	
182-136	33523-33532	Psychosis	_	
182-137	33533-33536	and	_	
182-138	33537-33540	Its	_	
182-139	33541-33550	Subgroups	_	
182-140	33551-33553	in	_	
182-141	33554-33557	the	_	
182-142	33558-33579	Bipolar-Schizophrenia	_	
182-143	33580-33587	Network	_	
182-144	33588-33590	on	_	
182-145	33591-33603	Intermediate	_	
182-146	33604-33614	Phenotypes	_	
182-147	33615-33621	Cohort	_	
182-148	33622-33637	Transdiagnostic	_	
182-149	33638-33650	Associations	_	
182-150	33651-33658	Between	_	
182-151	33659-33669	Functional	_	
182-152	33670-33675	Brain	_	
182-153	33676-33683	Network	_	
182-154	33684-33693	Integrity	_	
182-155	33694-33697	and	_	
182-156	33698-33707	Cognition	_	
182-157	33708-33715	Working	_	
182-158	33716-33722	memory	_	
182-159	33723-33731	networks	_	
182-160	33732-33735	and	_	
182-161	33736-33746	activation	_	
182-162	33747-33755	patterns	_	
182-163	33756-33758	in	_	
182-164	33759-33772	schizophrenia	_	
182-165	33773-33776	and	_	
182-166	33777-33784	bipolar	_	
182-167	33785-33793	disorder	_	
182-168	33793-33794	:	_	
182-169	33795-33805	comparison	_	
182-170	33806-33810	with	_	
182-171	33811-33818	healthy	_	
182-172	33819-33827	controls	_	
182-173	33828-33838	Multimodal	_	
182-174	33839-33845	fusion	_	
182-175	33846-33848	of	_	
182-176	33849-33854	brain	_	
182-177	33855-33862	imaging	_	
182-178	33863-33867	data	_	
182-179	33867-33868	:	_	
182-180	33869-33870	A	_	
182-181	33871-33874	key	_	
182-182	33875-33877	to	_	
182-183	33878-33885	finding	_	
182-184	33886-33889	the	_	
182-185	33890-33897	missing	_	
182-186	33898-33902	link	_	
182-187	33902-33903	(	_	
182-188	33903-33904	s	_	
182-189	33904-33905	)	_	
182-190	33906-33908	in	_	
182-191	33909-33916	complex	_	
182-192	33917-33923	mental	_	
182-193	33924-33931	illness	_	
182-194	33932-33934	In	_	
182-195	33935-33941	search	_	
182-196	33942-33944	of	_	
182-197	33945-33955	multimodal	_	
182-198	33956-33968	neuroimaging	_	
182-199	33969-33979	biomarkers	_	
182-200	33980-33982	of	_	
182-201	33983-33992	cognitive	_	
182-202	33993-34001	deficits	_	
182-203	34002-34004	in	_	
182-204	34005-34018	schizophrenia	_	
182-205	34019-34027	Distinct	_	
182-206	34028-34040	multivariate	_	
182-207	34041-34046	brain	_	
182-208	34047-34060	morphological	_	
182-209	34061-34069	patterns	_	
182-210	34070-34073	and	_	
182-211	34074-34079	their	_	
182-212	34080-34085	added	_	
182-213	34086-34096	predictive	_	
182-214	34097-34102	value	_	
182-215	34103-34107	with	_	
182-216	34108-34117	cognitive	_	
182-217	34118-34121	and	_	
182-218	34122-34131	polygenic	_	
182-219	34132-34136	risk	_	
182-220	34137-34143	scores	_	
182-221	34144-34146	in	_	
182-222	34147-34153	mental	_	
182-223	34154-34163	disorders	_	
182-224	34164-34174	Multimodal	_	
182-225	34175-34181	neural	_	
182-226	34182-34192	correlates	_	
182-227	34193-34195	of	_	
182-228	34196-34205	cognitive	_	
182-229	34206-34213	control	_	
182-230	34214-34216	in	_	
182-231	34217-34220	the	_	
182-232	34221-34226	Human	_	
182-233	34227-34237	Connectome	_	
182-234	34238-34245	Project	_	
182-235	34246-34247	A	_	
182-236	34248-34254	review	_	
182-237	34255-34257	of	_	
182-238	34258-34270	multivariate	_	
182-239	34271-34278	methods	_	
182-240	34279-34282	for	_	
182-241	34283-34293	multimodal	_	
182-242	34294-34300	fusion	_	
182-243	34301-34303	of	_	
182-244	34304-34309	brain	_	
182-245	34310-34317	imaging	_	
182-246	34318-34322	data	_	
182-247	34323-34332	Three-way	_	
182-248	34333-34353	FMRI-DTI-methylation	_	
182-249	34354-34358	data	_	
182-250	34359-34365	fusion	_	
182-251	34366-34371	based	_	
182-252	34372-34374	on	_	
182-253	34375-34379	mCCA	_	
182-254	34379-34380	+	_	
182-255	34380-34384	jICA	_	
182-256	34385-34388	and	_	
182-257	34389-34392	its	_	
182-258	34393-34404	application	_	
182-259	34405-34407	to	_	
182-260	34408-34421	schizophrenia	_	
182-261	34422-34436	Discriminating	_	
182-262	34437-34450	schizophrenia	_	
182-263	34451-34454	and	_	
182-264	34455-34462	bipolar	_	
182-265	34463-34471	disorder	_	
182-266	34472-34474	by	_	
182-267	34475-34481	fusing	_	
182-268	34482-34486	fMRI	_	
182-269	34487-34490	and	_	
182-270	34491-34494	DTI	_	
182-271	34495-34497	in	_	
182-272	34498-34499	a	_	
182-273	34500-34510	multimodal	_	
182-274	34511-34514	CCA	_	
182-275	34514-34515	+	_	
182-276	34516-34521	joint	_	
182-277	34522-34525	ICA	_	
182-278	34526-34531	model	_	
182-279	34532-34535	The	_	
182-280	34536-34543	WU-Minn	_	
182-281	34544-34549	Human	_	
182-282	34550-34560	Connectome	_	
182-283	34561-34568	Project	_	
182-284	34568-34569	:	_	
182-285	34570-34572	an	_	
182-286	34573-34581	overview	_	
182-287	34582-34583	A	_	
182-288	34584-34593	cognitive	_	
182-289	34594-34612	neuroscience-based	_	
182-290	34613-34625	computerized	_	
182-291	34626-34633	battery	_	
182-292	34634-34637	for	_	
182-293	34638-34647	efficient	_	
182-294	34648-34659	measurement	_	
182-295	34660-34662	of	_	
182-296	34663-34673	individual	_	
182-297	34674-34685	differences	_	
182-298	34685-34686	:	_	
182-299	34687-34702	standardization	_	
182-300	34703-34706	and	_	
182-301	34707-34714	initial	_	
182-302	34715-34724	construct	_	
182-303	34725-34735	validation	_	
182-304	34736-34739	The	_	
182-305	34740-34747	minimal	_	
182-306	34748-34761	preprocessing	_	
182-307	34762-34771	pipelines	_	
182-308	34772-34775	for	_	
182-309	34776-34779	the	_	
182-310	34780-34785	Human	_	
182-311	34786-34796	Connectome	_	
182-312	34797-34804	Project	_	
182-313	34805-34815	Generation	_	
182-314	34816-34819	and	_	
182-315	34820-34830	Evaluation	_	
182-316	34831-34833	of	_	
182-317	34834-34835	a	_	
182-318	34836-34844	Cortical	_	
182-319	34845-34849	Area	_	
182-320	34850-34862	Parcellation	_	
182-321	34863-34867	from	_	
182-322	34868-34881	Resting-State	_	
182-323	34882-34894	Correlations	_	
182-324	34896-34905	Canonical	_	
182-325	34906-34917	Correlation	_	
182-326	34918-34926	Analysis	_	
182-327	34927-34930	for	_	
182-328	34931-34944	Feature-Based	_	
182-329	34945-34951	Fusion	_	
182-330	34952-34954	of	_	
182-331	34955-34965	Biomedical	_	
182-332	34966-34973	Imaging	_	
182-333	34974-34984	Modalities	_	
182-334	34985-34988	and	_	
182-335	34989-34992	Its	_	
182-336	34993-35004	Application	_	
182-337	35005-35007	to	_	
182-338	35008-35017	Detection	_	
182-339	35018-35020	of	_	
182-340	35021-35032	Associative	_	
182-341	35033-35041	Networks	_	
182-342	35042-35044	in	_	
182-343	35045-35058	Schizophrenia	_	
182-344	35059-35064	Joint	_	
182-345	35065-35070	Blind	_	
182-346	35071-35077	Source	_	
182-347	35078-35088	Separation	_	
182-348	35089-35091	by	_	
182-349	35092-35101	Multi-set	_	
182-350	35102-35111	Canonical	_	
182-351	35112-35123	Correlation	_	
182-352	35124-35132	Analysis	_	
182-353	35133-35134	A	_	
182-354	35135-35141	method	_	
182-355	35142-35145	for	_	
182-356	35146-35155	multitask	_	
182-357	35156-35160	fMRI	_	
182-358	35161-35165	data	_	
182-359	35166-35172	fusion	_	
182-360	35173-35180	applied	_	
182-361	35181-35183	to	_	
182-362	35184-35197	schizophrenia	_	
182-363	35198-35209	Controlling	_	
182-364	35210-35213	the	_	
182-365	35214-35219	False	_	
182-366	35220-35229	Discovery	_	
182-367	35230-35234	Rate	_	
182-368	35234-35235	:	_	
182-369	35236-35237	A	_	
182-370	35238-35247	Practical	_	
182-371	35248-35251	and	_	
182-372	35252-35260	Powerful	_	
182-373	35261-35269	Approach	_	
182-374	35270-35272	to	_	
182-375	35273-35281	Multiple	_	
182-376	35282-35289	Testing	_	
182-377	35290-35298	Distinct	_	
182-378	35299-35304	brain	_	
182-379	35305-35313	networks	_	
182-380	35314-35317	for	_	
182-381	35318-35326	adaptive	_	
182-382	35327-35330	and	_	
182-383	35331-35337	stable	_	
182-384	35338-35342	task	_	
182-385	35343-35350	control	_	
182-386	35351-35353	in	_	
182-387	35354-35360	humans	_	
182-388	35361-35369	Function	_	
182-389	35370-35372	in	_	
182-390	35373-35376	the	_	
182-391	35377-35382	human	_	
182-392	35383-35393	connectome	_	
182-393	35393-35394	:	_	
182-394	35395-35404	Task-fMRI	_	
182-395	35405-35408	and	_	
182-396	35409-35419	individual	_	
182-397	35420-35431	differences	_	
182-398	35432-35434	in	_	
182-399	35435-35443	behavior	_	
182-400	35444-35450	Vision	_	
182-401	35451-35453	in	_	
182-402	35454-35467	schizophrenia	_	
182-403	35467-35468	:	_	
182-404	35469-35472	why	_	
182-405	35473-35475	it	_	
182-406	35476-35483	matters	_	
182-407	35485-35492	Windows	_	
182-408	35493-35495	to	_	
182-409	35496-35499	the	_	
182-410	35500-35504	soul	_	
182-411	35504-35505	:	_	
182-412	35506-35512	vision	_	
182-413	35513-35520	science	_	
182-414	35521-35523	as	_	
182-415	35524-35525	a	_	
182-416	35526-35530	tool	_	
182-417	35531-35534	for	_	
182-418	35535-35543	studying	_	
182-419	35544-35554	biological	_	
182-420	35555-35565	mechanisms	_	
182-421	35566-35568	of	_	
182-422	35569-35580	information	_	
182-423	35581-35591	processing	_	
182-424	35592-35600	deficits	_	
182-425	35601-35603	in	_	
182-426	35604-35617	schizophrenia	_	
182-427	35618-35622	When	_	
182-428	35623-35628	doors	_	
182-429	35629-35631	of	_	
182-430	35632-35642	perception	_	
182-431	35643-35648	close	_	
182-432	35648-35649	:	_	
182-433	35650-35659	bottom-up	_	
182-434	35660-35666	models	_	
182-435	35667-35669	of	_	
182-436	35670-35679	disrupted	_	
182-437	35680-35689	cognition	_	
182-438	35690-35692	in	_	
182-439	35693-35706	schizophrenia	_	
182-440	35707-35714	Bipolar	_	
182-441	35715-35718	and	_	
182-442	35719-35732	schizophrenic	_	
182-443	35733-35741	patients	_	
182-444	35742-35748	differ	_	
182-445	35749-35751	in	_	
182-446	35752-35760	patterns	_	
182-447	35761-35763	of	_	
182-448	35764-35770	visual	_	
182-449	35771-35777	motion	_	
182-450	35778-35792	discrimination	_	
182-451	35793-35799	Visual	_	
182-452	35800-35806	motion	_	
182-453	35807-35818	integration	_	
182-454	35819-35821	in	_	
182-455	35822-35835	schizophrenia	_	
182-456	35836-35844	patients	_	
182-457	35844-35845	,	_	
182-458	35846-35851	their	_	
182-459	35852-35864	first-degree	_	
182-460	35865-35874	relatives	_	
182-461	35874-35875	,	_	
182-462	35876-35879	and	_	
182-463	35880-35888	patients	_	
182-464	35889-35893	with	_	
182-465	35894-35901	bipolar	_	
182-466	35902-35910	disorder	_	
182-467	35911-35917	Visual	_	
182-468	35918-35925	sensory	_	
182-469	35926-35936	processing	_	
182-470	35937-35945	deficits	_	
182-471	35946-35948	in	_	
182-472	35949-35957	patients	_	
182-473	35958-35962	with	_	
182-474	35963-35970	bipolar	_	
182-475	35971-35979	disorder	_	
182-476	35980-35988	revealed	_	
182-477	35989-35996	through	_	
182-478	35997-36009	high-density	_	
182-479	36010-36020	electrical	_	
182-480	36021-36028	mapping	_	
182-481	36029-36045	Cross-diagnostic	_	
182-482	36046-36056	comparison	_	
182-483	36057-36059	of	_	
182-484	36060-36066	visual	_	
182-485	36067-36077	processing	_	
182-486	36078-36080	in	_	
182-487	36081-36088	bipolar	_	
182-488	36089-36097	disorder	_	
182-489	36098-36101	and	_	
182-490	36102-36115	schizophrenia	_	
182-491	36116-36123	Altered	_	
182-492	36124-36130	visual	_	
182-493	36131-36142	information	_	
182-494	36143-36153	processing	_	
182-495	36154-36161	systems	_	
182-496	36162-36164	in	_	
182-497	36165-36172	bipolar	_	
182-498	36173-36181	disorder	_	
182-499	36181-36182	:	_	
182-500	36183-36191	evidence	_	
182-501	36192-36196	from	_	
182-502	36197-36203	visual	_	
182-503	36204-36207	MMN	_	
182-504	36208-36211	and	_	
182-505	36212-36214	P3	_	
182-506	36215-36223	Abnormal	_	
182-507	36224-36229	early	_	
182-508	36230-36235	brain	_	
182-509	36236-36245	responses	_	
182-510	36246-36252	during	_	
182-511	36253-36259	visual	_	
182-512	36260-36266	search	_	
182-513	36267-36270	are	_	
182-514	36271-36278	evident	_	
182-515	36279-36281	in	_	
182-516	36282-36295	schizophrenia	_	
182-517	36296-36299	but	_	
182-518	36300-36303	not	_	
182-519	36304-36311	bipolar	_	
182-520	36312-36321	affective	_	
182-521	36322-36330	disorder	_	
182-522	36331-36334	The	_	
182-523	36335-36343	coherent	_	
182-524	36344-36356	organization	_	
182-525	36357-36359	of	_	
182-526	36360-36366	mental	_	
182-527	36367-36371	life	_	
182-528	36372-36379	depends	_	
182-529	36380-36382	on	_	
182-530	36383-36393	mechanisms	_	
182-531	36394-36397	for	_	
182-532	36398-36415	context-sensitive	_	
182-533	36416-36428	gain-control	_	
182-534	36429-36433	that	_	
182-535	36434-36437	are	_	
182-536	36438-36446	impaired	_	
182-537	36447-36449	in	_	
182-538	36450-36463	schizophrenia	_	
182-539	36464-36478	Neurocognitive	_	
182-540	36479-36487	features	_	
182-541	36488-36490	in	_	
182-542	36491-36499	clinical	_	
182-543	36500-36509	subgroups	_	
182-544	36510-36512	of	_	
182-545	36513-36520	bipolar	_	
182-546	36521-36529	disorder	_	
182-547	36529-36530	:	_	
182-548	36531-36532	A	_	
182-549	36533-36546	meta-analysis	_	
182-550	36547-36554	Scatter	_	
182-551	36555-36560	plots	_	
182-552	36561-36563	of	_	
182-553	36564-36573	cognitive	_	
182-554	36574-36581	control	_	
182-555	36582-36585	and	_	
182-556	36586-36587	a	_	
182-557	36588-36594	priori	_	
182-558	36595-36598	ICs	_	
182-559	36599-36606	applied	_	
182-560	36607-36609	to	_	
182-561	36610-36619	psychosis	_	
182-562	36620-36626	cohort	_	
182-563	36627-36630	Two	_	
182-564	36631-36634	out	_	
182-565	36635-36637	of	_	
182-566	36638-36641	six	_	
182-567	36642-36652	modalities	_	
182-568	36653-36655	in	_	
182-569	36656-36663	HCP_gC1	_	
182-570	36663-36664	_	_	
182-571	36664-36667	IC3	_	
182-572	36668-36671	and	_	
182-573	36672-36679	HCP_gC1	_	
182-574	36679-36680	_	_	
182-575	36680-36683	IC7	_	
182-576	36684-36697	significantly	_	
182-577	36698-36707	predicted	_	
182-578	36708-36717	cognitive	_	
182-579	36718-36725	control	_	
182-580	36726-36737	performance	_	
182-581	36738-36740	in	_	
182-582	36741-36744	the	_	
182-583	36745-36754	psychosis	_	
182-584	36755-36761	cohort	_	
182-585	36761-36762	.	_	

#Text=Scatter plots of the other four modalities are available in fig.
183-1	36763-36770	Scatter	_	
183-2	36771-36776	plots	_	
183-3	36777-36779	of	_	
183-4	36780-36783	the	_	
183-5	36784-36789	other	_	
183-6	36790-36794	four	_	
183-7	36795-36805	modalities	_	
183-8	36806-36809	are	_	
183-9	36810-36819	available	_	
183-10	36820-36822	in	_	
183-11	36823-36826	fig	_	
183-12	36826-36827	.	_	

#Text=S3.
184-1	36828-36830	S3	_	
184-2	36830-36831	.	_	

#Text=Scatter plots of cognitive control and de novo IC3 imaging weights
#Text=Partial correlations between de novo IC3 imaging weights and cognitive control for all three groups pooled were significant for all three modalities.
185-1	36832-36839	Scatter	_	
185-2	36840-36845	plots	_	
185-3	36846-36848	of	_	
185-4	36849-36858	cognitive	_	
185-5	36859-36866	control	_	
185-6	36867-36870	and	_	
185-7	36871-36873	de	_	
185-8	36874-36878	novo	_	
185-9	36879-36882	IC3	_	
185-10	36883-36890	imaging	_	
185-11	36891-36898	weights	_	
185-12	36899-36906	Partial	_	
185-13	36907-36919	correlations	_	
185-14	36920-36927	between	_	
185-15	36928-36930	de	_	
185-16	36931-36935	novo	_	
185-17	36936-36939	IC3	_	
185-18	36940-36947	imaging	_	
185-19	36948-36955	weights	_	
185-20	36956-36959	and	_	
185-21	36960-36969	cognitive	_	
185-22	36970-36977	control	_	
185-23	36978-36981	for	_	
185-24	36982-36985	all	_	
185-25	36986-36991	three	_	
185-26	36992-36998	groups	_	
185-27	36999-37005	pooled	_	
185-28	37006-37010	were	_	
185-29	37011-37022	significant	_	
185-30	37023-37026	for	_	
185-31	37027-37030	all	_	
185-32	37031-37036	three	_	
185-33	37037-37047	modalities	_	
185-34	37047-37048	.	_	

#Text=Scatter-plots by group suggested that this may be driven by SZ participants, which was formally tested using regression analyses (tables S6–S8).
186-1	37049-37062	Scatter-plots	_	
186-2	37063-37065	by	_	
186-3	37066-37071	group	_	
186-4	37072-37081	suggested	_	
186-5	37082-37086	that	_	
186-6	37087-37091	this	_	
186-7	37092-37095	may	_	
186-8	37096-37098	be	_	
186-9	37099-37105	driven	_	
186-10	37106-37108	by	_	
186-11	37109-37111	SZ	_	
186-12	37112-37124	participants	_	
186-13	37124-37125	,	_	
186-14	37126-37131	which	_	
186-15	37132-37135	was	_	
186-16	37136-37144	formally	_	
186-17	37145-37151	tested	_	
186-18	37152-37157	using	_	
186-19	37158-37168	regression	_	
186-20	37169-37177	analyses	_	
186-21	37178-37179	(	_	
186-22	37179-37185	tables	_	
186-23	37186-37188	S6	_	
186-24	37188-37189	–	_	
186-25	37189-37191	S8	_	
186-26	37191-37192	)	_	
186-27	37192-37193	.	_	

#Text=Psychosis IC3 – sMRI modality
#Text=Given that mCCA+jICA generates component maps with a value at every vertex/voxel/pairwise-correlation, maps were thresholded at |Z|>2 to simplify interpretation of the spatial pattern of results in de novo IC3 (Sui, Pearlson et al. 2015, Lerman-Sinkoff, Sui et al. 2017).
187-1	37194-37203	Psychosis	_	
187-2	37204-37207	IC3	_	
187-3	37208-37209	–	_	
187-4	37210-37214	sMRI	_	
187-5	37215-37223	modality	_	
187-6	37224-37229	Given	_	
187-7	37230-37234	that	_	
187-8	37235-37239	mCCA	_	
187-9	37239-37240	+	_	
187-10	37240-37244	jICA	_	
187-11	37245-37254	generates	_	
187-12	37255-37264	component	_	
187-13	37265-37269	maps	_	
187-14	37270-37274	with	_	
187-15	37275-37276	a	_	
187-16	37277-37282	value	_	
187-17	37283-37285	at	_	
187-18	37286-37291	every	_	
187-19	37292-37298	vertex	_	
187-20	37298-37299	/	_	
187-21	37299-37304	voxel	_	
187-22	37304-37305	/	_	
187-23	37305-37325	pairwise-correlation	_	
187-24	37325-37326	,	_	
187-25	37327-37331	maps	_	
187-26	37332-37336	were	_	
187-27	37337-37348	thresholded	_	
187-28	37349-37351	at	_	
187-29	37352-37353	|	_	
187-30	37353-37354	Z	_	
187-31	37354-37355	|	_	
187-32	37355-37356	>	_	
187-33	37356-37357	2	_	
187-34	37358-37360	to	_	
187-35	37361-37369	simplify	_	
187-36	37370-37384	interpretation	_	
187-37	37385-37387	of	_	
187-38	37388-37391	the	_	
187-39	37392-37399	spatial	_	
187-40	37400-37407	pattern	_	
187-41	37408-37410	of	_	
187-42	37411-37418	results	_	
187-43	37419-37421	in	_	
187-44	37422-37424	de	_	
187-45	37425-37429	novo	_	
187-46	37430-37433	IC3	_	
187-47	37434-37435	(	_	
187-48	37435-37438	Sui	_	
187-49	37438-37439	,	_	
187-50	37440-37448	Pearlson	_	
187-51	37449-37451	et	_	
187-52	37452-37454	al	_	
187-53	37454-37455	.	_	
187-54	37456-37460	2015	_	
187-55	37460-37461	,	_	
187-56	37462-37476	Lerman-Sinkoff	_	
187-57	37476-37477	,	_	
187-58	37478-37481	Sui	_	
187-59	37482-37484	et	_	
187-60	37485-37487	al	_	
187-61	37487-37488	.	_	
187-62	37489-37493	2017	_	
187-63	37493-37494	)	_	
187-64	37494-37495	.	_	

#Text=Thus, the maps presented in (Fig, 3–5, S1, S2) highlight those elements in the map that were strongest relative to all other elements in the given map (unthresholded maps are available in the supplement, figs.
188-1	37496-37500	Thus	_	
188-2	37500-37501	,	_	
188-3	37502-37505	the	_	
188-4	37506-37510	maps	_	
188-5	37511-37520	presented	_	
188-6	37521-37523	in	_	
188-7	37524-37525	(	_	
188-8	37525-37528	Fig	_	
188-9	37528-37529	,	_	
188-10	37530-37531	3	_	
188-11	37531-37532	–	_	
188-12	37532-37533	5	_	
188-13	37533-37534	,	_	
188-14	37535-37537	S1	_	
188-15	37537-37538	,	_	
188-16	37539-37541	S2	_	
188-17	37541-37542	)	_	
188-18	37543-37552	highlight	_	
188-19	37553-37558	those	_	
188-20	37559-37567	elements	_	
188-21	37568-37570	in	_	
188-22	37571-37574	the	_	
188-23	37575-37578	map	_	
188-24	37579-37583	that	_	
188-25	37584-37588	were	_	
188-26	37589-37598	strongest	_	
188-27	37599-37607	relative	_	
188-28	37608-37610	to	_	
188-29	37611-37614	all	_	
188-30	37615-37620	other	_	
188-31	37621-37629	elements	_	
188-32	37630-37632	in	_	
188-33	37633-37636	the	_	
188-34	37637-37642	given	_	
188-35	37643-37646	map	_	
188-36	37647-37648	(	_	
188-37	37648-37661	unthresholded	_	
188-38	37662-37666	maps	_	
188-39	37667-37670	are	_	
188-40	37671-37680	available	_	
188-41	37681-37683	in	_	
188-42	37684-37687	the	_	
188-43	37688-37698	supplement	_	
188-44	37698-37699	,	_	
188-45	37700-37704	figs	_	
188-46	37704-37705	.	_	

#Text=S4–S6).
189-1	37706-37708	S4	_	
189-2	37708-37709	–	_	
189-3	37709-37711	S6	_	
189-4	37711-37712	)	_	
189-5	37712-37713	.	_	

#Text=Top row: Thresholded IC3 sMRI map displayed on the HCP Q1–Q6 440 Subject midthickness surface map.
190-1	37714-37717	Top	_	
190-2	37718-37721	row	_	
190-3	37721-37722	:	_	
190-4	37723-37734	Thresholded	_	
190-5	37735-37738	IC3	_	
190-6	37739-37743	sMRI	_	
190-7	37744-37747	map	_	
190-8	37748-37757	displayed	_	
190-9	37758-37760	on	_	
190-10	37761-37764	the	_	
190-11	37765-37768	HCP	_	
190-12	37769-37771	Q1	_	
190-13	37771-37772	–	_	
190-14	37772-37774	Q6	_	
190-15	37775-37778	440	_	
190-16	37779-37786	Subject	_	
190-17	37787-37799	midthickness	_	
190-18	37800-37807	surface	_	
190-19	37808-37811	map	_	
190-20	37811-37812	.	_	

#Text=Bottom row: same sMRI map displayed on the HCP Q1–Q6 440 Subject inflated surface map.
191-1	37813-37819	Bottom	_	
191-2	37820-37823	row	_	
191-3	37823-37824	:	_	
191-4	37825-37829	same	_	
191-5	37830-37834	sMRI	_	
191-6	37835-37838	map	_	
191-7	37839-37848	displayed	_	
191-8	37849-37851	on	_	
191-9	37852-37855	the	_	
191-10	37856-37859	HCP	_	
191-11	37860-37862	Q1	_	
191-12	37862-37863	–	_	
191-13	37863-37865	Q6	_	
191-14	37866-37869	440	_	
191-15	37870-37877	Subject	_	
191-16	37878-37886	inflated	_	
191-17	37887-37894	surface	_	
191-18	37895-37898	map	_	
191-19	37898-37899	.	_	

#Text=Psychosis IC3 – rsfcMRI modality
#Text=rsfcMRI correlation matrix from psychosis IC3, thresholded at |Z|>2 (see figure 3 caption for threshold rationale).
192-1	37900-37909	Psychosis	_	
192-2	37910-37913	IC3	_	
192-3	37914-37915	–	_	
192-4	37916-37923	rsfcMRI	_	
192-5	37924-37932	modality	_	
192-6	37933-37940	rsfcMRI	_	
192-7	37941-37952	correlation	_	
192-8	37953-37959	matrix	_	
192-9	37960-37964	from	_	
192-10	37965-37974	psychosis	_	
192-11	37975-37978	IC3	_	
192-12	37978-37979	,	_	
192-13	37980-37991	thresholded	_	
192-14	37992-37994	at	_	
192-15	37995-37996	|	_	
192-16	37996-37997	Z	_	
192-17	37997-37998	|	_	
192-18	37998-37999	>	_	
192-19	37999-38000	2	_	
192-20	38001-38002	(	_	
192-21	38002-38005	see	_	
192-22	38006-38012	figure	_	
192-23	38013-38014	3	_	
192-24	38015-38022	caption	_	
192-25	38023-38026	for	_	
192-26	38027-38036	threshold	_	
192-27	38037-38046	rationale	_	
192-28	38046-38047	)	_	
192-29	38047-38048	.	_	

#Text=Network labels: A= None, B= Default Mode, C= Context, D= Fronto-Parietal, E= Salience, F= Cingulo-Opercular, G= Parietal Encoding and Retrieval, H= Dorsal Attention, I= Ventral Attention, J= Visual, K= Somatomotor Hand, L=Somatomotor Mouth, M= Auditory.
193-1	38049-38056	Network	_	
193-2	38057-38063	labels	_	
193-3	38063-38064	:	_	
193-4	38065-38066	A	_	
193-5	38066-38067	=	_	
193-6	38068-38072	None	_	
193-7	38072-38073	,	_	
193-8	38074-38075	B	_	
193-9	38075-38076	=	_	
193-10	38077-38084	Default	_	
193-11	38085-38089	Mode	_	
193-12	38089-38090	,	_	
193-13	38091-38092	C	_	
193-14	38092-38093	=	_	
193-15	38094-38101	Context	_	
193-16	38101-38102	,	_	
193-17	38103-38104	D	_	
193-18	38104-38105	=	_	
193-19	38106-38121	Fronto-Parietal	_	
193-20	38121-38122	,	_	
193-21	38123-38124	E	_	
193-22	38124-38125	=	_	
193-23	38126-38134	Salience	_	
193-24	38134-38135	,	_	
193-25	38136-38137	F	_	
193-26	38137-38138	=	_	
193-27	38139-38156	Cingulo-Opercular	_	
193-28	38156-38157	,	_	
193-29	38158-38159	G	_	
193-30	38159-38160	=	_	
193-31	38161-38169	Parietal	_	
193-32	38170-38178	Encoding	_	
193-33	38179-38182	and	_	
193-34	38183-38192	Retrieval	_	
193-35	38192-38193	,	_	
193-36	38194-38195	H	_	
193-37	38195-38196	=	_	
193-38	38197-38203	Dorsal	_	
193-39	38204-38213	Attention	_	
193-40	38213-38214	,	_	
193-41	38215-38216	I	_	
193-42	38216-38217	=	_	
193-43	38218-38225	Ventral	_	
193-44	38226-38235	Attention	_	
193-45	38235-38236	,	_	
193-46	38237-38238	J	_	
193-47	38238-38239	=	_	
193-48	38240-38246	Visual	_	
193-49	38246-38247	,	_	
193-50	38248-38249	K	_	
193-51	38249-38250	=	_	
193-52	38251-38262	Somatomotor	_	
193-53	38263-38267	Hand	_	
193-54	38267-38268	,	_	
193-55	38269-38270	L	_	
193-56	38270-38271	=	_	
193-57	38271-38282	Somatomotor	_	
193-58	38283-38288	Mouth	_	
193-59	38288-38289	,	_	
193-60	38290-38291	M	_	
193-61	38291-38292	=	_	
193-62	38293-38301	Auditory	_	
193-63	38301-38302	.	_	

#Text=Psychosis IC3 – working memory tfMRI modality
#Text=Working memory tfMRI from psychosis IC3, thresholded at |Z|>2 (see figure 3 caption for threshold rationale).
194-1	38303-38312	Psychosis	_	
194-2	38313-38316	IC3	_	
194-3	38317-38318	–	_	
194-4	38319-38326	working	_	
194-5	38327-38333	memory	_	
194-6	38334-38339	tfMRI	_	
194-7	38340-38348	modality	_	
194-8	38349-38356	Working	_	
194-9	38357-38363	memory	_	
194-10	38364-38369	tfMRI	_	
194-11	38370-38374	from	_	
194-12	38375-38384	psychosis	_	
194-13	38385-38388	IC3	_	
194-14	38388-38389	,	_	
194-15	38390-38401	thresholded	_	
194-16	38402-38404	at	_	
194-17	38405-38406	|	_	
194-18	38406-38407	Z	_	
194-19	38407-38408	|	_	
194-20	38408-38409	>	_	
194-21	38409-38410	2	_	
194-22	38411-38412	(	_	
194-23	38412-38415	see	_	
194-24	38416-38422	figure	_	
194-25	38423-38424	3	_	
194-26	38425-38432	caption	_	
194-27	38433-38436	for	_	
194-28	38437-38446	threshold	_	
194-29	38447-38456	rationale	_	
194-30	38456-38457	)	_	
194-31	38457-38458	.	_	

#Text=Top row: Thresholded IC3 tfMRI map displayed on the HCP Q1–Q6 440 Subject midthickness surface map.
195-1	38459-38462	Top	_	
195-2	38463-38466	row	_	
195-3	38466-38467	:	_	
195-4	38468-38479	Thresholded	_	
195-5	38480-38483	IC3	_	
195-6	38484-38489	tfMRI	_	
195-7	38490-38493	map	_	
195-8	38494-38503	displayed	_	
195-9	38504-38506	on	_	
195-10	38507-38510	the	_	
195-11	38511-38514	HCP	_	
195-12	38515-38517	Q1	_	
195-13	38517-38518	–	_	
195-14	38518-38520	Q6	_	
195-15	38521-38524	440	_	
195-16	38525-38532	Subject	_	
195-17	38533-38545	midthickness	_	
195-18	38546-38553	surface	_	
195-19	38554-38557	map	_	
195-20	38557-38558	.	_	

#Text=Bottom row: same tfMRI map displayed on the HCP Q1–Q6 440 Subject very inflated surface map.
196-1	38559-38565	Bottom	_	
196-2	38566-38569	row	_	
196-3	38569-38570	:	_	
196-4	38571-38575	same	_	
196-5	38576-38581	tfMRI	_	
196-6	38582-38585	map	_	
196-7	38586-38595	displayed	_	
196-8	38596-38598	on	_	
196-9	38599-38602	the	_	
196-10	38603-38606	HCP	_	
196-11	38607-38609	Q1	_	
196-12	38609-38610	–	_	
196-13	38610-38612	Q6	_	
196-14	38613-38616	440	_	
196-15	38617-38624	Subject	_	
196-16	38625-38629	very	_	
196-17	38630-38638	inflated	_	
196-18	38639-38646	surface	_	
196-19	38647-38650	map	_	
196-20	38650-38651	.	_	

#Text=Demographics, Clinical symptoms, and Behavioral Performance
#Text=\tHealthy Controls (HC)\tBipolar (BP)\tSchizophrenia (SZ)\tOmnibus test statistic\tp-values\t \tAge\t24.6±3.1 (30)\t26.7±3.0 (27)\t24.9±3.7 (23)\tF(2,77)=3.21\tOmnibus p=0.046HC vs SZ p=0.943HC vs BP p=0.049BP vs SZ p=0.145\t \tGender\t14F,16M\t13F,13M\t4F,18M\tχ2=6.034\tOmnibus p=0.197\t \tEthnicity (%Caucasian)\t57%\t80%\t29%\tχ2=0.006\tOmnibus p=0.002HC vs SZ p=0.047HC vs BP p=0.066BP vs SZ p<0.000\t \tYears of education\t16.2±2.4 (30)\t15.3±2.3 (26)\t13.0±1.4 (22)\tF(2,75)=14.9\tOmnibus p<0.000HC vs SZ p<0.000HC vs BP p=0.264BP vs SZ p=0.001\t \tParental level of education/SES proxy\t2.04±1.3 (27)\t2.28±1.3 (25)\t2.76±1.1 (17)\tF(2,66)=1.71\tOmnibus p=0.189\t \tSAPS\t0.1±0.7 (30)\t2.1±2.9 (27)\t4.6±3.2 (23)\tF(2,77)=21.03\tOmnibus p<0.000HC vs SZ p<0.000HC vs BP p=0.008BP vs SZ p=0.003\t \tSANS\t0.8±1.7 (29)\t3.3±3.5 (27)\t6.3±3.0 (23)\tF(2,76)=24.67\tOmnibus p<0.000HC vs SZ p<0.000HC vs BP p=0.003BP vs SZ p=0.002\t \tWERCAP Psychosis history\t0.90±3.2 (30)\t8.78±7.4 (27)\t31.83±11.59 (23)\tF(2,77)=106.76\tOmnibus p<0.000HC vs SZ p<0.000HC vs BP p=0.001BP vs SZ p<0.000\t \tCognitive control composite\t0.40±0.46 (30)\t0.16±0.58 (27)\t−0.36±0.85 (23)\tF(2,77)=9.579\tOmnibus p<0.000HC vs SZ p<0.000HC vs BP p=0.332BP vs SZ p=0.013\t \t
#Text=Text: mean +/− std (n).
197-1	38652-38664	Demographics	_	
197-2	38664-38665	,	_	
197-3	38666-38674	Clinical	_	
197-4	38675-38683	symptoms	_	
197-5	38683-38684	,	_	
197-6	38685-38688	and	_	
197-7	38689-38699	Behavioral	_	
197-8	38700-38711	Performance	_	
197-9	38713-38720	Healthy	_	
197-10	38721-38729	Controls	_	
197-11	38730-38731	(	_	
197-12	38731-38733	HC	_	
197-13	38733-38734	)	_	
197-14	38735-38742	Bipolar	_	
197-15	38743-38744	(	_	
197-16	38744-38746	BP	_	
197-17	38746-38747	)	_	
197-18	38748-38761	Schizophrenia	_	
197-19	38762-38763	(	_	
197-20	38763-38765	SZ	_	
197-21	38765-38766	)	_	
197-22	38767-38774	Omnibus	_	
197-23	38775-38779	test	_	
197-24	38780-38789	statistic	_	
197-25	38790-38798	p-values	_	
197-26	38801-38804	Age	_	
197-27	38805-38809	24.6	_	
197-28	38809-38810	±	_	
197-29	38810-38813	3.1	_	
197-30	38814-38815	(	_	
197-31	38815-38817	30	_	
197-32	38817-38818	)	_	
197-33	38819-38823	26.7	_	
197-34	38823-38824	±	_	
197-35	38824-38827	3.0	_	
197-36	38828-38829	(	_	
197-37	38829-38831	27	_	
197-38	38831-38832	)	_	
197-39	38833-38837	24.9	_	
197-40	38837-38838	±	_	
197-41	38838-38841	3.7	_	
197-42	38842-38843	(	_	
197-43	38843-38845	23	_	
197-44	38845-38846	)	_	
197-45	38847-38848	F	_	
197-46	38848-38849	(	_	
197-47	38849-38853	2,77	_	
197-48	38853-38854	)	_	
197-49	38854-38855	=	_	
197-50	38855-38859	3.21	_	
197-51	38860-38867	Omnibus	_	
197-52	38868-38869	p	_	
197-53	38869-38870	=	_	
197-54	38870-38877	0.046HC	_	
197-55	38878-38880	vs	_	
197-56	38881-38883	SZ	_	
197-57	38884-38885	p	_	
197-58	38885-38886	=	_	
197-59	38886-38893	0.943HC	_	
197-60	38894-38896	vs	_	
197-61	38897-38899	BP	_	
197-62	38900-38901	p	_	
197-63	38901-38902	=	_	
197-64	38902-38909	0.049BP	_	
197-65	38910-38912	vs	_	
197-66	38913-38915	SZ	_	
197-67	38916-38917	p	_	
197-68	38917-38918	=	_	
197-69	38918-38923	0.145	_	
197-70	38926-38932	Gender	_	
197-71	38933-38936	14F	_	
197-72	38936-38937	,	_	
197-73	38937-38940	16M	_	
197-74	38941-38944	13F	_	
197-75	38944-38945	,	_	
197-76	38945-38948	13M	_	
197-77	38949-38951	4F	_	
197-78	38951-38952	,	_	
197-79	38952-38955	18M	_	
197-80	38956-38958	χ2	_	
197-81	38958-38959	=	_	
197-82	38959-38964	6.034	_	
197-83	38965-38972	Omnibus	_	
197-84	38973-38974	p	_	
197-85	38974-38975	=	_	
197-86	38975-38980	0.197	_	
197-87	38983-38992	Ethnicity	_	
197-88	38993-38994	(	_	
197-89	38994-38995	%	_	
197-90	38995-39004	Caucasian	_	
197-91	39004-39005	)	_	
197-92	39006-39009	57%	_	
197-93	39010-39013	80%	_	
197-94	39014-39017	29%	_	
197-95	39018-39020	χ2	_	
197-96	39020-39021	=	_	
197-97	39021-39026	0.006	_	
197-98	39027-39034	Omnibus	_	
197-99	39035-39036	p	_	
197-100	39036-39037	=	_	
197-101	39037-39044	0.002HC	_	
197-102	39045-39047	vs	_	
197-103	39048-39050	SZ	_	
197-104	39051-39052	p	_	
197-105	39052-39053	=	_	
197-106	39053-39060	0.047HC	_	
197-107	39061-39063	vs	_	
197-108	39064-39066	BP	_	
197-109	39067-39068	p	_	
197-110	39068-39069	=	_	
197-111	39069-39076	0.066BP	_	
197-112	39077-39079	vs	_	
197-113	39080-39082	SZ	_	
197-114	39083-39084	p	_	
197-115	39084-39085	<	_	
197-116	39085-39090	0.000	_	
197-117	39093-39098	Years	_	
197-118	39099-39101	of	_	
197-119	39102-39111	education	_	
197-120	39112-39116	16.2	_	
197-121	39116-39117	±	_	
197-122	39117-39120	2.4	_	
197-123	39121-39122	(	_	
197-124	39122-39124	30	_	
197-125	39124-39125	)	_	
197-126	39126-39130	15.3	_	
197-127	39130-39131	±	_	
197-128	39131-39134	2.3	_	
197-129	39135-39136	(	_	
197-130	39136-39138	26	_	
197-131	39138-39139	)	_	
197-132	39140-39144	13.0	_	
197-133	39144-39145	±	_	
197-134	39145-39148	1.4	_	
197-135	39149-39150	(	_	
197-136	39150-39152	22	_	
197-137	39152-39153	)	_	
197-138	39154-39155	F	_	
197-139	39155-39156	(	_	
197-140	39156-39160	2,75	_	
197-141	39160-39161	)	_	
197-142	39161-39162	=	_	
197-143	39162-39166	14.9	_	
197-144	39167-39174	Omnibus	_	
197-145	39175-39176	p	_	
197-146	39176-39177	<	_	
197-147	39177-39184	0.000HC	_	
197-148	39185-39187	vs	_	
197-149	39188-39190	SZ	_	
197-150	39191-39192	p	_	
197-151	39192-39193	<	_	
197-152	39193-39200	0.000HC	_	
197-153	39201-39203	vs	_	
197-154	39204-39206	BP	_	
197-155	39207-39208	p	_	
197-156	39208-39209	=	_	
197-157	39209-39216	0.264BP	_	
197-158	39217-39219	vs	_	
197-159	39220-39222	SZ	_	
197-160	39223-39224	p	_	
197-161	39224-39225	=	_	
197-162	39225-39230	0.001	_	
197-163	39233-39241	Parental	_	
197-164	39242-39247	level	_	
197-165	39248-39250	of	_	
197-166	39251-39260	education	_	
197-167	39260-39261	/	_	
197-168	39261-39264	SES	_	
197-169	39265-39270	proxy	_	
197-170	39271-39275	2.04	_	
197-171	39275-39276	±	_	
197-172	39276-39279	1.3	_	
197-173	39280-39281	(	_	
197-174	39281-39283	27	_	
197-175	39283-39284	)	_	
197-176	39285-39289	2.28	_	
197-177	39289-39290	±	_	
197-178	39290-39293	1.3	_	
197-179	39294-39295	(	_	
197-180	39295-39297	25	_	
197-181	39297-39298	)	_	
197-182	39299-39303	2.76	_	
197-183	39303-39304	±	_	
197-184	39304-39307	1.1	_	
197-185	39308-39309	(	_	
197-186	39309-39311	17	_	
197-187	39311-39312	)	_	
197-188	39313-39314	F	_	
197-189	39314-39315	(	_	
197-190	39315-39319	2,66	_	
197-191	39319-39320	)	_	
197-192	39320-39321	=	_	
197-193	39321-39325	1.71	_	
197-194	39326-39333	Omnibus	_	
197-195	39334-39335	p	_	
197-196	39335-39336	=	_	
197-197	39336-39341	0.189	_	
197-198	39344-39348	SAPS	_	
197-199	39349-39352	0.1	_	
197-200	39352-39353	±	_	
197-201	39353-39356	0.7	_	
197-202	39357-39358	(	_	
197-203	39358-39360	30	_	
197-204	39360-39361	)	_	
197-205	39362-39365	2.1	_	
197-206	39365-39366	±	_	
197-207	39366-39369	2.9	_	
197-208	39370-39371	(	_	
197-209	39371-39373	27	_	
197-210	39373-39374	)	_	
197-211	39375-39378	4.6	_	
197-212	39378-39379	±	_	
197-213	39379-39382	3.2	_	
197-214	39383-39384	(	_	
197-215	39384-39386	23	_	
197-216	39386-39387	)	_	
197-217	39388-39389	F	_	
197-218	39389-39390	(	_	
197-219	39390-39394	2,77	_	
197-220	39394-39395	)	_	
197-221	39395-39396	=	_	
197-222	39396-39401	21.03	_	
197-223	39402-39409	Omnibus	_	
197-224	39410-39411	p	_	
197-225	39411-39412	<	_	
197-226	39412-39419	0.000HC	_	
197-227	39420-39422	vs	_	
197-228	39423-39425	SZ	_	
197-229	39426-39427	p	_	
197-230	39427-39428	<	_	
197-231	39428-39435	0.000HC	_	
197-232	39436-39438	vs	_	
197-233	39439-39441	BP	_	
197-234	39442-39443	p	_	
197-235	39443-39444	=	_	
197-236	39444-39451	0.008BP	_	
197-237	39452-39454	vs	_	
197-238	39455-39457	SZ	_	
197-239	39458-39459	p	_	
197-240	39459-39460	=	_	
197-241	39460-39465	0.003	_	
197-242	39468-39472	SANS	_	
197-243	39473-39476	0.8	_	
197-244	39476-39477	±	_	
197-245	39477-39480	1.7	_	
197-246	39481-39482	(	_	
197-247	39482-39484	29	_	
197-248	39484-39485	)	_	
197-249	39486-39489	3.3	_	
197-250	39489-39490	±	_	
197-251	39490-39493	3.5	_	
197-252	39494-39495	(	_	
197-253	39495-39497	27	_	
197-254	39497-39498	)	_	
197-255	39499-39502	6.3	_	
197-256	39502-39503	±	_	
197-257	39503-39506	3.0	_	
197-258	39507-39508	(	_	
197-259	39508-39510	23	_	
197-260	39510-39511	)	_	
197-261	39512-39513	F	_	
197-262	39513-39514	(	_	
197-263	39514-39518	2,76	_	
197-264	39518-39519	)	_	
197-265	39519-39520	=	_	
197-266	39520-39525	24.67	_	
197-267	39526-39533	Omnibus	_	
197-268	39534-39535	p	_	
197-269	39535-39536	<	_	
197-270	39536-39543	0.000HC	_	
197-271	39544-39546	vs	_	
197-272	39547-39549	SZ	_	
197-273	39550-39551	p	_	
197-274	39551-39552	<	_	
197-275	39552-39559	0.000HC	_	
197-276	39560-39562	vs	_	
197-277	39563-39565	BP	_	
197-278	39566-39567	p	_	
197-279	39567-39568	=	_	
197-280	39568-39575	0.003BP	_	
197-281	39576-39578	vs	_	
197-282	39579-39581	SZ	_	
197-283	39582-39583	p	_	
197-284	39583-39584	=	_	
197-285	39584-39589	0.002	_	
197-286	39592-39598	WERCAP	_	
197-287	39599-39608	Psychosis	_	
197-288	39609-39616	history	_	
197-289	39617-39621	0.90	_	
197-290	39621-39622	±	_	
197-291	39622-39625	3.2	_	
197-292	39626-39627	(	_	
197-293	39627-39629	30	_	
197-294	39629-39630	)	_	
197-295	39631-39635	8.78	_	
197-296	39635-39636	±	_	
197-297	39636-39639	7.4	_	
197-298	39640-39641	(	_	
197-299	39641-39643	27	_	
197-300	39643-39644	)	_	
197-301	39645-39650	31.83	_	
197-302	39650-39651	±	_	
197-303	39651-39656	11.59	_	
197-304	39657-39658	(	_	
197-305	39658-39660	23	_	
197-306	39660-39661	)	_	
197-307	39662-39663	F	_	
197-308	39663-39664	(	_	
197-309	39664-39668	2,77	_	
197-310	39668-39669	)	_	
197-311	39669-39670	=	_	
197-312	39670-39676	106.76	_	
197-313	39677-39684	Omnibus	_	
197-314	39685-39686	p	_	
197-315	39686-39687	<	_	
197-316	39687-39694	0.000HC	_	
197-317	39695-39697	vs	_	
197-318	39698-39700	SZ	_	
197-319	39701-39702	p	_	
197-320	39702-39703	<	_	
197-321	39703-39710	0.000HC	_	
197-322	39711-39713	vs	_	
197-323	39714-39716	BP	_	
197-324	39717-39718	p	_	
197-325	39718-39719	=	_	
197-326	39719-39726	0.001BP	_	
197-327	39727-39729	vs	_	
197-328	39730-39732	SZ	_	
197-329	39733-39734	p	_	
197-330	39734-39735	<	_	
197-331	39735-39740	0.000	_	
197-332	39743-39752	Cognitive	_	
197-333	39753-39760	control	_	
197-334	39761-39770	composite	_	
197-335	39771-39775	0.40	_	
197-336	39775-39776	±	_	
197-337	39776-39780	0.46	_	
197-338	39781-39782	(	_	
197-339	39782-39784	30	_	
197-340	39784-39785	)	_	
197-341	39786-39790	0.16	_	
197-342	39790-39791	±	_	
197-343	39791-39795	0.58	_	
197-344	39796-39797	(	_	
197-345	39797-39799	27	_	
197-346	39799-39800	)	_	
197-347	39801-39802	−	_	
197-348	39802-39806	0.36	_	
197-349	39806-39807	±	_	
197-350	39807-39811	0.85	_	
197-351	39812-39813	(	_	
197-352	39813-39815	23	_	
197-353	39815-39816	)	_	
197-354	39817-39818	F	_	
197-355	39818-39819	(	_	
197-356	39819-39823	2,77	_	
197-357	39823-39824	)	_	
197-358	39824-39825	=	_	
197-359	39825-39830	9.579	_	
197-360	39831-39838	Omnibus	_	
197-361	39839-39840	p	_	
197-362	39840-39841	<	_	
197-363	39841-39848	0.000HC	_	
197-364	39849-39851	vs	_	
197-365	39852-39854	SZ	_	
197-366	39855-39856	p	_	
197-367	39856-39857	<	_	
197-368	39857-39864	0.000HC	_	
197-369	39865-39867	vs	_	
197-370	39868-39870	BP	_	
197-371	39871-39872	p	_	
197-372	39872-39873	=	_	
197-373	39873-39880	0.332BP	_	
197-374	39881-39883	vs	_	
197-375	39884-39886	SZ	_	
197-376	39887-39888	p	_	
197-377	39888-39889	=	_	
197-378	39889-39894	0.013	_	
197-379	39898-39902	Text	_	
197-380	39902-39903	:	_	
197-381	39904-39908	mean	_	
197-382	39909-39910	+	_	
197-383	39910-39911	/	_	
197-384	39911-39912	−	_	
197-385	39913-39916	std	_	
197-386	39917-39918	(	_	
197-387	39918-39919	n	_	
197-388	39919-39920	)	_	
197-389	39920-39921	.	_	

#Text=N-values vary slightly due to missing data.
198-1	39922-39930	N-values	_	
198-2	39931-39935	vary	_	
198-3	39936-39944	slightly	_	
198-4	39945-39948	due	_	
198-5	39949-39951	to	_	
198-6	39952-39959	missing	_	
198-7	39960-39964	data	_	
198-8	39964-39965	.	_	

#Text=F=Female; M=Male.
199-1	39966-39967	F	_	
199-2	39967-39968	=	_	
199-3	39968-39974	Female	_	
199-4	39974-39975	;	_	
199-5	39976-39977	M	_	
199-6	39977-39978	=	_	
199-7	39978-39982	Male	_	
199-8	39982-39983	.	_	

#Text=Level of education scale: 1=Graduate professional training; 2=Completed undergraduate; 3=Partial college; 4=High school graduate; 5=Partial high school; 6=Junior high school; 7=less than seven years of education.
200-1	39984-39989	Level	_	
200-2	39990-39992	of	_	
200-3	39993-40002	education	_	
200-4	40003-40008	scale	_	
200-5	40008-40009	:	_	
200-6	40010-40011	1	_	
200-7	40011-40012	=	_	
200-8	40012-40020	Graduate	_	
200-9	40021-40033	professional	_	
200-10	40034-40042	training	_	
200-11	40042-40043	;	_	
200-12	40044-40045	2	_	
200-13	40045-40046	=	_	
200-14	40046-40055	Completed	_	
200-15	40056-40069	undergraduate	_	
200-16	40069-40070	;	_	
200-17	40071-40072	3	_	
200-18	40072-40073	=	_	
200-19	40073-40080	Partial	_	
200-20	40081-40088	college	_	
200-21	40088-40089	;	_	
200-22	40090-40091	4	_	
200-23	40091-40092	=	_	
200-24	40092-40096	High	_	
200-25	40097-40103	school	_	
200-26	40104-40112	graduate	_	
200-27	40112-40113	;	_	
200-28	40114-40115	5	_	
200-29	40115-40116	=	_	
200-30	40116-40123	Partial	_	
200-31	40124-40128	high	_	
200-32	40129-40135	school	_	
200-33	40135-40136	;	_	
200-34	40137-40138	6	_	
200-35	40138-40139	=	_	
200-36	40139-40145	Junior	_	
200-37	40146-40150	high	_	
200-38	40151-40157	school	_	
200-39	40157-40158	;	_	
200-40	40159-40160	7	_	
200-41	40160-40161	=	_	
200-42	40161-40165	less	_	
200-43	40166-40170	than	_	
200-44	40171-40176	seven	_	
200-45	40177-40182	years	_	
200-46	40183-40185	of	_	
200-47	40186-40195	education	_	
200-48	40195-40196	.	_	

#Text=Tukey post-hoc tests used to assess for differences across groups.
201-1	40197-40202	Tukey	_	
201-2	40203-40211	post-hoc	_	
201-3	40212-40217	tests	_	
201-4	40218-40222	used	_	
201-5	40223-40225	to	_	
201-6	40226-40232	assess	_	
201-7	40233-40236	for	_	
201-8	40237-40248	differences	_	
201-9	40249-40255	across	_	
201-10	40256-40262	groups	_	
201-11	40262-40263	.	_	

#Text=WERCAP - Washington Early Recognition Center Affectivity and Psychosis screen.
202-1	40264-40270	WERCAP	_	
202-2	40271-40272	-	_	
202-3	40273-40283	Washington	_	
202-4	40284-40289	Early	_	
202-5	40290-40301	Recognition	_	
202-6	40302-40308	Center	_	
202-7	40309-40320	Affectivity	_	
202-8	40321-40324	and	_	
202-9	40325-40334	Psychosis	_	
202-10	40335-40341	screen	_	
202-11	40341-40342	.	_	

#Text=SAPS – Scale for the Assessment of Positive Symptoms.
203-1	40343-40347	SAPS	_	
203-2	40348-40349	–	_	
203-3	40350-40355	Scale	_	
203-4	40356-40359	for	_	
203-5	40360-40363	the	_	
203-6	40364-40374	Assessment	_	
203-7	40375-40377	of	_	
203-8	40378-40386	Positive	_	
203-9	40387-40395	Symptoms	_	
203-10	40395-40396	.	_	

#Text=SANS – Scale for the Assessment of Negative Symptoms.
204-1	40397-40401	SANS	_	
204-2	40402-40403	–	_	
204-3	40404-40409	Scale	_	
204-4	40410-40413	for	_	
204-5	40414-40417	the	_	
204-6	40418-40428	Assessment	_	
204-7	40429-40431	of	_	
204-8	40432-40440	Negative	_	
204-9	40441-40449	Symptoms	_	
204-10	40449-40450	.	_	

#Text=Partial correlation results for application of a priori components and de novo component
#Text=Imaging modality\tA priori HCP_gC1_IC3 application\tA priori HCP_gC1_IC7 application\tDe novo IC3\t \tCortical Thickness\tr = 0.133\tr = 0.233*\tr = 0.287*\t \tp = 0.244\tp = 0.040\tp = 0.011\t \tn=80\tn=80\tn=80\t \tResting State Connectivity\tr = 0.016\tr = 0.117†\tr = 0.258*\t \tp = 0.887\tp = 0.308\tp = 0.022\t \tn=80\tn=80\tn=80\t \t2 Back Working memory tfMRI\tr = 0.438**\tr = 0.078\tr = 0.363**\t \tp < 0.000\tp = 0.498\tp = 0.001\t \tn=80\tn=80\tn = 80\t \t
#Text=p<0.05,
#Text=p<0.01.
205-1	40451-40458	Partial	_	
205-2	40459-40470	correlation	_	
205-3	40471-40478	results	_	
205-4	40479-40482	for	_	
205-5	40483-40494	application	_	
205-6	40495-40497	of	_	
205-7	40498-40499	a	_	
205-8	40500-40506	priori	_	
205-9	40507-40517	components	_	
205-10	40518-40521	and	_	
205-11	40522-40524	de	_	
205-12	40525-40529	novo	_	
205-13	40530-40539	component	_	
205-14	40540-40547	Imaging	_	
205-15	40548-40556	modality	_	
205-16	40557-40558	A	_	
205-17	40559-40565	priori	_	
205-18	40566-40573	HCP_gC1	_	
205-19	40573-40574	_	_	
205-20	40574-40577	IC3	_	
205-21	40578-40589	application	_	
205-22	40590-40591	A	_	
205-23	40592-40598	priori	_	
205-24	40599-40606	HCP_gC1	_	
205-25	40606-40607	_	_	
205-26	40607-40610	IC7	_	
205-27	40611-40622	application	_	
205-28	40623-40625	De	_	
205-29	40626-40630	novo	_	
205-30	40631-40634	IC3	_	
205-31	40637-40645	Cortical	_	
205-32	40646-40655	Thickness	_	
205-33	40656-40657	r	_	
205-34	40658-40659	=	_	
205-35	40660-40665	0.133	_	
205-36	40666-40667	r	_	
205-37	40668-40669	=	_	
205-38	40670-40675	0.233	_	
205-39	40675-40676	*	_	
205-40	40677-40678	r	_	
205-41	40679-40680	=	_	
205-42	40681-40686	0.287	_	
205-43	40686-40687	*	_	
205-44	40690-40691	p	_	
205-45	40692-40693	=	_	
205-46	40694-40699	0.244	_	
205-47	40700-40701	p	_	
205-48	40702-40703	=	_	
205-49	40704-40709	0.040	_	
205-50	40710-40711	p	_	
205-51	40712-40713	=	_	
205-52	40714-40719	0.011	_	
205-53	40722-40723	n	_	
205-54	40723-40724	=	_	
205-55	40724-40726	80	_	
205-56	40727-40728	n	_	
205-57	40728-40729	=	_	
205-58	40729-40731	80	_	
205-59	40732-40733	n	_	
205-60	40733-40734	=	_	
205-61	40734-40736	80	_	
205-62	40739-40746	Resting	_	
205-63	40747-40752	State	_	
205-64	40753-40765	Connectivity	_	
205-65	40766-40767	r	_	
205-66	40768-40769	=	_	
205-67	40770-40775	0.016	_	
205-68	40776-40777	r	_	
205-69	40778-40779	=	_	
205-70	40780-40785	0.117	_	
205-71	40785-40786	†	_	
205-72	40787-40788	r	_	
205-73	40789-40790	=	_	
205-74	40791-40796	0.258	_	
205-75	40796-40797	*	_	
205-76	40800-40801	p	_	
205-77	40802-40803	=	_	
205-78	40804-40809	0.887	_	
205-79	40810-40811	p	_	
205-80	40812-40813	=	_	
205-81	40814-40819	0.308	_	
205-82	40820-40821	p	_	
205-83	40822-40823	=	_	
205-84	40824-40829	0.022	_	
205-85	40832-40833	n	_	
205-86	40833-40834	=	_	
205-87	40834-40836	80	_	
205-88	40837-40838	n	_	
205-89	40838-40839	=	_	
205-90	40839-40841	80	_	
205-91	40842-40843	n	_	
205-92	40843-40844	=	_	
205-93	40844-40846	80	_	
205-94	40849-40850	2	_	
205-95	40851-40855	Back	_	
205-96	40856-40863	Working	_	
205-97	40864-40870	memory	_	
205-98	40871-40876	tfMRI	_	
205-99	40877-40878	r	_	
205-100	40879-40880	=	_	
205-101	40881-40886	0.438	_	
205-102	40886-40887	*	_	
205-103	40887-40888	*	_	
205-104	40889-40890	r	_	
205-105	40891-40892	=	_	
205-106	40893-40898	0.078	_	
205-107	40899-40900	r	_	
205-108	40901-40902	=	_	
205-109	40903-40908	0.363	_	
205-110	40908-40909	*	_	
205-111	40909-40910	*	_	
205-112	40913-40914	p	_	
205-113	40915-40916	<	_	
205-114	40917-40922	0.000	_	
205-115	40923-40924	p	_	
205-116	40925-40926	=	_	
205-117	40927-40932	0.498	_	
205-118	40933-40934	p	_	
205-119	40935-40936	=	_	
205-120	40937-40942	0.001	_	
205-121	40945-40946	n	_	
205-122	40946-40947	=	_	
205-123	40947-40949	80	_	
205-124	40950-40951	n	_	
205-125	40951-40952	=	_	
205-126	40952-40954	80	_	
205-127	40955-40956	n	_	
205-128	40957-40958	=	_	
205-129	40959-40961	80	_	
205-130	40965-40966	p	_	
205-131	40966-40967	<	_	
205-132	40967-40971	0.05	_	
205-133	40971-40972	,	_	
205-134	40973-40974	p	_	
205-135	40974-40975	<	_	
205-136	40975-40979	0.01	_	
205-137	40979-40980	.	_	

#Text=All correlations are partial Pearson correlations corrected for group mean differences.
206-1	40981-40984	All	_	
206-2	40985-40997	correlations	_	
206-3	40998-41001	are	_	
206-4	41002-41009	partial	_	
206-5	41010-41017	Pearson	_	
206-6	41018-41030	correlations	_	
206-7	41031-41040	corrected	_	
206-8	41041-41044	for	_	
206-9	41045-41050	group	_	
206-10	41051-41055	mean	_	
206-11	41056-41067	differences	_	
206-12	41067-41068	.	_	

#Text=Resting state connectivity data from HCP_gC1_IC7 were not significantly correlated with cognitive control performance in the normative data (Lerman-Sinkoff, Sui et al. 2017) and thus were not predicted to be significantly predictive of cognitive control in the present dataset.
207-1	41069-41076	Resting	_	
207-2	41077-41082	state	_	
207-3	41083-41095	connectivity	_	
207-4	41096-41100	data	_	
207-5	41101-41105	from	_	
207-6	41106-41113	HCP_gC1	_	
207-7	41113-41114	_	_	
207-8	41114-41117	IC7	_	
207-9	41118-41122	were	_	
207-10	41123-41126	not	_	
207-11	41127-41140	significantly	_	
207-12	41141-41151	correlated	_	
207-13	41152-41156	with	_	
207-14	41157-41166	cognitive	_	
207-15	41167-41174	control	_	
207-16	41175-41186	performance	_	
207-17	41187-41189	in	_	
207-18	41190-41193	the	_	
207-19	41194-41203	normative	_	
207-20	41204-41208	data	_	
207-21	41209-41210	(	_	
207-22	41210-41224	Lerman-Sinkoff	_	
207-23	41224-41225	,	_	
207-24	41226-41229	Sui	_	
207-25	41230-41232	et	_	
207-26	41233-41235	al	_	
207-27	41235-41236	.	_	
207-28	41237-41241	2017	_	
207-29	41241-41242	)	_	
207-30	41243-41246	and	_	
207-31	41247-41251	thus	_	
207-32	41252-41256	were	_	
207-33	41257-41260	not	_	
207-34	41261-41270	predicted	_	
207-35	41271-41273	to	_	
207-36	41274-41276	be	_	
207-37	41277-41290	significantly	_	
207-38	41291-41301	predictive	_	
207-39	41302-41304	of	_	
207-40	41305-41314	cognitive	_	
207-41	41315-41322	control	_	
207-42	41323-41325	in	_	
207-43	41326-41329	the	_	
207-44	41330-41337	present	_	
207-45	41338-41345	dataset	_	
207-46	41345-41346	.	_	

#Text=Correlations for a priori ICs are not FDR corrected as we had strong predictions from our prior work that these modalities would predict cognitive control performance in psychosis. p-values listed for de novo IC3 are the original uncorrected p-values; all three p-values meet the FDR-determined critical p-value of 0.022.
208-1	41347-41359	Correlations	_	
208-2	41360-41363	for	_	
208-3	41364-41365	a	_	
208-4	41366-41372	priori	_	
208-5	41373-41376	ICs	_	
208-6	41377-41380	are	_	
208-7	41381-41384	not	_	
208-8	41385-41388	FDR	_	
208-9	41389-41398	corrected	_	
208-10	41399-41401	as	_	
208-11	41402-41404	we	_	
208-12	41405-41408	had	_	
208-13	41409-41415	strong	_	
208-14	41416-41427	predictions	_	
208-15	41428-41432	from	_	
208-16	41433-41436	our	_	
208-17	41437-41442	prior	_	
208-18	41443-41447	work	_	
208-19	41448-41452	that	_	
208-20	41453-41458	these	_	
208-21	41459-41469	modalities	_	
208-22	41470-41475	would	_	
208-23	41476-41483	predict	_	
208-24	41484-41493	cognitive	_	
208-25	41494-41501	control	_	
208-26	41502-41513	performance	_	
208-27	41514-41516	in	_	
208-28	41517-41526	psychosis	_	
208-29	41526-41527	.	_	
208-30	41528-41536	p-values	_	
208-31	41537-41543	listed	_	
208-32	41544-41547	for	_	
208-33	41548-41550	de	_	
208-34	41551-41555	novo	_	
208-35	41556-41559	IC3	_	
208-36	41560-41563	are	_	
208-37	41564-41567	the	_	
208-38	41568-41576	original	_	
208-39	41577-41588	uncorrected	_	
208-40	41589-41597	p-values	_	
208-41	41597-41598	;	_	
208-42	41599-41602	all	_	
208-43	41603-41608	three	_	
208-44	41609-41617	p-values	_	
208-45	41618-41622	meet	_	
208-46	41623-41626	the	_	
208-47	41627-41641	FDR-determined	_	
208-48	41642-41650	critical	_	
208-49	41651-41658	p-value	_	
208-50	41659-41661	of	_	
208-51	41662-41667	0.022	_	
208-52	41667-41668	.	_	

#Text=IC3 group-discrimination MANOVA results
#Text=\tItem\tValue\tTest Statistic\tp-values\tPartial η2\t \tOmnibus tests\tPillai’s Trace\t0.219\tF(6,154)=3.15\tp=0.006\t0.109\t \tWilk’s Lambda\t0.78\tF(6,152)=3.21\tp=0.005\t0.113\t \t\t\t\t\t\t\t \tBetween Subjects Effects\tsMRI\tn/a\tF(2,78)=2.52\tp=0.087\t0.047\t \trsfcMRI\tn/a\tF(2,78)=1.91\tp=0.156\t0.061\t \ttfMRI\tn/a\tF(2,78)=4.59\tp=0.013\t0.105\t \t\t\t\t\t\t\t \tPost-hoc tests\tItem\tMean Difference\tStandard Error\tp-values\t\t \tsMRI: HC - BP\t0.001\t0.018\tp=0.936\t\t \tsMRI: HC - SZ\t0.038\t0.018\tp=0.044\t\t \tsMRI: BP - SZ\t0.036\t0.019\tp=0.060\t\t \trsfcMRI: HC - BP\t−0.008\t0.019\tp=0.679\t\t \trsfcMRI: HC - SZ\t0.030\t0.020\tp=0.132\t\t \trsfcMRI: BP - SZ\t0.038\t0.020\tp=0.066\t\t \ttfMRI: HC - BP\t0.025\t0.022\tp=0.255\t\t \ttfMRI: HC - SZ\t0.070\t0.023\tp=0.003\t\t \ttfMRI: BP - SZ\t0.045\t0.024\tp=0.066
209-1	41669-41672	IC3	_	
209-2	41673-41693	group-discrimination	_	
209-3	41694-41700	MANOVA	_	
209-4	41701-41708	results	_	
209-5	41710-41714	Item	_	
209-6	41715-41720	Value	_	
209-7	41721-41725	Test	_	
209-8	41726-41735	Statistic	_	
209-9	41736-41744	p-values	_	
209-10	41745-41752	Partial	_	
209-11	41753-41755	η2	_	
209-12	41758-41765	Omnibus	_	
209-13	41766-41771	tests	_	
209-14	41772-41778	Pillai	_	
209-15	41778-41779	’	_	
209-16	41779-41780	s	_	
209-17	41781-41786	Trace	_	
209-18	41787-41792	0.219	_	
209-19	41793-41794	F	_	
209-20	41794-41795	(	_	
209-21	41795-41800	6,154	_	
209-22	41800-41801	)	_	
209-23	41801-41802	=	_	
209-24	41802-41806	3.15	_	
209-25	41807-41808	p	_	
209-26	41808-41809	=	_	
209-27	41809-41814	0.006	_	
209-28	41815-41820	0.109	_	
209-29	41823-41827	Wilk	_	
209-30	41827-41828	’	_	
209-31	41828-41829	s	_	
209-32	41830-41836	Lambda	_	
209-33	41837-41841	0.78	_	
209-34	41842-41843	F	_	
209-35	41843-41844	(	_	
209-36	41844-41849	6,152	_	
209-37	41849-41850	)	_	
209-38	41850-41851	=	_	
209-39	41851-41855	3.21	_	
209-40	41856-41857	p	_	
209-41	41857-41858	=	_	
209-42	41858-41863	0.005	_	
209-43	41864-41869	0.113	_	
209-44	41880-41887	Between	_	
209-45	41888-41896	Subjects	_	
209-46	41897-41904	Effects	_	
209-47	41905-41909	sMRI	_	
209-48	41910-41911	n	_	
209-49	41911-41912	/	_	
209-50	41912-41913	a	_	
209-51	41914-41915	F	_	
209-52	41915-41916	(	_	
209-53	41916-41920	2,78	_	
209-54	41920-41921	)	_	
209-55	41921-41922	=	_	
209-56	41922-41926	2.52	_	
209-57	41927-41928	p	_	
209-58	41928-41929	=	_	
209-59	41929-41934	0.087	_	
209-60	41935-41940	0.047	_	
209-61	41943-41950	rsfcMRI	_	
209-62	41951-41952	n	_	
209-63	41952-41953	/	_	
209-64	41953-41954	a	_	
209-65	41955-41956	F	_	
209-66	41956-41957	(	_	
209-67	41957-41961	2,78	_	
209-68	41961-41962	)	_	
209-69	41962-41963	=	_	
209-70	41963-41967	1.91	_	
209-71	41968-41969	p	_	
209-72	41969-41970	=	_	
209-73	41970-41975	0.156	_	
209-74	41976-41981	0.061	_	
209-75	41984-41989	tfMRI	_	
209-76	41990-41991	n	_	
209-77	41991-41992	/	_	
209-78	41992-41993	a	_	
209-79	41994-41995	F	_	
209-80	41995-41996	(	_	
209-81	41996-42000	2,78	_	
209-82	42000-42001	)	_	
209-83	42001-42002	=	_	
209-84	42002-42006	4.59	_	
209-85	42007-42008	p	_	
209-86	42008-42009	=	_	
209-87	42009-42014	0.013	_	
209-88	42015-42020	0.105	_	
209-89	42031-42039	Post-hoc	_	
209-90	42040-42045	tests	_	
209-91	42046-42050	Item	_	
209-92	42051-42055	Mean	_	
209-93	42056-42066	Difference	_	
209-94	42067-42075	Standard	_	
209-95	42076-42081	Error	_	
209-96	42082-42090	p-values	_	
209-97	42094-42098	sMRI	_	
209-98	42098-42099	:	_	
209-99	42100-42102	HC	_	
209-100	42103-42104	-	_	
209-101	42105-42107	BP	_	
209-102	42108-42113	0.001	_	
209-103	42114-42119	0.018	_	
209-104	42120-42121	p	_	
209-105	42121-42122	=	_	
209-106	42122-42127	0.936	_	
209-107	42131-42135	sMRI	_	
209-108	42135-42136	:	_	
209-109	42137-42139	HC	_	
209-110	42140-42141	-	_	
209-111	42142-42144	SZ	_	
209-112	42145-42150	0.038	_	
209-113	42151-42156	0.018	_	
209-114	42157-42158	p	_	
209-115	42158-42159	=	_	
209-116	42159-42164	0.044	_	
209-117	42168-42172	sMRI	_	
209-118	42172-42173	:	_	
209-119	42174-42176	BP	_	
209-120	42177-42178	-	_	
209-121	42179-42181	SZ	_	
209-122	42182-42187	0.036	_	
209-123	42188-42193	0.019	_	
209-124	42194-42195	p	_	
209-125	42195-42196	=	_	
209-126	42196-42201	0.060	_	
209-127	42205-42212	rsfcMRI	_	
209-128	42212-42213	:	_	
209-129	42214-42216	HC	_	
209-130	42217-42218	-	_	
209-131	42219-42221	BP	_	
209-132	42222-42223	−	_	
209-133	42223-42228	0.008	_	
209-134	42229-42234	0.019	_	
209-135	42235-42236	p	_	
209-136	42236-42237	=	_	
209-137	42237-42242	0.679	_	
209-138	42246-42253	rsfcMRI	_	
209-139	42253-42254	:	_	
209-140	42255-42257	HC	_	
209-141	42258-42259	-	_	
209-142	42260-42262	SZ	_	
209-143	42263-42268	0.030	_	
209-144	42269-42274	0.020	_	
209-145	42275-42276	p	_	
209-146	42276-42277	=	_	
209-147	42277-42282	0.132	_	
209-148	42286-42293	rsfcMRI	_	
209-149	42293-42294	:	_	
209-150	42295-42297	BP	_	
209-151	42298-42299	-	_	
209-152	42300-42302	SZ	_	
209-153	42303-42308	0.038	_	
209-154	42309-42314	0.020	_	
209-155	42315-42316	p	_	
209-156	42316-42317	=	_	
209-157	42317-42322	0.066	_	
209-158	42326-42331	tfMRI	_	
209-159	42331-42332	:	_	
209-160	42333-42335	HC	_	
209-161	42336-42337	-	_	
209-162	42338-42340	BP	_	
209-163	42341-42346	0.025	_	
209-164	42347-42352	0.022	_	
209-165	42353-42354	p	_	
209-166	42354-42355	=	_	
209-167	42355-42360	0.255	_	
209-168	42364-42369	tfMRI	_	
209-169	42369-42370	:	_	
209-170	42371-42373	HC	_	
209-171	42374-42375	-	_	
209-172	42376-42378	SZ	_	
209-173	42379-42384	0.070	_	
209-174	42385-42390	0.023	_	
209-175	42391-42392	p	_	
209-176	42392-42393	=	_	
209-177	42393-42398	0.003	_	
209-178	42402-42407	tfMRI	_	
209-179	42407-42408	:	_	
209-180	42409-42411	BP	_	
209-181	42412-42413	-	_	
209-182	42414-42416	SZ	_	
209-183	42417-42422	0.045	_	
209-184	42423-42428	0.024	_	
209-185	42429-42430	p	_	
209-186	42430-42431	=	_	
209-187	42431-42436	0.066	_	
